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Vector-borne diseases (VBDs) are human illnesses that are transmitted by 
vectors such as ticks, mosquitoes, and fleas. These arthropods transmit infectious 
pathogens such as viruses, protozoa, and bacteria, to humans during their blood-
feeding. According to the estimation of the WHO, billions of people are affected by 
VBDs worldwide, and about 700,000 deaths are reported annually. Currently, very few 
reliable VBDs control approaches and vaccines available to treat various VBDs. 
Additionally, approaches to control arthropod’ proliferation and migration are difficult to 
develop. Furthermore, molecular determinants and mechanisms for the transmission 
are poorly understood. This work describes two studies identifying the novel role for 
exosomes in facilitating transmission of viral infectious material and viral infections.  
The first study focused on tick-borne pathogen transmission via exosomes 
derived from several different cell types. The conclusions suggested that exosomes 
could protect full-length viral RNA genomes, and viral proteins from host immune 
surveillance. The results showed the exosomes assistance in the transmission of viral 
materials from infected cells to naïve cells leading to active viral replication in the 
recipient cells. The exosomal viral materials were highly infectious and replicative in 
   
 
recipient cells. However, treatment with GW4869, a commercial inhibitor for neutral 
Sphingomyelinases that mediated-exosome formation and release, resulted in reduced 
viral transmission via exosomes and affected the viral replication in recipient cells. 
These findings suggested a novel and promising therapeutic approach to block 
exosome-mediated viral transmission from arthropods to humans. 
The second study demonstrated mosquito-borne arboviruses used exosomes for 
dissemination and infection of recipient vertebrate host cells as well. Results showed 
that ZIKV uses exosomes as mediators of viral transmission, and readily infected these 
neuronal cells. Neuronal exosomes enclosed both ZIKV viral RNA and proteins inside. 
Furthermore, the results addressed ZIKV induced both activity and gene expression of 
neutral Sphingomyelinase (nSMase)-2/SMPD3, a critical molecule regulates the 
formation and release of exosomes. The silencing of SMPD3 in neuronal cells resulted 
in decreased viral burden and dissemination via exosomes. Overall, this research 
elucidated that ZIKV mediated SMPD3 activity in cortical neurons for its infection and 
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INTRODUCTION AND BACKGROUND 
 
1.1 VECTOR-BORNE DISEASES 
Vector-borne diseases (VBDs) are human illnesses that are transmitted by arthropods 
such as ticks, mosquitoes, fleas, sandflies, lice, and tsetse flies that are carrying 
viruses, bacteria, and parasites (Feinleib, 2001; Roberts and Janovy, 2009). Many 
deadliest VBDs such as malaria, dengue, yellow fever, Japanese encephalitis cause 
almost one million deaths annually. According to WHO 2019 reports, in over 128 
countries, more than 3.9 billion people are at the risk of dengue infection (WHO, 2019). 
Malaria causes more than half a million deaths per year all over the world. VBDs 
account for more than 17% of all known infectious diseases’ cases (WHO, 2019). VBDs 
distribution is determined by various factors such as environmental and social factors, 
global travel and trade, lacking medical knowledge in developing counties, complex 
demography and poverty, and mutations in pathogens caused by climate change and 
human activities (Feinleib, 2001; Roberts and Janovy, 2009). All these factors contribute 
to an unstable, uncertain situation to control, prevent, and estimate VBDs. Additionally, 
pathogen transmission is hard and complicated to predict. Many people die annually 
due to vector-borne diseases all over the world (WHO, 2004) (Figure 1). 
 
Vectors 
A vector is defined as an agent that carries and disseminates infectious pathogens to 
another living organism. Arthropods such as mosquitoes, ticks, flies, fleas, and mites 
are the major group of vectors for pathogens (Patz et al., 1996; Schmidt et al., 2013) 
These vectors can transmit specific pathogens to other hosts, especially humans by 
biting and blood-feeding. Vectors can transmit infectious pathogens to the host by 
releasing their infectious saliva, feces, and directly poking into host bloodstream (Patz 
et al., 1996; Schmidt et al., 2013). The most well-known vectors are ticks and 
mosquitoes that can carry dangerous pathogens such as Plasmodium falciparum, 
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DENV, ZIKV (mosquitoes), and POWV, TBEV, and Borrelia (ticks). Figure 2 shows the 
major vectors and their specific pathogens. These vectors have several life stages; for 
example, ticks have four morphological stages, egg, larva, nymph and adult (Stanek et 
al., 1986); Mosquitoes have four life stages as well, egg, larva, pupa, and adult (Crans, 
2004). Ticks need blood meals to develop to the next life cycle stage. However, adult 




Figure 1. Deaths from Vector-Borne Disease 
The image showed the distribution of deaths from VBDs all over the world. Africa, southeast and 
southwest Asia and south America indicate more burden of deaths caused by VBDs. The image was 
adapted from “Malaria control: the power of integrated action”, a report of The Health and Environment 




There are more than 850 ticks’ existing that are divided into two broad groups: hard 
ticks and soft ticks (Arthur, 1962; Jongejan and Uilenberg, 2004; Sonenshine and Roe, 
2013). In the United States, there are several main ticks that transmit several pathogens 
3  
 
to humans. Ixodes scapularis, also referred to as black-legged ticks, are distributed 
across the Eastern United States (CDC, 2019). They transmit Borrelia burgdorferi and 
B. mayonii that cause Lyme disease, Anaplasma phagocytophilum, the agent of human 
granulocytic anaplasmosis, POWV and TBEV that cause Powassan virus disease and 
encephalitis. Amblyomma americanum, also known as lone star ticks, are widely 
distributed in the southeastern United States. These ticks transmit Ehrlichia chaffeensis, 
the agent of human ehrlichiosis, Heartland virus, the agent of Heartland virus disease, 




Figure 2. Main Vectors and Vector-Borne Diseases 
Some of the important vector-borne diseases and vectors were shown. Ticks and mosquitoes are the 
most common vectors that can transmit several pathogens, causing lethal diseases in humans. The 
information shown in this figure was collected from the WHO’s website on main vectors and vector-borne 
diseases (https://www.who.int/news-room/fact sheets/detail/vector-borne-diseases).  
 
 
variabilis, also called American dog ticks, are distributed east of the Rocky Mountains. 
These ticks transmit Rickettsia rickettsia, the agent of Rocky Mountain spotted fever. 
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Other common ticks’ species like Rhipicephalus sanguineus, Ixodes cookie, 
Amblyomma maculatum, Dermacentor andersoni, and Ixodes pacificus are widely 
distributed in the United States as well (Arthur, 1962; Jongejan and Uilenberg, 2004; 
Sonenshine and Roe, 2013). 
 
Mosquitoes 
There are 3,500 species mosquitoes living on earth, and morphologically, they consist 
of a slender segmented body, one pair of wings, three pairs of long legs, and an 
elongated mouthpart (Bates, 1949; Clements, 1992; Becker et al., 2010). The four life 
cycle stages in mosquitoes are egg, larva, pupa, and adult. Upon a blood meal, female 
mosquitos’ mate and lay eggs on the water surface. The eggs hatch into larva that can 
feed on aquatic algae or organic material and molt into a pupa. Adult mosquitoes 
emerge from the pupa. Female mosquitoes feed on blood in need of protein and iron to 
produce eggs. Female mosquitoes take blood meals by poking through host skin using 
their tube-like mouthparts. Mosquitoes can feed on various vertebrate hosts such as 
mammals, birds, and amphibians but sometimes on fish, which is an invertebrate. 
Mosquitoes spit saliva onto the host during the bite and blood-feeding (Bates, 1949; 
Clements, 1992; Becker et al., 2010). If an infected mosquito took a blood meal, the 
infectious organism is disseminated through mosquito’s saliva to host blood, resulting in 
the infection in the host. That is the reason why mosquitoes are considered as a most 
dangerous disease-causing vector. Several VBDs are transmitted by mosquitoes, 
including P.falciparum, yellow fever, Chikungunya, Zika, Dengue and West Nile 
disease. Annually, many people die from mosquito-borne disease infection. Several 
well-known mosquito species that are also primary pathogen vectors are introduced 
below. 
Aedes aegypti is the primary vector that transmits several tropical fevers causing 
pathogens, including Dengue fever, Zika fever, yellow fever, and Chikungunya fever 
(Black IV et al., 2002; Nene et al., 2007). These mosquitoes originated from Africa. 
They can be recognized by white markings on their legs and they are distributed in 
tropical, subtropical, and temperate regions throughout the world. Aedes 
aegypti mosquitoes prefer to feed at dusk and dawn time, indoors and shady areas, or 
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on a cloudy day. For seeking a blood meal, Aedes aegypti can detect and attracted to 
chemical compounds such as ammonia, lactic acid, and carbon dioxide that are emitted 
by mammals (Bates, 1949; Clements, 1992; Becker et al., 2010). 
Another well-known mosquito species is Aedes albopictus, also known as tiger 
mosquito (striking white and black pattern) or forest mosquito that is native to the 
tropical and subtropical areas of Southeast Asia. This kind of mosquitoes is about 2 to 
10 mm length, and male is 20% smaller than female. Adults mosquitoes vary in size and 
this depends on several optimal conditions including the density of larval population, 
food supply, the environment near breeding water, their predators, and local climate. 
Recently, this species has spread to many other countries and areas through the 
transport of goods and travels. They fly and feed in day-time but sometimes at dusk and 
dawn as well. Since this species is more closely associated with humans, it has become 
a significant pest in human communities. Epidemiologically, Aedes albopictus is an 
important pathogen vector as well since it can transmit many infectious organisms that 
cause yellow fever, dengue fever, Chikungunya fever and, Wolbachia infection. In 
addition, this vector is capable of hosting and transmitting  Zika virus to humans (Black 
IV et al., 2002; Nene et al., 2007).  
Culex, also called house mosquito, is the most common type in the United 
States. This group includes Culex Pipiens and Culex restuans Theobald. This pale 
brown with white stripes mosquito is usually found near remaining polluted water or 
leftover water such as a birdbath, pet dishes, and storm drains. The female mosquito 
can lay about 400 eggs, and it typically takes 10 to 14 days to hatch or longer 
depending on the weather. Culex can also transmit a variety of viruses and parasites to 
humans (Nasci et al., 2001). Additionally, Culex quinquefasciatus, also called southern 
mosquito, is another mosquito that shares similar physical and behavioral characters 
with Culex. They are mid-night feeders and the primary vector of the St. Louis 
encephalitis virus and West Nile virus (Nasci et al., 2001). 
 
Vector Control 
Vector control is a significant approach for controlling some specific pathogens or the 
only way for protecting humans from several deadly infectious organisms such as ZIKV, 
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DENV, and WNV that, by far, there is no effective cure. It is a method to limit or 
eradicate vectors that transmit pathogens to humans and animals. Several methods 
have been used that show effectiveness in this approach; These methods are divided 
into four approaches, habitat and environment control, reducing contact, chemical 
control and biological control (Organization, 2006, 2012; Golding et al., 2015). Habitat 
and environment control mean reducing or removing the habitats or potential breeding 
areas of vectors, for example, removing polluted water or rubbish area that can breed 
mosquitoes and mowing grass for reducing tick bite. These can reduce the opportunity 
for mosquitoes and ticks spreading diseases to humans via saliva and feces. Reducing 
contact means decreasing chances for exposure to infectious vectors, subsequently 
affecting pathogen transmission. For example, it could be done by installing bed nets, 
window screens, or wear more protective clothing. All these can significantly reduce the 
contact with infectious vectors. Insecticides, larvicides, repellents, rodenticides and 
lethal ovitraps have been used for chemical control (Organization, 2006, 2012; Golding 
et al., 2015).  Application of insecticides to walls and bed nets, spraying repellents on 
human skin, treating leftover water where larvae may breed with larvicides, and 
pesticides for vectors have been promoted and proved by the WHO to be highly 
effective. The last approach is biological control, which means the use of vector 
predators, such as introducing fishes that eat mosquito larvae, using bacterial toxins or 
botanical compounds to kill vectors. This approach has been proved significantly 
reducing the risks of vector-borne disease infection. Recently, a new pest control 
method has been developed that could effectively reduce the infection of mosquito-
borne diseases (Organization, 2006, 2012; Golding et al., 2015). This method is called 
the sterile insect technique (SIT) (Vreysen et al., 2000). This is an environmentally 
friendly insect pest control method that involves radiation on a target pest, breeding in a 
mass-rearing and sterilization, followed by releasing the sterile males by air over 
defined area systematically and widely. SIT-engineering males mate with females 
resulting in no production of offspring and a reduction of the pest population. This 
technology has many advantages. The sterile insects are not self-replicating, so they 
can’t be established in nature, and the SIT doesn’t introduce any invading species into 
the local ecosystem which makes this method safe and friendly to the environment 
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(Vreysen et al., 2000). Furthermore, after using this technique, a significant reduction in 
crop and livestock production loss has been observed. This method is different from the 
classical vector control and has been proved to be efficient and successful in the past 
60 years that was applied in six continents. This technique also has some 
disadvantages, such as a) radiation, transport and treatment of releasing insects can 
reduce male mating efficiency and, b) breeding sterile insect generation from mass-
rearing and irradiation require very careful process to avoid releasing unexpected sterile 
insects. In addition, gender separation is hard, and it is uncertain whether the sterile 
male is competitive to wild-type males. In general, SIT is economically and 
environmentally beneficial in many regions all over the world on saving billions of dollars 
annually (Vreysen et al., 2000). 
However, although these approaches have been proved to be effective to some 
extent, the high cost for these treatments make it very difficult for developing countries 
to proceed with these measures. Less developed countries may have more zones to 
treat due to poverty, lack of knowledge and education in the population, and awareness 
of vector-borne diseases and information on effective treatment.  Infectious vectors 
transported from these areas to the other parts of the world via the transport of goods 
and international travel are hard to be controlled. This may also impact the vector 
control measures in developed areas. 
 
1.2 EXOSOMES 
Exosomes are small membranous extracellular microvesicles with the size ranging from 
30 nm to 250 nm, which are of endocytic origin formed in the late endosomal 
compartments (as multivesicular bodies; MVBs) (Mellman, 1996; Fevrier and Raposo, 
2004; Couzin, 2005; Keller et al., 2006; Raposo and Stoorvogel, 2013). Exosomes are 
produced from most eukaryotic cells. They have biological lipid bilayer membrane 
structure that gained from cells by exocytosis into a biological fluid such as blood, urine, 
saliva, and cerebrospinal fluid. Initially, exosomes were considered as garbage bins to 
discard unwanted cellular components. However, other studies showed that exosomes 
are mere cell debris, apoptotic blebs, and signs of cell death (Mellman, 1996; Keller et 
al., 2006; Raposo and Stoorvogel, 2013). Recent studies have suggested that 
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exosomes could play significant roles for the intercellular communication process and 
are therapeutic targets for neurological disorders, cancer, and autoimmune diseases. 
Exosomes derived from several different cells have been shown to function as signaling 
related vesicles, transporting cell-specific collections of several proteins such as 
cytoskeletal protein (actin, myosin, and tubulin), heat shock proteins (HSPs), cytokines 
and tetraspanin domain containing family proteins, lipids, and nucleic acids such as 
DNA, RNA and microRNA (Thery et al., 2002; Alvarez et al., 2012; Xiao et al., 2012; 
Schageman et al., 2013; Villarroya-Beltri et al., 2014; Schey et al., 2015). Due to the 
presence of lipid bilayer membrane structure, exosomes derived from one cell can 
easily merge with other cells through the circulatory system and exchange contents 
from the inside or luminal part of exosomes. Exosomes can transfer messages over 
longer distances for e.g., between different tissues or multiple organs (Fevrier and 
Raposo, 2004; Ohno et al., 2013; Zhang et al., 2015; Ding et al., 2018). Recently, our 
studies have shown that exosomes serve as modes of arthropod-borne flavivirus’ 
transmission from ticks and mosquitoes to humans and disseminate viral RNA and 
proteins among different types of cells (Zhou et al., 2018a). 
Due to their small size and instability under normal laboratory conditions, 
exosome isolation needs to strictly follow ultracentrifugation protocol under cold 
temperature, which has been standardized by expert exosome researchers. After 
isolation, exosome samples should be processed for Western blots and probing for 
exosomal biomarkers such as CD9, CD63, CD81, HSP 70, Flotillin, and Alix (Keller et 
al., 2007; Baietti et al., 2012; Lin et al., 2015), followed by Micro scoping detection (TEM 
and Cryo-EM are recommended). Figure 3 shows the Cryo-EM image of exosomes 
derived from murine cortical neurons. 
Studies have also shown that exosomes are vesicles of transmission for a variety 
of microorganisms and some pathogens use exosomes to manipulate local 
microenvironments (Bobrie et al., 2011; Dreux et al., 2012; Ohno et al., 2013). As an 
example, malaria parasites, Plasmodium falciparum, use exosomes for communication 
between infected red blood cells (Regev-Rudzki et al., 2013). Hepatitis C virus (HCV), 
an enveloped RNA virus, associates with exosomes isolated from cell culture 










1.3 LANGAT VIRUS (LGTV) 
Langat virus (LGTV, strain TP-21) was first isolated in Malaysia and Thailand in 1955 
from Ixodes granulatus ticks from the forest. It is considered as a model pathogen 
closely related to tick-borne encephalitis virus (TBEV) and is used as a biosafety level 2 
(BSL2) pathogen to study pathogenesis of TBEV (Mellman, 1996; Labuda and 
Randolph, 1999; Nuttall and Labuda, 2003b), due to its 74% similarity in its genome 
with TBEV. LGTV is about 50 nm particle, belongs to the Flaviviridae family, with 11 Kb 
positive-sense single-stranded RNA genome (Smith, 1956; Gritsun et al., 2003; 
Rumyantsev et al., 2006). Ixodes ticks transmit several other flaviviruses, including 
Powassan virus (POWV), tick-borne encephalitis virus (TBEV), and Louping ill virus 
(LIV).  
Figure 3. Cryo-EM Image Shows Exosomes from Murine Cortical Neuronal Cells 
The image showed exosomes in a variety of sizes with a bilayer membrane structure. Cortical 
neuronal cells were isolated from pregnant C57BL/6 female mice E16 days embryo. Exosomes were 
isolated by ultracentrifugation from supernatant collected from 5 days cortical neuronal cell culture. 




In nature, LGTV can infect rodents but not humans, although it shares more than 
74% nucleotides similarity with TBEV (Smith, 1956; Gritsun et al., 2003; Rumyantsev et 
al., 2006). Under laboratory conditions, LGTV is barely virulent for adult mice and 
primates. Till now, there is no good evidence showing LGTV causing any disease in 
humans. However, antibodies against LGTV can be detectable in the sera of local 
people in the Malaysian region. Compare to TBEV, LGTV is non-virulent to humans. 
LGTV induces antibodies in humans and has significant homology in its genome with 
TBEV. All these features suggest LGTV could be an ideal candidate for developing a 
vaccine against TBEV (Shapoval et al., 1989). LGTV has been widely used in many 
research laboratories as a substitute for TBEV. 
 
1.4 ZIKA VIRUS (ZIKV) 
Zika virus is a mosquito-borne positive-sense single-stranded RNA Flavivirus 
transmitted by Aedes mosquitoes, basically A. aegypti and A. albopictus (Wang et al., 
2017a). People first isolated this virus from a forest of Uganda in Africa called “Zika” in 
1947, and that is where the virus name came from (Russo and Beltrao-Braga, 2017; 
van den Pol et al., 2017b; Wang et al., 2017a). It is highly like its other members of the 
Flavivirus family such as Dengue virus (DENV), West Nile virus (WNV), Yellow Fever 
virus (YFV), and Japanese Encephalitis virus (JEV). Zika virus’ 10 kilobases genome 
encodes three structural proteins and seven non-structural proteins, making a 40-50 nm 
virion. Originally it was endemic in Africa and Asia; however, it has spread out to the 
Americas, leading to the Zika virus outbreak in 2015 to 2016 (Brasil et al., 2016; 
Schuler-Faccini, 2016). Aedes mosquitoes release saliva and feces on our skin when 
they are biting and feeding for blood meals. The direct contact with infected mosquito 
saliva and feces will transmit the virus to keratinocytes at the wound site. Then this 
blood-borne virus will spread through the cell to cell transmission and via the circulatory 
system through bloodstream (Brasil et al., 2016; Schuler-Faccini, 2016). Zika virus 
infects the placental cells after it crosses the placental barrier (Campos et al., 2015; 
Musso et al., 2015).  
Most infected people don’t develop strong symptoms, but some will show up 
symptoms such as red eyes, headache, rash, joint pain, muscle pain and fever which 
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are shown in Figure 4. ZIKV infection has been shown to affect both the Central 
Nervous System (CNS) and the Peripheral Nervous System (PNS) and is associated 
with severe neurological complications. In some immoral scenarios, it will result in 
severe Guillain-Barre Syndrome (GBS) but eventually, people will recover back (Faizan 
et al., 2016; Oh et al., 2017b; Russo and Beltrao-Braga, 2017; van den Pol et al., 
2017b; Wang et al., 2017a). However, the significant reason that people become 
panicked from the Zika virus is that pregnant women are highly vulnerable to the 









Figure 4. Human Zika Virus Infection Symptoms 
The image showed several symptoms on different parts of the human body after ZIKV infection. The 





fetus, killing the primary stem cells of fetal brains, resulting in the smaller size of heads 
termed as microcephaly.  Microcephaly, a less studied neurodevelopmental disorder is 
a marked reduction in brain size and intellectual disability with defective cell proliferation 
and severe death of cortical progenitor cells and their neuronal progeny. Because of the 
severity of microcephaly, babies will suffer different problems due to underdeveloped 
brains. These problems include intellectual disability, problems with movement, and 
balance, difficulties with talking, sitting and walking, hearing loss and vision problems. 
Undoubtedly, all these make Zika virus infection as a disaster to mothers and families. 
Due to its harmfulness to humans, research on the Zika virus is significantly important 




Figure 5. World Map of Areas with Risk of Zika  
The image showed areas with a risk of ZIKV infection. Americas, Southeast and Southwest Asia and 
some regions in Africa are under high risk of ZIKV infection. The image was adapted from the CDC’s 




1.5 SPHINGOMYELIN PHOSPHODIESTERASE 3 (SMPD3) 
Neutral sphingomyelinase, also known as sphingomyelin phosphodiesterase or SMase, 
is a hydrolase enzyme that is involved in sphingolipid metabolism reaction (Aslan et al., 
2014a; Aslan et al., 2014b; Albi et al., 2019). It belongs to DNase I family and its 
function is to break down sphingomyelin lipid into phosphocholine and ceramide, which 
is the major pathway for ceramides responding to cellular stress. SMases are divided 
into five types: Lysosomal acid SMase, Secreted zinc-dependent acid SMase, 
Magnesium-independent neutral SMase, Magnesium-dependent neutral SMase and 
Alkaline SMase (Jung et al., 2000; Hannun and Obeid, 2002; Ago et al., 2006). They 
are divided into different families according to their cation dependence and pH optima of 
actin. The lysosomal acidic SMase and the magnesium-dependent neutral SMase are 
considered as major candidates for producing ceramide and dealing with cell stress 
(Jung et al., 2000; Hannun and Obeid, 2002; Ago et al., 2006).  
Sphingomyelin Phosphodiesterase 3 (SMPD3), also called Neutral 
Sphingomyelinase II or nSMase II is a key enzyme for catalyzing the hydrolysis of 
sphingomyelin to form ceramide and phosphocholine (Miyauchi et al., 2017). Ceramide 
can mediate lots of cellular functions such as apoptosis, growth arrest, cellular stress 
responses and exosome-mediated intercellular communication. SMPD3 is a protein-
coding gene that is associated with some diseases such as Deafness, Autosomal 
Recessive and Gaucher Disease, Type III and it is involved in Sphingolipid metabolism 













EXOSOMES SERVE AS NOVEL MODES OF TICK-BORNE FLAVIVIRUS 
TRANSMISSION FROM ARTHROPOD TO HUMAN CELLS AND 
FACILITATES DISSEMINATION OF VIRAL RNA AND PROTEINS TO 




Recently, the function of exosomes has been emphasized in significant medical and 
clinical research on cancer and autoimmune diseases and they are now considered as 
novel therapeutic targets for neurological disorders such as Parkinson's disease 
(Kooijmans et al., 2012; Pant et al., 2012; Vader et al., 2014). Over the past decade, 
exosomes have been given potential biological significance by identifying a variety of 
their specific roles (Keller et al., 2006; Pant et al., 2012; Raposo and Stoorvogel, 2013; 
Apte-Sengupta et al., 2014). Exosomes are released into circulation after their fusion 
with the plasma membrane and these vesicles would serve as mediators of molecular 
transmission (Keller et al., 2006; Thery et al., 2006; Bobrie et al., 2011; Colombo et al., 
2014). Recent conclusions of HCV transmission through hepatic exosomes establish 
infection provides new perception into hepatitis drug development (Greenhill, 2013; 
Cosset and Dreux, 2014). Exosomes also charge in the transfer of immuno-stimulatory 
viral RNA from HCV-infected cells to co-cultured plasmacytoid dendritic cells (Dreux et 
al., 2012). Besides, exosomes speed up the receptor-independent transmission of 
replication-competent HCV viral RNA that was discovered to be in complex with Ago2-
miR122- HSP90 in HCV-infected individuals or infected hepatocytes (Bukong et al., 
2014). Interestingly, exosomes have been shown to perform dual roles in the 
 
The content of this chapter is reprinted with permissions from Zhou, W., Woodson, M., Neupane, B., Bai, 
F., Sherman, M.B., Choi, K.H., Neelakanta, G., and Sultana, H., 2018. Exosomes serve as novel modes 
of tick-borne flavivirus transmission from arthropod to human cells and facilitates dissemination of viral 
RNA and proteins to the vertebrate neuronal cells. PLoS Pathog 14 (1): e1006764. Copyright 2018. 
PLOS journals. The manuscript can be found online at https://doi.org/10.1371/journal. ppat.1006764 
(Creative Commons CC-BY-ND per PLOS journals) 
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transmission of Hepatitis A virus (HAV) and HCV, thereby evading antibody-mediated 
immune responses (Longatti, 2015). Several studies have suggested exosomes as 
important mediators in HIV-1 pathogenesis (Arenaccio et al., 2014; Madison and 
Okeoma, 2015). Exosome secreted HIV Nef protein has been proved to trigger 
apoptosis in CD4 + T cells; also, the Gag p17 coding RNA is also marked to the 
exosomes (Lenassi et al., 2010; Columba Cabezas and Federico, 2013). HIV-infected 
cell-derived exosomes have been revealed to contain the TAR (Trans-Activation 
Response Element) miRNA that facilitates the production of pro-inflammatory cytokines 
(Narayanan et al., 2013; Sampey et al., 2016). Moreover, a recent but very highlighting 
study showed that uninfected cell-derived exosome activates the transcription of HIV-1 
in the latent stage (Barclay et al., 2017).  
Ixodes ticks transmit several viruses belonging to the family Flaviviridae such as 
tick-borne encephalitis virus (TBEV), Powassan virus (POWV) and Langat virus (LGTV) 
(Randolph et al., 1996; Labuda et al., 1996; Labuda and Randolph, 1999; Nuttall and 
Labuda, 2003a). LGTV is considered as a model biosafety level 2 (BSL2) pathogen to 
study the pathogenesis of TBEV, due to their significant genome homology with the 
later virus. Transmission modes of these arthropod-borne flaviviruses (with positive-
sense single-stranded RNA) are still poorly understood (Liu et al., 2014). For the first 
time, it was noted that arthropod exosomes facilitate the transmission of flavivirus RNA 
and proteins from tick to human cells (Zhou et al., 2018). The data demonstrated that 
cells from the medically important vector, Ixodes scapularis tick, secreted exosomes 
that mediated transmission of tickborne LGTV RNA and proteins from arthropod to 
human cells (Zhou et al., 2018). In addition, the presence of abundant amounts of LGTV 
RNA and proteins in exosomes isolated from arthropod and neuronal cells was noted. It 
was also found that LGTV-infected tick cell-derived exosomes were capable of 
transmigrating and infecting naive human skin keratinocytes (the initial barrier lining the 
human cells that come in contact during bites from infected ticks) and human vascular 
endothelial cells (HUVEC) (the barrier that comes in contact during arthropod blood-
feeding) (Zhou et al., 2018). The data showed that vertebrate exosomes mediate the 
transmission of tick-borne LGTV RNA and proteins from infected brain microvascular 
endothelial cells (a component of the blood-brain barrier; BBB) to neuronal cells. In 
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addition, it has been demonstrated that exosomes containing tick-borne LGTV and 
mosquito-borne West Nile virus (WNV) facilitate the transmission of viral RNA and 
proteins from one neuronal cell to others, suggesting their novel role in 
neuropathogenesis (Zhou et al., 2018). Dihydrochloride hydrate, GW4869 (a selective 
and commercial inhibitor for neutral sphingomyelinase; N-SMase, an enzyme that 
regulates formation and release of exosomes), hampered LGTV loads in exosomes and 
inhibited the transmission of viral RNA and proteins in not only arthropods’ but also 
vertebrate host cells (Zhou et al., 2018). Overall, this study suggests that exosomes are 
the mediators for transmission of arthropod-borne flavivirus RNA and proteins from 
arthropod to the vertebrate host, along with promoting the dissemination of this 
infectious viral material within the vertebrate host, including allowing neuro-invasion and 












Detection of Tick Cell-Derived Exosomes by Cryo-EM and Western Blot 
Cryo-Electron Microscopy (cryo-EM) performed on tick cell-derived exosomal fractions 
showed the presence of purified arthropod exosomes with the size in diameter from 30 
to 250 nm (Figure 6A), the same as exosomes isolated from mammalian cells (Fevrier 
and Raposo, 2004; Couzin, 2005; Keller et al., 2006). Exosomes isolated from 
arthropod cells showed a heterogeneous population of vesicles in the cryo-EM analysis 
(Zhou et al., 2018). In order to understand such heterogeneity in the exosome 
population, quantitative analysis was done using images collected from both uninfected 
and LGTV-infected tick cell-derived exosomes. Counting of exosomes per image 
showed a higher number of exosomes in LGTV-infected (n = 14) in comparison to the 
uninfected (n = 27) group (Figure 6B). It was noted that the majority of the exosomes 
were of sizes between 50 to 100 nm in both uninfected and infected fractions (Figures 
6C and 6D). However, exosomes of other sizes 100 to 150 nm and 150 to 200 nm were 
evenly spread in infected preparation when compared to the uninfected preparation 
(Figures 6C and 6D). Fewer vesicles from sizes of 200 to 250 nm were marginally more 
in uninfected (10.1%) in comparison to the infected group (6.5%) (Zhou et al., 2018). 
The large exosomes were very few in number and were from 0 to 1.5% in both the 
uninfected and infected groups (Figures 6C and 6D). This data suggested that LGTV-
infection (72 h p.i.) might enhance the production and release of exosomes (Zhou et al., 
2018). The OptiPrep (DG-Exo-iso) method (Tauro et al., 2012) purified various sizes of 
exosomes in six different fractions. Immunoblotting analysis (with highly cross-reactive 
4G2 monoclonal antibody that identified the viral Envelope (E)- protein) of these 
fractions (20 μl) proved the presence of LGTV E-protein in all six fractions but enriched 
lots of E-protein were present in fractions four and five in comparison to the other 
fractions (Figure 6E). These results were connected with the size analysis data (Figures 
6B-6D). Enhanced detection of LGTV-E protein in fractions four may correspond to the 
50 to 100 nm (fraction 4) size exosomes that are in a higher population (Figure 6E). As 
expected, E-protein in the fractions from uninfected control was not detectable. Total 
cell lysates (20 μg) from uninfected and LGTV-infected fractions were used as internal 
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controls to compare the amounts of E-protein in the 20 μl of different fractions (Figure 












Figure 6. Cryo-EM Images and Western Blot Show Exosomes Derived from Un-infected and LGTV 
Infected Tick Cells 
(A) Cryo-EM images showed exosomes derived from uninfected and LGTV-infected (MOI 1; 72 h p.i.), 
ISE6 tick cells. Scale bar indicates 100nm.  
(B) A comparison of exosome numbers per cryo-EM image from uninfected and infected groups.  
(C-D) Quantification of diameter or sizes for heterogenous population of exosomes from uninfected or 
LGTV- infected tick cell-derived exosomes. 
(E) DG-Exos showed the presence of LGTV envelope protein in fractions 1 to 6. 




Tick Cell-Derived Exosomes Containing Viral RNA and Exosomes are Infectious 
Quantitative Real-Time PCR (QRT-PCR) analysis revealed the presence of LGTV total 
RNA in exosomes isolated from infected tick cells (Figure 7A). The replication numbers 
of viral RNA in LGTV-infected (72 h p.i.) exosomes derived tick cells is shown in (Figure 
7B). Furthermore, the presence of both positive and negative sense LGTV RNA strands 
in tick cells-derived exosomes (Figure 7C) was also determined. LGTV RNA was also 
perceptible in exosomes from tick cells cultured and infected in exosome-depleted FBS 
medium (with no cross-contaminating bovine exosomes presence in regular commercial 
FBS), further indicating the presence of viral RNA in tick cell-derived exosomes (Figure 
7D). During the isolation of tick exosomes, pellets (exosomes fraction) and supernatant 
fraction (collected after pelleting exosomes and before PBS wash; See Figure 8) was 
tested in plaque assays to determine the infectivity and replication of LGTV RNA and 
titers as described in methods. Plaque assays carried out with the tick cell-derived 
exosome pellet fractions formed plaques at dilutions of 1:10 and 1:100 that were too 
many to count, and around 20 to 22 plaques at a dilution of 1:1000 (Figures 7E-7G). No 
plaques were visible in plates where Vero cells were treated with the supernatant 
fractions at any trial dilutions (Figures 7E-7G). Plaque assays demonstrated the 
presence of infectious LGTV RNA or proteins in infected exosomes that resulted in high 
loads of LGTV in Vero cells (6.6 x 104 pfu/ml) and developed formation of viral plaques. 
Plaque assays further verified that tick cell-derived exosomes contain LGTV RNA and 
proteins capable of replication and forming viable plaques that are extremely infectious 
to mammalian cells (Figures 7E-7G). No viral plaques detected after treatment with the 
supernatant fraction (depleted of exosomes) suggests the presence of abundant 


















Figure 7. Arthropod Exosomes Contain Infectious LGTV RNA and Exosomes Form Plaques  
(A) QRT-PCR analysis showed total LGTV loads.  
(B) The copy number of LGTV RNA. 
(C) The levels of LGTV positive-sense strand and negative-sense strand in exosomes isolated from 
tick cells at 72 h (p.i.), Uninfected cells serve as a control.  
(D) QRT-PCR analysis showed LGTV total loads from LGTV infected tick cells at 72 h p.i. (5 x 106 tick 
cells, infected with 1 MOI of LGTV). Cells were grown in commercially exosome-free FBS medium. 
LGTV transcript levels were normalized to tick beta-actin. 
(E-F) Plaque assays performed with different dilutions (1:10, 1:100, 1:1000) of exosomes fraction or 
corresponding different volumes (600, 60, 6 μl) of supernatant fractions prepared from tick cells. The 
rulers at the top determines scale for the represented plaque assays. 
(G) Quantitative assessment of the number of plaques in exosomal and supernatant fractions was 
shown. TMTC indicates “too many to count”. 



















Figure 8. Schematic Representation of the Method Used for Exosomes Isolation from Different 
Cells 
Cell culture supernatant/fluid was spun at 300 g for 10 min to remove floating cells, and supernatant 
fraction was collected. The supernatant was spun at 2000 g for 10 min to remove dead cells, and the 
resulting supernatant fraction was collected and spun again at 10, 000 g for 30 min to remove any 
remaining cell debris. The supernatant fraction collected from the previous step was spun at 100, 000 
g for 70 min (for bEnd.3 cells, N2a cells, cortical neurons) or for 155 min (for tick cells) in an 
ultracentrifugation unit. Supernatants resulted after the above longer spin step were used in all the 
experiments as supernatant fractions. The exosomes containing pellet fraction was washed in ice-cold 
PBS and spun at 100, 000 g for 70 min (for bEnd.3 cells, N2a cells or cortical neurons) or for 155 min 
(for tick cells). The pellet resulted after this wash was considered as exosome fraction in all the 
experiments. The exosome pellet/fraction was either dissolved in PBS (for performing re-infection, 
plaque or trans-well assays, Native PAGE and 4G2-antibody-beads-binding assay), or in RNA lysis 
buffer (for total RNA extractions) or in modified RIPA buffer for protein extractions. This figure was 






Tick Cell Exosomes Contain Viral Proteins inside the Luminal Region 
The presence of LGTV E-protein in tick cells-derived exosomes was further recognized 
by SDS-PAGE followed by immunoblotting with 4G2 antibody (Figure 9A). More E-
protein loads were detected (at ~50kDa) in total cell lysates in comparison to exosomal 
fractions (Figure 9A). Immunoblotting with monoclonal anti-LGTV NS1 (Clone 6E11) 
antibody (obtained from BEI resources) also pointed out that NS1 presents in both tick 
cell-derived exosomes and total cell lysates (Figure 9A). Remarkably, the presence of 
tick HSP70 (heat-shock cognate protein 70, a specific exosomal marker in mammalian 
cells) in exosomal lysates had been detected (Figure 9A). Presumably, due to a low 
amount in cell lysates, no HSP70 was detected in the tested condition (Figure 9A). Total 
protein lysates prepared from the same batch of uninfected or LGTV-infected tick cell-
derived exosomes or from whole tick cells served as a loading control for all 
immunoblots (Figure 9A). In addition, native-PAGE followed by immunoblotting with 
4G2 antibody, showed higher levels of LGTV E-protein (at <250kDa; in native state) in 
Triton-X-100 (a detergent that lyses the exosomal lipid bilayer membranes) treated 
exosomes (30 min, RT) with in comparison to the exosomes treated for three rounds of 
freeze-thaw cycle (1 h, at -80°C) or the MOCK group (untreated exosomes) held at 4°C 
(Figure 9B). Total protein lysates generated from uninfected or LGTV-infected tick cell-
derived exosomes with same treatments served as controls in this immunoblotting 
analysis (Figure 9B). The treatment with Proteinase K (0.5 μg/μl or 50 μg/ml, 15 min at 
37°C) suggested working concentrations (50 to 100 μg/ml) that digested all proteins 
(Figure 9C). In untreated infected samples, E-protein was detected. However, no E-
protein was detected in Proteinase K-treated infected samples. Uninfected samples 
either treated or untreated served as internal controls (Figure 9C). The Ponceau S 
stained blot proved no proteins detected in both infected and uninfected proteinase K-
treated samples (Figure 9C). Detection of LGTV E-protein inside exosomes (but not 
outside from PBS suspensions) was further performed with E-protein-4G2-antibody-
beads binding assay as described in methods. No significant (P>0.05) differences in 
viral loads were obtained in LGTV-infected (72 h p.i.) exosomes that were either, 
untreated, or treated with 4G2 antibody (that binds to LGTV E-protein) or relevant 
isotype antibody that served as control (Figure 9D). Similar results were obtained with 
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LGTV-infected exosomal fractions that derived from GW4869 inhibitor-treated tick cells 
(of 72 h p.i.) (Figure 9D). Native-PAGE and the beads assay clearly suggested that 
exosomes contain viral RNA and proteins inside exosomes. To further evaluate if viral 
E-protein was indeed inside the exosomes, the protease-resistance assay was 
performed with Proteinase K that basically digest proteins in all biological specimens. 
Overall, these results suggested that the majority of the LGTV RNA and proteins 
escape from tick cells via exosomes which could mediate not only LGTV transmission 
and infection, but also possibly other closely related viruses such as TBEV and POWV. 
 
Human Keratinocytes were Infected by Tick Cell-Derived Exosomes and Viral 
RNA Presences was Detected in Exosomes but not in the Supernatant 
The LGTV infection kinetics of HaCaT cells showed no difference between all three-time 
points, demonstrating that instead of holding viral replication inside of these cells, 
HaCaT cells prefer to free of viral material by releasing exosome to neighboring cells 
(Figure 10A). Tick cell-derived exosomes and the relative fraction supernatant (after 
exosome ultracentrifugation isolation) were treated on HaCaT cells. The results showed 
that the majority of viral RNA was present in exosomes but not in the supernatant. This 
data suggests that viral RNA is concentrated in exosomes, and very few exosomes may 
remain in the supernatant fraction after isolation (Figure 10B).  The finding of exosomes 
derived from HaCaT cells re-infecting HaCaT cells indicated that the exosomes of 
HaCaT cells were also infectious. However, the relative supernatant was not very 
infectious since the load is invisible. The reason could be that very few exosomes 
remain in the supernatant. These observations prove again that the majority of viral 
RNA was present in the exosomes and not in the supernatant (Figure 10C). Trans-well 
assay mimicked the process of how exosomes assist viral infectious material comes 
across the human skin barrier and infects human keratinocytes. Tick cells derived 
exosomes pass through the membrane between upper and lower chambers, and then 
infected naïve HaCaT cells growing on the lower chamber of the plate. With the use of 
exosome inhibitor, exosomes production and virus load were inhibited, demonstrating 






Figure 9. Arthropod Exosomes Contain LGTV Proteins Inside 
(A) Immunoblotting analysis showed the detection of LGTV E-glycoprotein and viral NS1 protein in 
exosome fraction and total lysates from the cells prepared from uninfected (UI) or infected (I) tick cells 
at 72 h (p.i.). Uninfected samples and total protein profiles serve as controls.  
(B) Native-PAGE followed by immunoblotting analysis showed the presence of E-protein from LGTV-
infected (MOI 1; 72 h p.i.) or uninfected tick cell-derived exosomes treated with Triton-X-100 (0.03%), 
or freeze-thaw cycles (3 times freezing at -80°C for 1 h each cycle) or untreated samples held on ice. 
Coomassie-stained gel showed the total protein profiles that serve as a loading control.  
(C) Immunoblot gel image showed the levels of E-protein or total protein loads (Ponceau stained) in 
LGTV-infected tick cell-derived exosomes treated with proteinase K (50 μg/ml, 15 min, 37°C). 
(D) Antibody-beads binding assay performed on LGTV infected (MOI 1) tick cell-derived exosomes 
(collected from tick cells either untreated or treated with GW4869; 5 μM, exosome inhibitor) showed 
no differences in Langat-E protein loads between 4G2, isotype, and untreated samples. 


















Figure 10. Exosomes Derived from Tick Cells and HaCaT Cells are more Infectious to Human 
Keratinocytes 
(A) QRT-PCR analysis showed the levels of LGTV in HaCaT cells at different time points (24, 48, and 
72 h p.i.). LGTV (6 MOI) was used to infect 1 x 105 HaCaT cells.  
(B) Viral re-infection kinetics as determined by the presence of total LGTV loads in HaCaT cells (1 x 
105 cells) at different time points treated with exosomes (20 μl) or supernatant fractions (400 μl) 
prepared from 72 h p.i. LGTV-infected tick cells were shown.  
(C) Viral re-infection kinetics as determined by the presence of LGTV in HaCaT cells (1 x 105 cells at 
24, 48, and 72 h p.i.) infected by treatment with exosome (20 μl) or supernatant (400 μl) fractions 
prepared from 72 h p.i. LGTV-infected tick cells that were seeded in exosome-free FBS medium were 
shown.  
(D) Viral loads at 48 h p.i. was determined by the presence of LGTV in a trans-well assay performed 
with tick cells (1 x 105, upper chamber) or HaCaT cells (1 x 105, lower chamber) treated with tick 
exosome fraction (20 μl, upper chamber) for 4 h in the presence or absence of 5 μM exosome inhibitor 
GW4869. Tick cells infected with LGTV laboratory stocks were used as controls. LGTV transcript 
levels were normalized to human beta-actin. P values were determined by the Student's two-tail t-test. 





Human Vascular Endothelial Cells (HUVEC) were Infected by LGTV and 
Exosomes Assisted Viral RNA Transmitted from Brain Endothelial Cells to 
Neuronal Cells 
The data also showed that LGTV (laboratory viral stocks, generated from Vero cells) 
was able to infect human vascular endothelial (HUVEC) cells with no changes in viral 
loads at 24 h p.i. in comparison to later time points (48 and 72 h p.i.) (Figure 11A). 
HUVEC cells treated with exosomes-carrying-LGTV showed magnificently (P<0.05) 
increased viral loads at 48 h p.i. in comparison to the supernatant fractions treated cells, 
suggested that LGTV RNA is concentrated in exosomes (Figure 11B). Due to the 
transmission to vertebrate host, arthropod-borne neurotropic encephalitis viruses were 
noticed to first reproduced in the blood and peripheral organs (spleen and liver), cross 
the Blood-Brain Barrier (BBB) and invade the CNS (Chambers and Diamond, 2003; 
Samuel and Diamond, 2006). Mouse brain-microvascular endothelial cells (bEnd.3 
cells; that served as the BBB) was used to address if infectious viral RNA and proteins 
are transmitted to neurons by the mediation of bEnd.3 cell-derived exosomes. LGTV 
rapidly infected and replicated in bEnd.3 cells at all the time points (48 and 72 h p.i.) 
(Figure 12A). Furthermore, it was shown that the viral loads in brain endothelial cells 
were not impressively different over the infection period as revealed by the viral loads at 
much later time points (96 and 120 h p.i.) (Figure 12B). QRT-PCR analysis revealed 
significantly (P<0.05) increased viral burden and replication numbers in exosomes 
derived from bEnd.3 cells at 24 h p.i. in comparison to the other checking points (48, 72, 
96 and 120 h p.i.) (Figures 11C and Figure 12C). Higher loads of LGTV positive and 
negative sense RNA strands were found at 24 and 48 h p.i., in comparison to the other 
tested time points (72, 96 and 120 h p.i.) (Figure 11D). LGTV infected and replicated in 
neuronal cells (mouse N2a cells) in a time-dependent manner with a peak infection at 
72 h p.i. (Figure 12D). N2a cells were infected later with bEnd.3 cell-derived exosomes 
collected at different time points (24 and 48 h p.i.). The bEnd.3 cells derived exosomes 
containing viral RNA and proteins were tested to be infectious to N2a cells with a peak 
level of infection, which is observed with exosomes derived from endothelial cells at 48 
h (p.i.) (Figure 11E). N2a cells treated with supernatant fractions (collected at the 
indicated time points) derived from endothelial cells resulted in significantly (P<0.05) 
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less viral loads in comparison to the treatments with exosome fractions isolated from the 
bEnd.3 cells (Figure 11E). Trans-well assays performed with exosomes isolated from 
LGTV-infected-brain endothelial cells indicated the transmission of viral RNA and 
proteins from bEnd.3 cells (plated in upper chamber) to uninfected/naive N2a cells split 
in the lower plate (Figure 11F). The presence of exosome inhibitor significantly reduced 
transmission of infectious viral RNA from bEnd.3 cell-derived exosomes to N2a cells 
(Figure 11F). Infection of bEnd.3 cells with 6 MOI virus stocks showed the transmission 
of LGTV to N2a cells (by crossing the membrane barriers in trans-well plates) and 
served as a control in this assay (Figure 11F). These results suggested that exosomes 
derived from brain-endothelial cells were perhaps the mediators of BBB permeability 
(crossing of infectious exosomes from infected-endothelial cells lining the BBB and 
transmission to the neuronal cells) that may stimulate neuro-invasion of tick-borne 
viruses such as LGTV, TBEV, and POWV. 
 
Exosomes Derived from Un-infected and LGTV-Infected Neuronal Cells were 
Successfully Isolated and Characterized by Cryo-EM Images and Western Blot 
Analysis 
Upon entry into the brain, tick-borne neuro-invasive viruses (such as TBEV) infect 
neuronal cells. To investigate if exosomes mediate viruses’ transmission within the brain 
from one neuronal cell to another; N2a cells were infected with LGTV. The presence of 
purified exosome with the size range of 30 to 250 nm in diameter derived from neuronal 
cell was observed with Cryo-EM (Figure 13A), much the same to exosomes isolated 
from tick cells. Parallel to arthropod exosomes, neuronal cell-derived exosomes also 
showed a heterogeneous population of vesicles. In a very coincident way, quantitative 
analysis was done depending on cryo-EM images collected from both uninfected and 
LGTV-infected N2a cell-derived exosomes. Counting of exosomes per image indicated 
a bigger number of exosomes in LGTV-infected (n = 13) cells in comparison to the 
uninfected (n = 9) group (Figure 13B). This result suggested that LGTV-infection (72 h 
p.i.) possibly, enhance the formation and release of exosomes. Majority of these 
exosomes were also varying from 50 to 100 nm in both uninfected and infected groups 
(Figures 13C and 13D). Smaller sizes of exosomes (0 to 50 nm) were of slightly higher 
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percentages in the infected exosomes when compared to the uninfected group (Figures 
13C and 13D). Fewer vesicles from sizes of 150 to 200 nm (9 to 11%) or 200 to 250 nm 









Figure 11. Human Endothelial Cells are Infected by LGTV and Endothelial Cell-Derived 
Exosomes Mediate Transmission of LGTV RNA from bEnd.3 Cells to N2a Neuronal Cells 
(A) QRT-PCR analysis showed the levels of LGTV in HUVEC cells at different time points.  
(B) Infection of HUVEC cells with infectious tick cell exosomes or supernatant fractions showed the 
LGTV loads at 48 h p.i.  




















(D) QRT-PCR analysis showed the levels of LGTV positive-sense strand or negative-sense strand in 
exosomes isolated from bEnd.3 cells at different time points (24, 48, 72, 96, and 120 h p.i.).  
(E) Viral loads were determined after 24 h p.i. by the presence of LGTV in N2a cells (1 x 105) treated 
with LGTV containing exosomes (20 μl) or supernatant (400 μl) fractions prepared from bEnd.3 cells. 
(F) Viral loads at 48 h p.i. of N2a cells (lower chamber) as determined by the presence of LGTV in a 
trans-well assay performed with 1x 105 of bEnd.3 cells treated with 20 μl brain endothelial cell-derived 
exosomes (upper chamber) for 4 h in the presence or absence of exosome inhibitor (5 μM) (upper 
chamber) or infected with LGTV laboratory virus stocks were shown. 
This figure was reproduced from the published journal article (Zhou et al., 2018). 
 
 
Figure 12. LGTV Infection Kinetics in bEnd.3 and N2a Cells 
(A-B) QRT-PCR analysis showed the levels of LGTV in bEnd.3 cells (24, 48, 72, 96, and 120 h p.i.). 
(C) The LGTV copy numbers at different time points (24, 48, 72, 96, and 120 h p.i.) were shown for 
bEnd.3 cells (1 x 105 cells, LGTV, MOI 6). 
(D) Infection kinetics with increasing LGTV loads in N2a cells (1 x 105 cells, LGTV, MOI 6) was shown. 
UI indicates uninfected, and I indicate LGTV-infected. LGTV transcript levels were normalized to 
mouse beta-actin. P values were determined by the Student’s two-tailed t-test. 





Less than 1% of larger vesicles (sizes of 250 to 350 nm) were found in infected group  
(Figures 13C and 13D). The OptiPrep density gradient (that separates exosomes from 
viruses and large micro-vesicles) yielded purified exosomes into six different fractions of 
different sizes. Immunoblotting analysis (using 4G2 antibody) of these fractions (20 μl) 
elucidated the presence of LGTV E-protein in all fractions but concentrated amounts of 
E-protein were present in fractions 4 and 5 in comparison to the other fractions (Figure 
13E). E-protein was not detected in the fractions from uninfected control. The cell 
lysates (20 μg) from uninfected and infected preparations were used as controls to 
compare the amounts of E-protein detected in the different fractions volume (Figure 
13E). Immunoblotting with anti-HSP70 antibody detected enriched amounts of HSP70 
(exosomal marker) in the 4th fraction of both uninfected and infected samples (Figure 
13E). HSP70 levels were also found in 3 and 5 of infected fractions but not in uninfected 
fractions (Figure 13E). Besides the HSP70, it had also been analyzed the CD9 (another 
exosomal marker) levels in uninfected and infected fractions. CD9 was detected in all 
six of the uninfected fractions in a boosting manner, with higher levels in fractions 4 and 
5 (Figure 13E). However, CD9 was detected in 2 to 5 of infected fractions with higher-
level detection in fractions 3 and 4 (Figure 13E). It was intriguing to aware that LGTV E-
protein was enhanced in similar exosomal fractions (fractions 3 to 5) that had more 
concentrated HSP70 and CD9 protein, suggesting that infectious exosomes in fraction 4 
have higher levels of exosomal markers. OptiPrep DG-isolation of exosomes using 0.1 
μm filter (culture supernatants were filtered to condense volume, any molecule smaller 
than 5 KDa would filter away) detected E-protein also in fraction 4, suggesting that 
these infectious exosomes have sizes of 50 to 100 nm (Figure 13E). This result also 
connected with the quantitative analysis from cryo-EM images. For the curiosity to know 
where to do the intact LGTV particles present on the parallel gradients, OptiPrep DG-
isolation was performed with the laboratory stocks of LGTV (prepared in Vero cells, 
collected after 7 to 14 days post-infection and stored at -80oC). It was recognized as a 
differential pattern in E-protein loads when density gradients were performed with 
LGTV-infected exosomal fractions from N2a cells (Figure 13E) or with LGTV laboratory 
stocks containing viruses (Figure 13F). An enhanced E- protein signal was obtained in 















Figure 13. Exosomes Derived from Un-infected and Infected Neuronal Cells are Detected by 
Cryo-EM and Western Blot 
(A) Cryo-EM images showed exosomes isolated from uninfected and LGTV-infected (MOI 6; 72 h p.i.) 
N2a cells (1 x 107). Scale bar indicates 100nm.  
(B) A comparison of exosome numbers per image from uninfected and infected groups was shown.  
(C-D) Quantification of diameter or sizes for heterogenous population of exosomes from uninfected or 
LGTV- infected N2a cell-derived exosomes.  
(E) DG-Exos showed the presence of enhanced LGTV envelope protein loads in fractions 1 to 6. 
Fractions 3 to 5 showed enriched amounts of exosomal markers CD9 and HSP70. E-protein was 
detected in fraction 5 in 0.1 μm filtered samples that processed for OptiPrep DG-isolation.  
(F) E-protein was detected in OptiPrep DG-isolated fractions from laboratory virus stocks. 






Detection of E-protein in fractions 4, 3 and 2 from the laboratory virus stock suggested 
the presence of infectious exosomes containing viral E-protein (Figure 13F). This 
exciting result indicated that the viral stocks are not just the virions only but also are 
perhaps infectious exosomes mixtures carrying viral E-protein. 
 
Neuronal Cell Exosomes Contain Infectious Viral RNA and Proteins 
LGTV infected exosomes derived from N2a cells were collected at different time points 
(of 24, 48, 72 h p.i.) and evaluated for viral loads. QRT-PCR analysis disclosed an 
increased total viral RNA load and replication numbers at 72 h p.i. in comparison to the 
other measured time points (of 24 and 48 h p.i.) (Figures 14A and 14B). Both positive- 
and negative-sense viral RNA were detected with higher levels in the exosomes derived 
from N2a cells at 72 h p.i. in comparison to the other tested time points (Figure 14C). 
Immunoblotting analysis further indicated LGTV E-protein presented in the N2a cell-
derived exosomes (Figure 14D). The E-protein loads were one- to two-fold higher in 
total lysates when compared with the exosomal lysates derived from N2a cells (Figure 
14D). The smaller molecular mass of LGTV E protein was found in exosomes in 
comparison to the total lysates (Figure 14D), suggesting a possible de-glycosylation of 
the viral E protein in neuronal cell-derived exosomes. Similar de-glycosylation of the 
viral E protein in immunoblots performed on laboratory virus stocks was recorded 
(Figure 14E). A high level of CD9 was detected in the LGTV-infected exosomes, 
comparing to uninfected control and the LGTV-infected or uninfected N2a cells from 
total cell lysates low levels CD9 expression (Figure 14D). Total protein lysates in the 
immunoblotting served as a loading control (Figure 14D). 
 
Neuronal Cell-derived Exosomes Contain Infectious Viral RNA and Proteins 
inside the Luminal Region 
Next, studies were performed to address the possibility that viral RNA is perhaps 
binding to the outside of the exosomes and may be transmitted to the recipient cells. In 
order to test this possibility, freshly prepared LGTV-infected (72 h p.i.)- N2a cell-derived 











Figure 14. Detection of LGTV RNA and Proteins in Exosomes Isolated from N2a Cell Line 
(A) QRT-PCR analysis showed the levels of total LGTV loads in exosomes derived from N2a cells.  
(B) QRT-PCR analysis showed the copy numbers of LGTV in exosomes derived from N2a cells.  
(C) QRT-PCR analysis showed the levels of LGTV positive-sense or negative-sense strand loads in 
exosomes isolated from N2a cells. N2a (1 x 105) cells were infected with 6 MOI of LGTV. 
(D) Immunoblotting analysis showed the detection of LGTV E glycoprotein and mammalian exosomal 
marker CD9 in exosome fractions and total lysates from whole cells prepared at 48 h p.i. from 2 x 106 
uninfected (UI) or infected (I) N2a cells. Stain-free gels showed the total protein profiles that serve as 
the loading control.  
(E) Immunoblot analysis showed E-protein in de-glycosylated form from laboratory virus stocks. 




LGTV loads from infected treated or untreated groups was observed (Figure 15A). The 
uninfected group treated with RNase A was kept as an internal control (Figure 15A). In 
addition, exosomes isolated from LGTV-infected N2a cells were treated, with Triton-X-
100 (0.1%; for 45 min, at RT), or with RNase A (5 μg/ml, for 15 min, at 37°C). QRT-PCR 
analysis showed that exosomes treated with either Triton-X-100 RNase A has lower 
LGTV loads in comparison to untreated exosomes (Figure 15B). Enhanced levels of 
LGTV- E protein in neuronal exosomes treated with Triton-X-100 (0.03%; for 30 min, 
RT) in comparison to the exosomes treated after freeze-thaw cycle (thrice frozen and 
thawed at -80°C) or untreated exosomes held at 4°C was detected by native-PAGE 
followed by immunoblotting with 4G2 antibody (Figure 15C). E-protein was detected at 
higher molecular mass (<250kDa) in neuronal exosomes when samples were 
processed for native-PAGE analysis under non-reducing and non-denaturation 
conditions. Detection of NS1 protein in independent samples at the similar molecular 
mass suggests presence of other LGTV proteins or polyprotein in exosomes (Figure 
15C). Exosomes derived from uninfected N2a cells served as control (Figure 15C). 
Total protein lysates prepared from uninfected or LGTV-infected neuronal cell-derived 
exosomes after freeze-thaw or Triton-X-100 treatments or untreated samples served as 
loading control (Figure 15C). ELISA corroborate results of the native-PAGE, where 
higher loads of LGTV E-protein were detected when exosomes were treated with 0.1% 
of Triton-X-100 in comparison to untreated exosomal fractions (Figure 15D). Lower level 
of E-protein in LGTV-infected untreated neuronal exosomes was considered as 
background signal due to non-specific antibody binding (Figure 15D). Furthermore, the 
presence of E-protein inside neuronal exosomes by a 4G2-antibody-coated bead-
binding assay (as described in methods) was performed (Figure 15E). No significant 
(P>0.05) differences in viral loads were observed in LGTV-infected (72 h p.i.) neuronal 
exosome samples that were untreated/treated with either 4G2 antibody or isotype 
control antibody (Figure 15E). GW4869 inhibitor treated exosomes from LGTV-infected 
neuronal cells collected at 72 h p.i., followed by treatments with either 4G2 or isotype 
control also showed no significant (P>0.05) differences in viral load in comparison to 
untreated samples (Figure 15E). However, a significant decrease in LGTV loads were 




















Figure 15. Exosomes Derived from N2a Cell Line Contains LGTV RNA and Proteins Inside  
(A) The LGTV loads of the treatment of LGTV-infected (72 h p.i.) N2a cell-derived exosomes with 
RNase A were shown. The uninfected samples treated with RNase A serve as a control. 
(B) QRT-PCR analysis showed the LGTV loads in N2a cell-derived exosomes treated with Triton-X-
100, followed by RNase A.  
(C) Native-PAGE followed by immunoblotting analysis showed the presence of LGTV E- and NS1 
proteins from LGTV-infected (MOI 1; 72 h p.i.) or uninfected N2a cell-derived exosomes treated with 
Triton-X-100 (0.03%), or freeze-thaw cycles or untreated, held on ice. Coomassie-stained gel image 
showed total protein profiles that serve as a loading control.  
(D) ELISA performed on uninfected or LGTV-infected (MOI 6; 72 h p.i.) N2a cell-derived exosomes 
either untreated or treated with Triton-X-100 (0.1%).  
(E) Antibody-beads binding assay performed on infected (MOI 1, 72 h p.i.) N2a cell-derived exosomes 
(collected from N2a cells either untreated or treated with GW4869; 5 μM, exosome inhibitor) showed 
no differences in LGTV-E protein loads between 4G2, isotype, and untreated groups. 
(F) Immunoblotting analysis showed the E-protein of infected N2a cell-derived exosomes treated with 
proteinase K (100 μg/μl, 15 min, 37°C). The uninfected but untreated groups serve as a control. 





 (Figure 15E).In addition, treatment with Proteinase K (100 μg/μl, 15 min at 37°C) 
indicated that all proteins on the exosomes surface might have been digested, thereby, 
lysing the vesicles and allowing degradation of the exosomal luminal proteins (Figure 
15F). E-protein was detected in infected- untreated samples but not in treated samples. 
Untreated, uninfected samples served as internal controls (Figure 15F). The Ponceau S 
stained blot showed no proteins upon Proteinase K treatment (Figure 15F). 
 
Exosomes Derived from N2a Cells Contained Viral RNA and Proteins and these 
Exosomes were Infectious and allowed Viral Replication 
Moreover, plaque assays validated that LGTV-infected N2a cell-derived exosomes 
enclosed infectious viral RNA, with a magnificently higher number of plaques, 
depending on the evidence of infection with exosome fractions in comparison to the one 
with supernatant’ (Figures 16A and 16B). In addition, infectious exosomes containing 
LGTV RNA and proteins derived from N2a cells at different time points (24, 48, 72 h p.i.) 
were able to re-infecting naive N2a cells (Figure 16C). A significantly higher level of viral 
burden was detected in LGTV containing-exosomes derived from freshly infected N2a 
collected from 48 or 72 h (p.i.) in comparison to the infection with exosome fractions 
prepared from 24 h p.i. time points (Figure 16C). Re-infection with supernatant fractions 
elucidated undetectable levels of LGTV (Figure 16C). A marginal amount of viral load 
from re-infection kinetics were observed upon incubations with LGTV-infected N2a cell-
derived exosomes generated using commercial exosome isolation kit reagent (Figure 
16D). 
 
WNV Viral RNA was also Detected in Exosomes 
To investigate, whether mosquito-borne flaviviruses such as WNV viral RNA is present 
in exosomes as well, mouse N2a cells were co-incubated with WNV. Viral infection 
kinetics indicated that WNV rapidly infected N2a cells with increased viremia at 72 h p.i. 
(Figure 17A). Also, exosomes derived from WNV-infected N2a cells showed a viral 
infection peak at 72 h p.i. (Figure 17B), suggesting that WNV RNA might also serve 




Exosome-Mediated Viral Transmission is Clathrin-Dependent 
N2a cells were treated (4 h) with 5 μg of 4G2 monoclonal antibody, followed by infection 
with exosomes derived from LGTV-infected (72 h p.i.) N2a cells to test whether 
treatment with 4G2 antibody affects viral transmission. No differences were found in 
antibody treated or untreated preparations (Figure 17C). Then, it was determined if 
exosome mediated-viral transmission is receptor-dependent process and requires 
clathrin-mediated endocytosis. N2a cells were treated with clathrin specific inhibitor 




 Figure 16. Exosomes Derived from N2a Cells that Contains LGTV RNA and Proteins are 
Infectious and Replicable 
(A) Quantitative assessment of the number of plaques from exosomal and supernatant fractions was 
shown. TMTC indicates “too many to count”.  
(B) Plaque assays performed with different dilutions (1:10, 1:100, 1:1000) of exosome pellet or 
corresponding different volumes (600, 60, 6 μl) of supernatant fractions prepared from LGTV-infected 
N2a cells. The rulers at the top determined the scale for the plaques.  




















Figure 17. WNV Viral RNA Presents in Exosomes Transmission of LGTV through Infectious 
Exosome to Naïve Cells is Clathrin Dependent 
(A-B) QRT-PCR analysis showed the infection kinetics with WNV (MOI 5) at different times (24, 48, 72 
h) p.i., in N2a cells and N2a cell-derived exosomes. WNV E- gene transcript levels were normalized to 
mouse beta-actin.  
(C) QRT-PCR analysis showed the LGTV loads in N2a cells treated with a 4G2 antibody (5 μg for 4 h). 
Infected but untreated sample was served as a control. 
(D) QRT-PCR analysis showed the LGTV loads in N2a cells treated with Pitstop-2 clathrin inhibitor 
(treated 30 μM for 15 min at 37°C) and infected with LGTV-containing (72 h p.i.) N2a cell-derived  
 
 
exosomes (20 μl) or supernatant (400 μl) fractions prepared from 24, 48 and 72 h p.i. 
(D) QRT-PCR analysis of the infection of naïve neuronal N2a cells (1 x 105 cells) collected at 24 h p.i. 
with exosome (20 μl) fractions prepared from LGTV-infected N2a cells (from 24, 48 and 72 h p.i.) or 
uninfected cells showed the presence of LGTV RNA in infected cells.  










with infectious (LGTV; 72 h p.i.) exosomes derived from N2a cells. A significant 
(P<0.05) reduction in LGTV loads (72 h p.i.) in Pitstop-2 treated cells in comparison to 
the DMSO (vehicle) treated controls (Figure 17D) was noted. These results suggested 
that exosome-mediated LGTV transmission to naive cells via receptor-dependent 
endocytosis that requires clathrin. 
 
Exosome Inhibitor GW4869 Reduced Viral Loads and Transmission 
Using GW4869 exosome-inhibitor at different concentrations (1, 5 and 10 μM) 
significantly (P<0.05) depressed LGTV loads in exosomes (from N2a cells) in 
comparison to DMSO-treated controls (Figure 18A). Furthermore, exosomes isolated 
from inhibitor-treated (1 μM) N2a cells were magnificently hampered re-infection of 
naive N2a cells in comparison to DMSO-treated control (Figure 18B). In addition, it has 
been proved that exosomes derived from N2a cells that pre-treated with 5 μM inhibitor, 
then followed with LGTV infection, had significantly lower viral loads in comparison to 
exosomes isolated from cells post-treated with inhibitor after infection (Figure 18C). 
Whereas, viral loads in exosomes were significantly deducted in N2a cells in spite of 
pre- or post-inhibitor treatment in comparison to the LGTV infection performed with 5 
MOI laboratory viral stocks (Figure 18C). Plaque assays performed with exosomes 
derived from LGTV infected N2a cells DMSO-treated group yielded significantly 
increased number of plaques in comparison to the group’s with exosomes isolated from 
inhibitor-treated (Figures 18D and 18E). Also, plaque assays performed with exosome 
preparations from N2a cells revealed the viral titers for both N2a 1 μM-inhibitor treated 
group (2.3 x 103 pfu/ml) and N2a-DMSO control group (8 x 103 pfu/ml). The GW4869 
inhibitor effects on LGTV viral particles from virus stocks were also measured. 
Immunoblotting with 4G2 antibody showed no differences in 5 or 10 μM exosome 
inhibitor treated (4 h) groups, in comparison to the DMSO control (Figure 18F).  
exosomes. The infected and DMSO-treated group was served as control. LGTV transcript levels were 
normalized to mouse beta-actin. P values were determined by the Student's two-tail t-test.  






Infectious Viral RNA and Proteins were Transmitted from One Neuronal Cell to 
Others via Exosomes 
To investigate whether exosomes serve as the mediators of viral transmission from one 
neuronal cell to another, LGTV infections were executed on primary neuronal cultures of 
murine cortical neurons (isolated from female mice’s embryonic day E16 brains, as 
described in methods). Infection of cortical neurons with LGTV (MOI 4) showed kinetics 
of LGTV infection in a time dependent manna with increased viral burden at 72 to 96 h 
p.i. (Figure 19A). QRT-PCR analysis revealed magnificently (P<0.05) increased LGTV 
loads and replication numbers in exosomes derived from murine cortical neurons at 72 
h (p.i.), comparing to other tested time points exosomes preparations (of 24 and 48 h 
p.i.) (Figures 19B and 19C). Furthermore, higher loads of LGTV positive- and negative- 
sense RNA strands have been detected, suggesting the presence of both viral genomes 
in the LGTV infected neuronal cells derived exosomes (Figure 19D). Immunoblotting 
elucidated plentiful LGTV E-protein amounts (2 to 3 folds) in exosomes derived from 
cortical neurons in comparison to the loads found in total cell lysates (Figure 20A). Like 
N2a cells, possibly de-glycosylated LGTV E protein (with low molecular mass) was 
again, detected in exosomes derived from cortical neurons in comparison to the total 
cell lysates (with high molecular mass) isolated from cortical neurons (Figure 20A). 
Remarkable levels of CD9 (exosomal marker) were detected in the LGTV-infected 
cortical neurons derived exosomes and in total cell lysates in comparison to their 
alternatively uninfected controls (Figure 20A). Furthermore, levels of CD9 were 
dramatically enhanced in exosomes from LGTV-infected cortical neuronal cells in 
comparison to the levels in total cell lysates (Figure 20A), suggesting that LGTV 
infection may facilitate the enrichment of CD9 in neuronal cells derived exosomes. Also, 
exosomes from LGTV infected cortical neurons resulted in higher amounts of CD9 in 
comparison to the N2a cell-derived exosomes enclosing LGTV (Figures 14D and 20A). 
Total protein profiles were considered as loading control in the immunoblotting analysis 
(Figure 20A). Immunoblotting showed the presence of NS1 in both exosomes’ and in 
total cell lysates preparations, suggesting that exosomes from cortical neurons contain 



















Figure 18. Treatment of Neuronal N2a Cells with Exosome Inhibitor Affects LGTV Infection, if 
Treated either before or after Infection 
(A) QRT-PCR analysis showed the levels of LGTV in exosomes isolated from N2a cells at 48 h p.i. in 
the presence of exosomes-inhibitor at different concentrations (1, 5, 10 μM). 1 x 105 N2a cells were 
pre-treated with inhibitor for 4 h followed by infection with LGTV (6 MOI). Exosomes isolated from N2a 
cells treated with DMSO served as a loading control.  
(B) The levels of LGTV in N2a cells at 48 h p.i., infected by treatment with exosomes (20 μl) isolated 
from control or inhibitor-treated N2a cells were shown. 
(C) QRT-PCR analysis showed the levels of LGTV in N2a cells at 72 h p.i. Uninfected N2a cells were 
treated with 5 μM inhibitor. For LGTV-infection, N2a cells were first treated for 4 h with an inhibitor 
then followed by infection (Inhibitor/I) or cells were first infected for 4 h with LGTV and then treated 
with inhibitor (I/inhibitor). LGTV (6 MOI) was used to infect 1 x 105 N2a cells in the presence (5 μM) or 
absence of inhibitor. LGTV transcript levels were normalized to mouse beta-actin.  
(D) Plaque assays performed with different dilutions (1:10, 1:100, 1:1000) of exosomes fraction 
isolated from control DMSO-treated or inhibitor-treated N2a cells were shown. 
(E) Quantitative assessment of the number of plaques from DMSO-treated or inhibitor-treated was 
shown. P values were determined by the Student's two-tail t-test is shown.  
(F) The detection of E-protein of Laboratory virus stocks treated with either GW4869 inhibitor (5 and 
10 μM) or DMSO as control was shown.  













Figure 19. Detection of LGTV RNA in Exosomes of Mouse Cortical Neurons 
(A) QRT-PCR analysis showed the LGTV infection kinetics in primary cultures of mouse cortical 
neurons at different time points (24, 48, 72, 96 h p.i.).  
(B) QRT-PCR analysis showed the total LGTV loads in exosomes isolated from cortical neurons at 
different time points (24, 48, and 72 h p.i.). 
(C) QRT-PCR analysis showed the LGTV copy number in exosomes isolated from cortical neurons at 
different time points (24, 48, and 72 h p.i.). 
(D) QRT-PCR analysis showed the LGTV positive-sense and negative-sense strand in exosomes 
isolated from cortical neuronal cells at different time points (24, 48, and 72 h p.i.). LGTV (4 MOI) was 
used to infect 1 x 105 murine cortical neuronal cells. “UI” indicated uninfected and “I” indicated LGTV-
infected. LGTV transcript levels were normalized to mouse beta-actin. P values were determined by 
the Student's two-tailed t-test. Representative data were shown from at least three independent 
experiments. 













Figure 20. Detection of LGTV Proteins in Exosomes of Primary Cultures of Cortical Neurons 
(A) Immunoblotting analysis showed the detection of LGTV E-protein and mammalian exosomal 
marker CD9 in exosome fraction and total lysates from whole cells prepared from uninfected (UI) or 
infected (I) cortical neuronal cells at 48 h p.i. The stain-free gel showed the total protein profile that 
served as the loading control.  
(B) Immunoblotting analysis showed the NS1 levels in total neuronal lysates and exosomes derived 
from LGTV-infected (MOI 4; 72 h p.i.) cortical neurons. Uninfected (UI) cells and exosomes derived 
from these cells served as controls, in addition to total protein profiles. For immunoblotting assays, 2 x 
107 cortical neuronal cells were infected with 4 MOI of LGTV. 






Neuronal Exosomes Containing Viral RNA and Proteins are Infectious 
Plaque assays verified that exosomes derived from cortical neurons could carry 
infectious and reproductive viral RNA, because of the significantly increased number of 
plaques, with the evidence upon infection with exosomes (in different dilutions; of 1:10, 
1:100, 1:1000) in comparison to the infection with supernatant fractions (Figures 21A-
21C). Similar data were previously obtained for N2a cells, suggesting that LGTV is 
concentrated in neuronal exosomes. Additionally, exosome fractions derived from 
LGTV-infected cortical neurons at several time points (of 24, 48, 72 h p.i.) were able to 
re-infect naive cortical neuronal primary cultures (Figure 21D). A magnificent higher viral 
burden was detected in the cortical neurons which are infected with exosome fractions 
(collected from 24, 48, 72 h p.i.) in comparison to the infection with the supernatant 
preparations generated from alternative time points (Figure 21D). These results 
suggested that exosomes from LGTV-infected cortical neurons are potential mediators 
of LGTV transmission among neurons. 
 
Exosome Inhibitor GW4869 Treatment on Cortical Neuron Reduces Viral Infection 
Furthermore, the presence of exosome-inhibitor at 10 or 20 μM significantly reduced 
viral infection in cortical neurons when compared to DMSO-treated controls (Figure 
22A). However, no variation in the viral burden of cortical neurons were detected upon 
treatment with 1 μM exosome inhibitor in comparison to DMSO-treated control (Figure 
22A). Exosomes isolated from 10 μM-treated cortical neurons showed significantly 
depressed re-infecting viral loads of naive cortical neurons in comparison to the 
infections performed with exosomes derived from DMSO-treated control (Figure 22B). 
Plaque assays revealed that LGTV-containing exosomes derived from DMSO-treated 
neurons enclosed notable and increased LGTV loads, comparing to exosomes derived 
from 10 μM exosome inhibitor-treated group (Figures 22C and 22D). Overall, these 
results suggest that LGTV and maybe TBEV, use exosomes as novel modes of 














Figure 21. Exosomes Containing LGTV RNA and Proteins that Derived from Cortical Neurons 
are Infectious 
(A-B) Plaque assays performed with different dilutions (1:10, 1:100, 1:1000) of exosome pellet or 
corresponding different volumes (600, 60, 6 μl) of supernatant fractions prepared from LGTV-infected 
cortical neuronal cells were shown. The rulers at the top were determined the scale for the plaque 
assay from the representative images. Representative images from two independent experiments 
were shown.  
(C) Quantitative assessment of the number of plaques from exosomal and supernatant fractions was 
shown.  
(D) QRT-PCR analysis of viral loads in 1x 105 naïve cortical neuronal cells at 24 h p.i., infected 
through treatment with exosomes (20 μl) or supernatant fractions (400 μl) prepared from 24, 48 and 72 
h p.i., LGTV-infected neurons showed the presences of LGTV. LGTV transcript levels were normalized 
to mouse beta-actin. P values were determined by the Student's two-tailed t-test is shown. 
Representative data were shown from at least three independent experiments. 



















Figure 22. Treatment of Cortical Neurons with Exosome Inhibitor Affects LGTV Infection 
(A) QRT-PCR analysis showed the levels of LGTV in exosomes isolated from cortical neuronal cells at 
48 h p.i. in the presence of exosome inhibitor at different concentrations (1, 10, 20 μM). Cortical 
neuronal cells were pre-treated with exosomes inhibitor for 4 h followed by infection with LGTV. 
Exosomes isolated from cortical neuronal cells treated with DMSO served as a control.  
(B) QRT-PCR analysis showed the levels of LGTV in fresh cortical neuronal cells at 48 h p.i., infected 
by treatment with exosomes (20 μl) isolated from control or inhibitor-treated mouse cortical neuronal 
cells. “UI” indicated uninfected cells that served as control. LGTV transcript levels were normalized to 
mouse beta-actin.  
(C) Plaque assays performed with different dilutions (1:10, 1:100, 1:1000) of exosomes fractions 
isolated from control DMSO-treated or inhibitor-treated cortical neuronal cells were shown. The rulers 
at the top determined the scale for the plaque assay. Representative images were shown from two 
independent experiments.  
(D) Quantitative assessment of the number of plaques was shown. TMTC indicates “too many to 
count”. P values were determined by the Student's t-test is shown. Representative data were shown 
from three independent experiments. 







Exosomes contribute to the transmission and communication of intracellular materials 
among cells and from one tissue to the other as well (Fevrier and Raposo, 2004; Thery, 
2011; Bang and Thum, 2012). Several biological presumptions and medical 
requirements have been affixed with the exosomes as potential mediators of messages 
transmission and communication between cells and tissues (Thery et al., 2002; 
Johnstone, 2006; Keller et al., 2006; Van Niel et al., 2006). For the first time our 
appealing data show that exosomes are considered as novel mediators for transmission 
of arthropod-borne flaviviruses such as LGTV, WNV, and TBEV that infect a wide 
variety of vertebrate hosts, as well as humans. It has been found that tick cells secrete 
exosomes that are carriers of the tick-borne virus, LGTV, (Figures 6, 7, 9, and 10) 
suggest that other tick-borne flaviviruses such as TBEV and POWV might also use this 
mode of transmission from arthropods to humans. Cryo-EM data elucidated that 
exosomes derived from either arthropod or neuronal cell are of different sizes and were 
in the ranges of 30 to 250 nm (Figures 6A and 13A). Exosomes derived from both 
arthropod and neuronal cells had many of the exosome sizes between 50 to 100 nm 
and fewer vesicles from sizes of 200 to 250 nm in both uninfected and infected groups 
(Figures 6C, 6D, 13C and 13D), suggesting purity in isolation methods. Increased 
number of exosomes in LGTV infected in comparison to the uninfected groups (Figures 
6B and 13B), suggested higher production and release of exosomes. To generate virus 
preparations for structural investigations, concentrated supernatants, perhaps titers with 
109 to 1012 PFU/ml and centrifugal forces of 200,000g are performed (Fragnoud et al., 
2015), which are not similar in exosomal isolation methods. Whereas, with the purpose 
to minimize the viruses and large protein aggregates that co-sediments during 
ultracentrifugation, the buoyant density of exosomes was adopted for purification 
purposes. Continuous or discontinuous sucrose density gradient centrifugation has 
been performed thoroughly to purify exosomes. However, this approach does not permit 
division of exosomes from viruses, macro vesicles and large micro-vesicles with 
comparable sedimentation velocities (Tauro et al., 2012). Substituting sucrose with 
iodixanol (OptiPrep) in the velocity gradients using 5 to 40% density gradients has been 
48  
 
shown to conquer the restrictions and end up with purified exosomal fractions (Tauro et 
al., 2012). Detection of tick HSP70 in exosomal fractions (Figure 9A), suggesting that it 
could be a novel arthropod marker that may be transmitted in exosomes from saliva and 
facilitate tick feeding on vertebrate host. Recently, it is reported that arthropod HSP70 
may aid in the host fibrinogenlysis at the tick bite site (Vora et al., 2017). Detection of 
CD9 in all uninfected preparations and the enrichment in fractions 4 and 5 suggested 
that these fractions are exosomes. The visible shift in enrichment of CD9 in LGTV-
infected fraction 3 and 4, and no detection in fractions 1 and 6, suggested the presence 
and enrichment of other proteins or cargo (including viral E-protein in fraction 4) in those 
preparations. Our findings demonstrated the enrichment of both arthropod and neuronal 
E-protein in exosomal fractions 4 and 5 supported the presence of viral E-protein in 
exosomes (Figures 6E and 13E). It can be proposed that due to space limitation and 
narrowly regulated cargo sorting mechanisms, exosomes are undoubtedly filled with 
viral RNA and proteins that are trafficked to extracellular fate and later recycled back via 
merging with plasma membranes. If entire viral particles are perhaps exported through 
exosomes, it could be anticipated enclosure (or packaging) of few LGTV viruses of 40 to 
60 nm size in ~150 to 200 nm diameter of arthropod/neuronal cell-derived exosomes. 
No detection of any viral particles or fully assembled virions inside of the exosomes, in 
several of the preparations processed for cryo-electron microscopy. However, it doesn’t 
exclude the possibility of viral particles’ presence in the exosomes. Based on these 
findings, it is believed that if viral RNA (both positive- and negative-sense strands) and 
proteins are loaded into exosomes, they can be exported and consequently transmitted 
to the neighboring cells and far distant tissues for pathogenesis in short times. The 
matured virions of positive-sense RNA strand exit cells through membrane budding. 
However, the replicative which is the negative-sense viral RNA genome is cytosolic 
(Mukhopadhyay et al., 2005; Li et al., 2008; Apte-Sengupta et al., 2014; Kuhn et al., 
2015). Observations of both positive and negative-sense RNA strands in tick/neuronal 
cell-derived exosomes indicates that exosomes facilitate the transmission of both 
negative- and positive-sense strands RNA genomes. The higher loads of negative-
strand RNA in the exosomes derived from neuronal cells implied that LGTV negative-
strand RNA might simply get trafficked during endocytosis/uptake by these cells. The 
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negative strand of RNA generally exists as dsRNA with positive-sense strand. Thus, it 
seems that dsRNA may be present inside exosomes, instead of single-stranded positive 
or negative strand of LGTV. Furthermore, entry of more viral RNA and proteins into cells 
through receptor-mediated endocytosis mechanism may simply force the replicative 
viral RNA to exit the host cell and look for other neighboring cells via the exosome-
mediated transmission. The study shows that exosome-mediated viral transmission is 
clathrin dependent process (Figure 17D) further suggest a significant function for 
exosomes as viral RNA and protein transporters.  
Up-regulation of some proteins in LGTV-infected tick exosomal lysates, 
comparing to the uninfected controls indicates the importance of these proteins in 
assisting the transmission of tick-borne flaviviruses from exosomes derived from tick 
cells (Figure 9A). This research branch, in the future, should concentrate on the 
identification and characterization of these remarkable cargo proteins on arthropod 
exosomes that could be selected for the development of a novel transmission-blocking 
vaccine (Neelakanta and Sultana, 2015). The presence of LGTV RNA (of RNase A 
treatment studies) and E- protein inside exosomes but not outside in suspensions of 
exosomal fractions, suggest that exosomes not only securely carry and protect the viral 
RNA (both positive and negative strands), but also transport the essential viral E-protein 
into host endosomal membranes, then to release viral content inside cells. It has been 
noted that exosome-mediated viral transmission is clathrin-dependent suggests a 
possibility that receptor-mediated endocytosis may uptake of infectious exosomes into 
naive cells. The trans-well assays data performed with tick cell-derived exosomes and 
human keratinocytes, HaCaT cells, (Figure 10D) suggest that tick spit/secreted saliva 
containing exosomes (loaded with LGTV viral RNA and proteins), could assist the 
transmission of this virus from the tick bite site to the vertebrate host skin side. No 
differences, or flat kinetics of LGTV infection in human keratinocytes, suggested that 
these cells may not keep persistent infection but prefer to transmit viruses to dendritic/ 
other migratory immune cells in the skin at their earliest. It is assumed as well that 
keratinocytes are probably highly immune tolerant and may keep viral infections at a low 
level. Plenty of infectious LGTV RNA and proteins inside exosomes also indicates that 
exosomes may rapidly facilitate the dissemination of these viral factors within the tick 
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body (for instance, upon entry, from hemolymph to salivary glands, then midgut during 
transmission) or transmission through saliva to the vertebrate host upon infected 
arthropod bite or blood-feeding. Infection of vascular endothelial cells with tick cell-
derived exosomes containing LGTV infectious RNA and proteins suggest that upon tick 
blood-feeding, arthropod exosomes facilitate infection of the blood endothelium in the 
vertebrate host. It is noteworthy that the GW4869 inhibitor significantly lowered LGTV in 
exosomes derived from tick, bEnd.3, N2a and neuronal cells (Figures 10D, 11F, 18A 
and 22A). These results demonstrate a common pathway shared in the formation and 
release of exosomes on both arthropods’ and vertebrates’ sides. Taken together, these 
data revealed a novel mode of flavivirus transmission from the arthropod vector to the 
vertebrate host via exosomes that could be considered as transmission-blocking 
strategies.  
Most of the flaviviruses can infect and replicate in the vertebrate brain 
microvascular endothelial cells that line and guard the BBB. Infected endothelial cells 
prefer the flaviviruses to come inside cells membrane and cause neuro-invasion of the 
CNS (Sultana et al., 2009; Sultana et al., 2012; Neal, 2014; Suen et al., 2014). It has 
been emphasized that initial entry of few infected exosomes isolated from endothelial 
cells, lining the BBB, may lead to the transmission of virus into the CNS. Infection of 
neuronal cells and secretion of large amount loads of infectious exosomes by neuronal 
cells may induce the breaching of the BBB, thus, allowing entry of more significant 
peripheral viral loads, as well as the trafficking of immune cells from the periphery. 
Based on the results (Figures 11C-11F), the assumption that the initial batch of 
infected-brain microvascular endothelial (bEnd.3) cell-derived exosomes containing 
more loads of infectious LGTV RNA and proteins might enter into the CNS at an early 
time point (24 h p.i. of endothelial cells). The higher viral loads in exosomes that derived 
from brain endothelial cells from early time points (24 h p.i.) in comparison to less loads 
in exosomes at later time points more distantly suggest that earlier transmission of viral 
RNA via exosomes that infect neighboring neuronal cells. It was also addressed that 
bEnd.3 cells (in infection kinetics assays) showed stronger resistant to LGTV infection 
without severe cytopathological effects in comparison to neuronal cells. It can be 
assumed that the brain endothelial cells may not tolerant the higher rate of viral 
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replication or persistent infection for longer time. This could end up with higher 
packaging of LGTV viral RNA and perhaps proteins in bEnd.3 cell-derived exosomes 
that would cause the dissemination of flaviviruses to neuronal cells at earlier times. The 
trans-well assay (Figure 11F) could imitate viral transmission in in vivo scenario, where 
infected bEnd.3 cells derived exosomes might transmigrate across astrocyte foot layer 
and infect neurons in the CNS. This result could be directly connected to the in vivo 
circumstance that proposes virus transmission from infected-brain microvascular 
endothelial cells (lining the BBB) to the interior of the CNS. Overall, these studies 
suggest that infected-brain endothelial cells may not delight flavivirus replication for 
longer times and thus, transmit this viral RNA and proteins to their neuronal 
counterparts via exosomes at the earliest.  
This study also demonstrates that neuronal exosomes are likely able to 
manipulate transmission of tick-borne flavivirus RNA and proteins from one neuron to 
the others. Higher loads of E-protein (2 to 4 folds more) in exosomes derived from 
murine cortical neurons when compared to the in vitro cultures of N2a cell-derived 
exosomes indicate higher packaging of viral RNA and proteins in cortical neurons 
(Figure 20A). It is considered that the observation of lower mass for LGTV E-protein in 
both N2a cells and cortical neurons is because of the possible de-glycosylation of E- 
protein. The de-glycosylated E-protein in laboratory viral stocks indicated a mixture of 
virions with exosomes in those frozen supernatants. Whereas, this effect showed no 
evidence in arthropod cell-derived exosomes, addressing that E-protein in arthropod 
exosomes may not undergo protein modification. Glycosylated form of LGTV E- protein 
in arthropod cells is maintained chances to speed up exosome fusion process and viral 
infection of host cells immediately respond to host-seeking and tick blood-feeding on the 
vertebrate host. It has also been seen that in mosquitoes, WNV E-protein is heavily 
glycosylated and is essential for pathogen transmission to the vertebrate host (Moudy et 
al., 2009). The assumption is that the presence of a de-glycosylated form of viral E-
protein in neuronal and other mammalian cell-derived exosomes may allow viral E-
protein to keep its stability in these small vesicles through the transmission from one cell 
to its neighbors. In addition, it can be assumed that more viral E-protein packing in 
vertebrate neuronal exosomes may be reasonable only if E-protein exists in the de-
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glycosylated form with less molecular mass when compared to the glycosylated form. 
Furthermore, arthropod and vertebrate host may prefer different conformations of E-
protein that would assist when substances inside exosomes are delivered to the host 
cytosol. The de-glycosylation of E protein in neuronal exosomes may also increase the 
infectious ability to form matured virions in a new hostile micro-environment. Higher 
loads of CD9 in exosomes derived from neurons prove that cortical neuronal cells might 
have a greater yield of exosomes, comparing to the in vitro cultured N2a cell line 
(Figures 14D and 20A). It is practical to consider that neurons have complex 
approaches of cell communication, including synaptic transmission and neurotransmitter 
release that might require a greater yield of exosomes in the CNS. Low total protein 
content was shown in the N2a and cortical neuronal exosomes in comparison to the 
protein content in the whole cells, suggesting that only a small portion of proteins could 
be essential and imported as cargo in LGTV-infected exosomes derived from cortical 
neurons. Total protein profiles in N2a cells showed a lack of some exosomal proteins 
upon LGTV infection, hinting that these proteins may affect or inhibit viral proteins in 
exosomes derived from N2a cells. Future studies in identifying these reduced exosomal 
proteins upon LGTV infection would assist in discovering novel therapeutic targets 
against transmission. The detection of E-protein at higher molecular mass (<250kDa) in 
native-PAGE gels, indicated that exosomes might contain a higher order structures of 
E-protein as oligomers. The presence of NS1 in same samples at similar molecular 
mass further indicated that exosomal preparations might enclose polyprotein (Figure 
15C). The presence of highly infectious LGTV RNA and proteins in exosomes from 
neuronal cells suggested that these cells upon infection, mediate viral dissemination in 
the CNS. Also, detected WNV in neurons derived exosomes, further addresses that 
exosomes as a novel transmission mode for both tick- and mosquito-borne flaviviruses 
in neuronal cells. The assumption is that exosomes may keep the viability of this viral 
RNA and proteins that may favor persistent pathogenesis.  
GW4869 (dihydrochloride hydrate) is a cell-permeable but selective inhibitor for 
neutral sphingomyelinase (an essential enzyme required for exosomes formation and 
release). The effect of this inhibitor on both arthropod and mammalian cells used in this 
study indicates neutral sphingomyelinase do present in these cells. Treatment with 
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GW4869 affected LGTV replication, loads and transmigration from one cell type to 
others supporting that LGTV or other tick-borne flaviviruses may use neutral 
sphingomyelinase for packaging into exosomes; furthermore, studies would interpret the 
role of neutral sphingomyelinase on LGTV and other flaviviruses packaging in arthropod 
or mammalian exosomes. In N2a cells, 1 μM of inhibitor was sufficient to decrease the 
loads of LGTV (as proved by infection, reinfection and plaque assay) in contrast to 
higher doses (10 and 20 μM) of GW4869 that was required for inhibition of viral loads in 
primary cortical neuronal cells (Figure 22A). The clear sensitivity of N2a cells upon 
GW4869 treatment could be elucidated by the possibility of a low number of exosomes 
or less neutral sphingomyelinase in these cells when compared to cortical neurons. The 
role of GW4869 on LGTV infection in N2a cells indicated that inhibition of exosomes 
either before or after infection would affect LGTV loads and transmission (Figure 18C). 
The results from this study suggested that inhibition of exosomes reduced LGTV loads 
in both arthropod and mammalian cells, furthermore, infection with tick-borne 
flaviviruses was affected when exosome formation and release were hampered with 
GW4869 treatment. The observation of no effects of GW4869 on laboratory viral stocks 
suggested that it is specific for blocking the release of exosomes and has no direct 
effect on viral particles. It would be intriguing to determine if GW4869 or other novel 
exosome inhibitor(s) could serve as potential therapeutic approaches for treating 
flaviviral infections. The model (Figure 23) clarified the role of exosomes in the 
transmission of tick-borne flavivirus RNA and proteins from the arthropod to human cells 
and disseminated these infectious exosomes within the vertebrate host. Overall, this 
study indicated that exosomes play magnificent roles: a) In the transmission of 
tick/mosquito-borne flaviviruses from infected arthropod to the vertebrate host cells. b) 
In the infection of the human skin keratinocytes (HaCaT) and vascular endothelial cells 
(HUVEC) during tick bite/blood feeding. c) In mediating brains, infectious exosomes 
invade microvascular endothelial cells and cause neuro-invasion. d) In the infection of 
neuronal cells resulting in a higher yield of exosomes containing infectious viral RNA 
and proteins, essential for the dissemination and infection of naive neuronal cells in the 



















Figure 23. Proposed Model Shows Arthropod-Borne Flaviviruses Transmission to Human Host 
via Arthropod Exosomes  
Tick bite or injection/spit of saliva from infected ticks’ deposits exosomes containing viral infectious 
RNA or proteins securely to humans. Exosomes derived from tick cells/saliva infect human skin 
(keratinocytes) or may directly deposit saliva enriched with exosome containing tick-borne viruses into 
the blood capillaries/vessels. Exosomes derived from vascular endothelial cells containing flaviviruses 
infect neighboring endothelial cells leading into infection of the peripheral system. Higher viral loads in 
peripheral tissues increase viremia in blood and eventually allow entry and replication of these 
arthropod-borne viruses in brain microvascular endothelial cells that line the BBB. Early production 
and higher loads of flaviviruses in brain endothelial cells would allow these viruses to cross BBB and 
infect neurons. Infected neurons produce high numbers of exosomes containing infectious RNA and 
proteins that fuse with cell membranes of naïve neuronal cells thereby infecting neighboring neurons 
and leading to the spread of infection and severe neuronal loss. This figure was reproduced from the 




2.4      EXPERIMENTAL PROCEDURE 
 
Cell Culture and Infection of in vitro Cell Lines 
Ixodes scapularis ISE6 tick cell line was obtained from Dr. Ulrike Munderloh, University 
of Minnesota. ISE6 cells were cultured as per the culture methods provided by Dr. 
Munderloh (Oliver et al., 2015). Human keratinocytes (HaCaT cells) or Human Umbilical 
Vein Endothelial Cells (HUVEC) were obtained from Drs. Loree Heller and John 
Catravas laboratories, respectively. Vero (African Green Monkey kidney), mouse brain 
endothelial (bEnd.3 cells) and mouse neuroblastoma Neuro-2a or N2a cells were 
purchased from ATCC and were grown according to Company guidelines. Briefly, 
HaCaT, Vero, bEnd.3 and N2a cells were grown in complete DMEM medium containing 
5 to 10% heat-inactivated FBS (Invitrogen/ ThermoScientific). HUVEC cells were grown 
in human lung MVEC medium (M199 medium containing 150 mg ECGF Exosomes 
bovine brain extract and 20% FBS) kindly provided by Dr. Catravas laboratory. To 
determine the infection kinetics, 1 x 105 cells were seeded in a 12-well plate, infected 
with various multiplication of infections (MOI 1; tick cells), (MOI 6: Vero, HaCaT, 
HUVEC, bEnd.3 and N2a cells) of LGTV. Wild type LGTV (LGT-TP21) strain used in 
this study was obtained from Dr. Alexander G. Pletnev, NIAID, NIH. Cells were collected 
at different time points (24, 48, and 72 or 96 and 120 h post-infection, p.i.) and 
processed for RNA or protein extractions. Details for infection studies corresponding to 
the data shown in different figures are mentioned in their respective Figure legends. 
Briefly, for infection experiments (or re-infection studies) with exosome fractions 
containing infectious LGTV RNA and proteins, 1 x 105 HaCaT/HUVEC cells or N2a cells 
were infected with 20 μl (from 150 μl) of tick (6.6 x 104 pfu/ml) or bEnd.3/N2a cells (3.5 x 
103 pfu/ml) derived exosomal fractions, respectively. The same ratio of supernatant 
fractions (collected from the step before PBS wash during exosome isolation) from tick 
or bEnd.3/ N2a cells were used. Titers were determined after plaque counting and 
calculations. For studies with exosomes and exosome-free supernatant fractions, 
infected cells (infected with exosomes or supernatant fractions collected at different time 
points) were either collected at 24 or 48 or 72 h p.i. and processed for RNA extractions. 
For infection of mouse N2a cells with WNV, CT2741 wild-type strain (MOI 5) had been 
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used and cells had been analyzed for WNV loads in cells and exosomes at different 
time points (24, 48 and 72 h p.i.). 
 
Cryo-Electron Microscopy 
Exosomes were vitrified as previously described (Sherman et al., 2006; Sherman et al., 
2009) on carbon holey film grids (R2x2 Quantifoil; Micro Tools GmbH, Jena, Germany; 
or C-flat, Protochips, Raleigh, North Carolina). Briefly, purified concentrated 
suspensions of exosomes in PBS were applied to the holey films in a volume of ca. 3 μl, 
blotted with filter paper, and plunged into liquid ethane cooled in a liquid Nitrogen bath. 
Computerized Vitrobot plunger (FEI, Hillsboro, OR) was used for freezing. Frozen grids 
were stored under liquid Nitrogen and transferred to a cryo-specimen holder (70 deg. 
626, Gatan, Inc., Pleasanton, CA, or 2550 cryo-tomography holder, E.A. Fischione 
Instruments, Inc., Export, PA) under liquid Nitrogen before loading into a JEOL 2200FS, 
or a JEOL 2100 electron microscopes (JEOL Ltd., 3-1-2 Musashino, Akishima, Tokyo 
196 to 8558, Japan). JEOL 2200FS was equipped with an in-column energy filter 
(omega type) and a field emission gun (FEG); JEOL 2100 had a LaB6 filament; both 
were operating at 200 keV. Grids were maintained at near-liquid Nitrogen temperature (-
172 to -180°C) during imaging. Preliminary screening and imaging of exosomes was 
done using a 4k x 4k Gatan US4000 CCD camera (Gatan, Inc., Pleasanton, CA), and 
final imaging was done at indicated 40,000x magnification with a 5k x 4k Direct Electron 
Detector camera (DE-20, Direct Electron, Inc., San Diego, CA) using a low-dose 
imaging procedure. An in-column omega electron energy filter was used during imaging 
with a zero-loss electron energy peak selected with a 20 eV slit. Images were acquired 
with a ca. 20 electrons/A2 dose; the pixel size corresponded to 1.5 A on the specimen 
scale. A 2.0 to 2.3 μm defocus range was used for imaging. Overall, individual exosome 
images were acquired from two-three independent batches of exosomes from tick and 
N2a cells. For quantitation of exosomes size ranges, the sizes were manually analyzed 
by using scale bar from cryo-EM images and counted exosomes per image in each 
group. Three independent estimations and counting were performed without any bias. 
Percentages (for size determination) were calculated based on the total number of 
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exosomes in each size range. In addition, the total number of exosomes/cryo-EM 
images were counted and analyzed. 
 
OptiPrep Density Gradient Exosome (DG-Exo) Isolation from Concentrated 
Culture Medium 
Tick cells (1.2 x 107 cells cultured in 12 of Nunc tubes; ThermoScientific) or N2a 
neuronal cells (8 x 107 cells cultured in 8 different T75 flask; Greiner) were infected with 
either 1 MOI (tick cells; six of each tube) or 5 MOI (five of each flask with N2a cells) of 
LGTV. Remaining tubes (6) or flasks (4) were maintained as uninfected controls. The 
detailed protocol is shown (Figure 24). Supernatants (20-50ml) from uninfected/infected 
cells of respective cell types were collected and centrifuged at 4°C (480g for 10 min 
followed by 2000g for 10min to remove cell debris and dead cells). Cell culture 
supernatants were either filtered first (using 0.1 μm filtering devices; VACUCAP filter for 
conical tubes; Pall Laboratory/VWR) and concentrated to 2 to 2.5ml using the Corning 
Spin-X UF concentrators or centrifugal filter device with a 5 k nominal molecular weight 
limit (NMWL). The concentrated culture medium was processed for OptiPrep (DG-Exos) 
isolation as described (Tauro et al., 2012). In the case of OptiPrep (DG-iso) on 
laboratory virus stocks (7.4 x 106 pfu/ml), concentrated stocks of 1.5 ml supernatants 
were added directly to the gradient cushion. Briefly, discontinuous gradient of 40% 
(w/v), 20% (w/v), 10% (w/v) and 5% (w/v) solutions of iodixanol was prepared from the 
stock solution of OptiPrep 60% (w/v) of aqueous iodixanol (Axis-Shield PoC, Norway) 
with 0.25M Sucrose/10mM Tris, pH 7.5. The polycarbonate bottles with cap (Beckman 
Coulter) and maximum volume capacity of 26.3 ml were used to load the discontinuous 
gradient of iodixanol (4ml each of 40% (w/v), 20% (w/v), 10% (w/v) and 3 ml of 5% (w/v) 
from bottom to top). The cell culture supernatants (2 to 2.5ml) was overlaid onto the top 
of the gradient, and centrifuged at 100,000g for 18 h at 4°C. Six individual uninfected or 
infected fractions of ~3ml were collected (from top to bottom) manually (with increasing 
density) and diluted with 5ml of sterile PBS. Fractions were centrifuged at 100,000g for 
3 h at 4°C, and followed by one more wash with 5ml of PBS and resuspended in 80 μl 










Figure 24. OptiPrep (DG-iso) Exosome Isolation Protocol 
The schematic showed the entire procedure of isolating exosomes from different cell lines using the 
OptiPrep (DG-iso) gradient. After spinning, six fractions were generated and were ready for next 





Isolation of Exosomes from Cell Culture Supernatant 
Exosomes were isolated and purified by either DG-Exo gradient method as described 
before or differential ultracentrifugation method as described by (Théry et al., 2006). 
Details for exosome isolation procedure and modifications (used in this study) are also 
schematically shown and discussed in Figs 8 and 24 and in corresponding figure 
legends. Briefly, cells were seeded for exosomal- RNA (5 x 106 tick cells; 1 x 105 of 
either bEnd3.1 or N2a or murine cortical neurons) or protein (1 x 106 tick cells, 2 x 106 
N2a cells or 2 x 107 cortical neurons) extractions in either 12/6-well or 10cm2 plates in 
complete L15, DMEM or Neurobasal medium with FBS for overnight, respectively. The 
next day, cells were changed to the respective medium containing bovine exosome free 
FBS (Systems Biosciences Inc; SBI). Tick cells plated in commercially available 
exosome free FBS medium showed severe loss of cells, but infectious loads were not 
affected. After 4 to 6 hours of medium replacement, cells were infected with LGTV (tick 
cells MOI 1; bEnd3.1 and N2a cells MOI 6; and cortical neurons MOI 4). Tick cells were 
susceptible to 2 or 3 MOI of infection and showed massive death; hence 1 MOI dose 
was used for tick cell infection studies. Cell culture supernatants were spun at 300 x g, 
for 10 min, cells pellet was discarded, and the supernatant was spun again at 2000 x g 
for 10min. The pellet containing dead cells was discarded and the supernatant was 
spun again at 10,000 x g for 30 min to remove cell debris. Increased centrifugation 
times and rotor types were shown to improve exosome yield and purity (Cvjetkovic et 
al., 2014) and, hence these modifications for isolation of exosomes from tick cells were 
used. Either supernatants were spun at 100,000 x g, for 70 min (for bEnd.3, N2a and 
cortical neurons) or for 155 min (for ISE6 tick cells). Supernatants collected after this 
spin step served as supernatant fractions and were used as controls in our study 
(indicated in Figure 8). For plaque assays performed in this study 600, 60 and 6 μl and 
for infection studies 400 μl of supernatant fractions were used for all except HUVEC 
cells (300 μl). The pellets containing exosomes and any contaminants were washed 
one- time with ice-cold PBS and spun again at 100,000 x g, for either 70 min (for 
bEnd.3, N2a, cortical neuronal cells) or 155 min (for tick cells), respectively. Resulting 
exosomes pellets are referred to as exosome fractions in this study. Freshly prepared 
exosome pellets were collected in PBS (and stored frozen at -80°C for re-infection 
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studies performed on uninfected cells or for plaque assays or other tested evaluations) 
or resuspended in RNA lysis buffer for total RNA extractions, or in modified RIPA buffer 
(G-Biosciences, Bio Express) for total protein extractions. Exosomes from N2a cells 
were isolated using the total exosome isolation reagent and extracted total RNA and 
proteins with total exosome RNA and Protein Isolation Kit (Invitrogen/ThermoScientific) 
as per the manufacturer's instruction. 
 
RNA Extraction, cDNA Synthesis and QRT-PCR Analysis 
Total RNA from ISE6 tick cells, HaCaT, Vero, HUVEC, bEnd.3, N2a cells or murine 
cortical neurons infected with various MOI of LGTV or WNV or uninfected controls were 
extracted using Aurum Total RNA Mini Kit (BioRad) following manufacturer's instruction. 
By using the BioRad iScript cDNA synthesis kit, 1 μg RNA was converted to cDNA and 
the generated cDNA was used as a template for the amplification and determination of 
the viral burden.  
For the determination of positive- or negative-sense strands of LGTV, the iTaq 
Universal SYBR Green One-Step Kit (BioRad) was used and followed the 
manufacturer's instructions. For the detection of positive- and negative-sense strands of 
LGTV RNA, published forward and reversed primers for Langat prM-E (Mitzel et al., 
2007) were used. For WNV detection, published primers for E gene were used (Sultana 
et al., 2012). To normalize the amounts of templates, either tick or mouse or human 
beta actin amplicons were quantified with published primers (Sultana et al., 2010; 
Sultana et al., 2012). Equal amounts of tick/mouse/human cDNA samples were used in 
parallel for beta actin and Langat prM-E. The ratio of Langat prM-E gene copy/beta 
actin gene copy was used as an index to determine the rate of infection in each 
analyzed sample. QRT-PCR was performed using iQ-SYBR Green Supermix (BioRad, 
USA). Standard curves were prepared using 10-fold serial dilutions starting from 
standard 1 to 6 of known quantities of actin or Langat prM-E gene fragments and QRT-
PCR reactions were performed as described (Sultana et al., 2009; Sultana et al., 2010; 
Sultana et al., 2012). To determine the copy number of viral RNA in exosomes, the 
LGTV RNA values with standards and converted to copy numbers were used using the 
formula: Number of copies (molecules) = (amount of amplicon) ng x 1023 molecules per 
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mole/ (length of dsDNA amplicon _ 660g per mole)² _1 x 109 ng per g. Alternatively, the 
online calculator was also used to convert viral loads to LGTV copy numbers 
(http://scienceprimer.com/copy-numbercalculator-for-realtime-pcr). For RNase A 
treatment, fresh exosomes from either uninfected or LGTV-infected N2a cells (2 x 107) 
were isolated, distributed the infected exosomes as treated (5 μg/ml RNase A, 37°C for 
15 min) or untreated groups. Exosomes were also treated with Triton X-100 (0.1%, for 
45 min at RT) and then followed by treatment with RNase A as before. N2a cells (2 x 
105) were infected (72 h p.i.) with these treated, or untreated LGTV-infected exosomal 
samples were processed for RNA extractions and QRT-PCR. Untreated exosomal 
samples from uninfected group served as internal controls. 
 
Immunoblotting 
Western blotting was performed as described (Sultana et al., 2009; Sultana et al., 
2012). For DG-Exos samples, equal volume (20 μl) of each fraction from 1 to 6 or 20 μg 
of total protein lysates from uninfected and infected cells or 10 μl of each fraction from 
virus stock samples were loaded onto 12% SDS-PAGE, followed by immunoblotting and 
labeling with highly cross-reactive 4G2 monoclonal antibody to detect LGTV E-protein 
or exosomal specific markers such as HSP70 (rabbit polyclonal; Cell Signaling 
Technologies, Inc) or CD9 (mouse monoclonal; Invitrogen/ThermoScientific) and 
respective secondary antibodies (Santa Cruz Biotechnologies, Inc). For immunoblotting 
using cell lysate and exosome lysates, briefly, 5 x 106 ISE6 tick cells, or 2 x 106 N2a 
cells or 2 x 107 cortical neurons were seeded in 10 cm2 plates and allowed to 
settle/adhere for overnight. The next day, the media on N2a cells and neurons was 
changed to DMEM or Neurobasal medium, respectively containing bovine exosome free 
FBS (Systems BioSciences, Inc; SBI). ISE6 cells were retained with complete L-15 
media containing 5% regular FBS (to avoid massive cell death and loss observed when 
processed for exosome isolation using commercially available exosome-free FBS; SBI). 
After 4 to 6 hours of media replacement, cells were infected with LGTV (tick cells, MOI 
1; N2a cells, MOI 6 and cortical neurons, MOI 4). After 72 h (tick cells) or 24, 48, 72 h 
p.i. (N2a cells and neurons), cell culture supernatants were collected and processed for 
exosome isolation by ultracentrifugation (Figure 8). The exosome fractions collected 
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after PBS wash and the adherent cells collected from the same plates (washed twice 
with 1 x PBS), were resuspended in modified RIPA buffer. Total protein amounts were 
estimated using the BCA kit (Pierce/ThermoScientific). 25 μg (tick cells) or 30 to 35 μg 
(N2a and cortical neurons) of total cell lysates or total exosomal proteins were loaded 
and separated them on either 12% (Laboratory casted) or pre-casted 4 to 20% SDS-
PAGE gradient stain-free gels (NuSep; BioExpress). Followed by gel electrophoresis, 
blots were blocked in buffers and probed with either highly cross-reactive 4G2 (obtained 
from Dr. Michel Ledizet, L2 Diagnostics; under non-reducing conditions) or CD9 
(Invitrogen/ThermoScientific; under non-reducing conditions) or monoclonal anti-Langat 
virus NS1 (Clone 6E11; BEI Resources) antibodies, followed by mouse monoclonal 
HRP-conjugated secondary antibodies (Santa Cruz Technologies, Inc). Total protein 
profiles (images obtained from stain-free gels after running or imaged from Coomassie-
stained gels) serve as loading controls. For protease-resistance assay using proteinase 
K (that generally digest proteins in biological samples), typical working concentrations of 
50 to 100 μg/ ml (for tick cells; 50 μg/ml) or much above the concentrations (for N2a 
cells; 100 μg/μl)were used. Briefly, fresh exosomes (ultracentrifugation methods) from 
tick (2 x 106) or N2a cells (2 x 107) were isolated and treated with Proteinase K for 15 
min at 37°C. Samples were then heat-inactivated at 60°C for 10 min and loaded on 
SDS-PAGE gels and processed for immunoblotting with 4G2 antibody followed by 
relevant secondary antibody. Antibody binding was detected with the WesternBright 
ECL kit (Advansta, BioExpress). Blots were imaged using Chemidoc MP imaging 
system and processed using Image Lab software from the manufacturer (BioRad). 
 
Native-PAGE Analysis 
For the native-PAGE analysis, ISE6 tick cells (2 x 106) were seeded in regular L15 
medium for overnight and infected with LGTV (MOI 1). For N2a cells (5 x 106), they 
were plated in regular complete DMEM medium and allowed them to adhere for 
overnight, cells were then replaced with exosome-free FBS medium. After 4 h of media 
change, N2a cells were infected with LGTV (6 MOI). Post 72 h of infection, tick/N2a cell 
culture supernatants were processed for isolation of exosomes. Exosomes collected 
from uninfected or LGTV-infected tick/N2a cells were resuspended in PBS and 
63  
 
distributed into three groups (from the same preparations), that were either held as 
untreated group on ice, treated with Triton-X-100 (0.03%; 30 min, RT), or processed for 
three cycles of freezing at -80°C (for each freezing cycle samples were incubated for 1 
h). After treatment and processing, protein lysates were prepared in a non-reducing and 
non-denaturizing sample buffer (62.5 mM Tris-HCL, pH 6.8, 25% Glycerol and 1% 
Bromophenol blue), that maintained the proteins secondary structure and native charge 
density. Gels were pre-run for 60 min in gel running buffer (25 mM Tris and 192 mM 
Glycine). Uninfected or LGTV-infected exosomal preparations with different treatment or 
untreated samples were separated on 12% native-PAGE gels. Gels were transferred on 
to nitrocellulose membranes followed by immunoblotting using 4G2 or NS1 monoclonal 
antibodies followed by mouse monoclonal HRP-conjugated secondary antibodies 
(Santa Cruz Technologies, Inc). Total protein profiles (Coomassie-blue stained gel) 
serve as loading controls. Antibody binding was detected with WesternBright ECL Kit 
(Advansta, BioExpress). Blots were scanned using Chemidoc MP imaging system and 
instructions from the manufacturer (BioRad). 
 
ELISA 
N2a cell-derived exosomes from 5 x 106 uninfected or LGTV-infected (MOI 6; 72 h p.i.) 
cells were collected and resuspended in PBS (250 μl/sample). Exosomal fractions were 
grouped as untreated or treated with 0.1% of Triton-X-100 for 30 min. Nunc grade 
ELISA plates were coated with 50 μl of untreated or Triton-X-100 treated- uninfected or 
infected samples for overnight and incubated at 4°C. Samples were incubated with 4G2 
antibody for 1 h, followed by HRP-conjugated mouse monoclonal secondary antibody 
for another 1h as described (Sultana et al., 2009). SureBlue TMB Microwell Peroxidase 
substrate and Stop solution (KPL) were used and followed the manufacturer's 
instructions. After stopping the reactions with TMB Stop solution, optical density was 
measured from triplicate samples at an absorbance of 450nm using a Multimode infinite 





E-Protein-Antibody-Beads Binding Assays 
LGTV-infected tick or N2a cell-derived exosomes (from 72 h p.i.) were freshly isolated 
from 2 x 106 tick cells (infected with MOI 1) or 5 x 105 N2a cells (infected with 6 MOI). 
Exosomes from GW4869 inhibitor (5 μM) treated tick or N2a cells were isolated. For 
inhibitor treatment, cells were seeded in plates for overnight, changed to exosome-free 
FBS medium (in case of N2a cells) and after 4 h, treated with exosome release 
GW4869 inhibitor for 4h, followed by infection with LGTV for 72 h p.i. The exosomes 
collected from untreated or inhibitor treated cells were resuspended in PBS and 
grouped into three categories for both inhibitors treated or untreated samples as; 
untreated, treated with 4G2 antibody (that recognizes LGTV E-protein) or relevant 
isotype control antibody (R & D Systems) groups. Exosomal fractions were incubated 
for 1 h (RT) with respective antibodies followed by incubation (4°C) with protein A/G 
agarose beads (Pierce/ThermoScientific) for another 30 min. The antibody-beads 
complexes were spun (13,000 rpm) at 4°C for 30 min and supernatants were collected 
and lysed in RNA lysis buffer, processed for RNA extractions, followed by cDNA 
synthesis and QRT-PCR to detect LGTV loads. 
 
Trans-Well Assays 
Assays were performed to analyze the trans-migration of infectious exosomes from 
infected cells (seeded in inserts; upper chamber) to uninfected cells seeded in 12-well 
plates (lower chamber). Sterile, polycarbonate tissue culture-treated trans-well inserts 
(12mm insert size) with 0.4 μm microporous membrane pore size were used in our 
assays (Corning). 1 x 105 ISE6 tick or bEnd.3 cells in inserts (upper chamber) were 
plated and 1 x 105 HaCaT or N2a cells were seeded in 12-well plates (lower chamber). 
Inserts with tick or bEnd.3 cells were first kept in a separate 12-well plate containing 0.5 
ml (in order to keep microporous membranes moist/ wet) of L-15 (tick cells) or DMEM 
complete medium (bEnd.3 cells), respectively. Inhibitor treated group in trans-well 
assays was treated with 5 μM of GW4869 inhibitor, and at 24 h post-treatment, tick cells 
or bEnd.3 cells were either infected with exosomes containing LGTV (25 μl of the 
exosome fraction collected from infected tick or bEnd.3 cells) or with LGTV from 
laboratory viral stocks (MOI 1 for tick cells or MOI 6 for bEnd.3 cells) prepared from 
65  
 
infected Vero cell culture supernatants. Four hours post-infection inserts with tick or 
bEnd.3 cells (with the change of new media) were moved to 12-well plates containing 
HaCaT or N2a cells, respectively. Exosomes containing viral RNA and proteins 
produced from tick or bEnd.3 cells could transmigrate and infect HaCaT or N2a cells 
(that were kept uninfected). After, 48 h post incubation with inserts (containing either 
infected tick or bEnd.3 cells in inserts or upper chambers), HaCaT or N2a cells from 
lower chamber were washed with ice-cold PBS (3x) and collected for RNA extractions, 
cDNA synthesis and QRT-PCR to determine viral loads from cells. 
 
Plaque Assays 
Plaque assays were performed as described (Sultana et al., 2009). To determine 
infectious and replicative viruses after incubation with exosome and exosome-free 
supernatant fractions, Vero cells were seeded in 6-well plates at densities of 1 x 106 
cells per well, allowed them to adhere and grow as monolayers to reach 65 to 85% 
confluency (for ~24 h). Exosome fractions containing unknown PFU (plaque forming 
units) of LGTV viral genomes were collected from tick cells (5 x 106 cells) or N2a cells or 
murine cortical neurons (1 x 105 cells) and resuspended in 250 μl of PBS, 30 μl of this 
suspension (exosome fraction) was used for plaque assays. Exosome free 
supernatants (600 μl) that corresponds to the same ratio of exosome fractions were 
used as controls. Serial dilutions (1:10, 1:100 and 1:1000) of the exosomes or 
supernatant fractions were prepared in duplicate (shown are the representative plate 
images from two-three independent experiments). Monolayers of Vero cells were 
infected with exosomes or supernatant fractions or with exosomes from 1 μM or 10 
μM(LGTV-infected N2a cells or mouse cortical neurons) of GW4869 inhibitor-treated or 
DMSO-treated controls. Four hours post-infection, medium was removed and warm 2% 
Seaplaque agarose (Lonza) overlay with complete DMEM media (1:1 ratio) containing 
antibiotic and antimycotics solution (1% each; Sigma) was added. Plates were 
incubated for 6 to 7 days, at 37°C, 5% CO2. After incubation period, plaques were 
stained with 0.03% of Neutral Red (Sigma) for 4 h, and the stain was removed to either 
count plaques on the same day or otherwise plates were incubated (inverted and 
66  
 
covered in foil) for overnight, and then plaques were counted next day to determine the 
viral titers from LGTV-infected exosomal fractions from tick/neuronal cells. 
 
Isolation and Infection of Murine Cortical Neurons 
Gestation period (day 13) wild-type female C57BL/6 (Charles River Laboratories) mice 
were purchased and allowed to reacclimatize. All animal experiments were done in 
accordance with the University Animal Care and Use Committee regulations. Primary 
cortical neurons were isolated from embryonic day-16 (E16) brains (Sultana et al., 2009; 
Sultana et al., 2012). Murine cortical neurons (1 x 105) were seeded in a 12-well plate 
coated with poly-L-Lysine and cultures were established in neurobasal complete 
medium with FBS. After 24h of plating, half of the medium was replaced with FBS free 
neurobasal media, to slow growth of glial cells. For infection kinetics, cortical neurons 
were infected with LGTV (MOI 4) (after 48 h of post-seeding), neurons were collected at 
different time points (24, 48, 72 and 96 h p.i.) and processed for RNA extractions. For 
infection with neuronal cell-derived exosomes or supernatant fractions, 1 x 105 murine 
cortical neurons were infected with 20 μl of neuronal exosomes (2.2 x 103 pfu/ml) or 400 
μl of exosome free supernatant fractions (collected from the step before PBS wash 
during exosome isolation, See Figure 8). Cells were harvested at 48 h p.i. and 
processed for RNA extraction. Protein extractions were collected from uninfected or 
LGTV-infected cortical neurons (seeded at 1 x 107 cells) or from exosomes isolated 
from these cell culture supernatants. 
 
Inhibitor Treatments 
For exosome inhibition studies, GW4869, a cell-permeable, a selective inhibitor for 
Neutral Sphingomyelinase (N-SMase) (Santa Cruz Biotechnologies, Inc) was used and 
DMSO worked as controls. Cells did not show any toxicity at tested doses. For both 
trans-well assays, inhibitor-treated group was treated with 5 μM exosome inhibitor. N2a 
cells or murine cortical neurons were seeded at 1 x 105 cells in a 12-well plate. Next 
day, before treatment with inhibitor, cells were replaced with bovine exosome free-FBS 
(Systems BioSciences, Inc.) containing DMEM (N2a cells) or neurobasal medium 
(neurons). Cells were treated with either 1, 5 or 10 μM (N2a cells) or with 1, 10 or 20 μM 
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(neurons) of inhibitor for 4 h, followed by infection with LGTV (N2a cells, MOI 6; cortical 
neurons MOI 4). Plaque assays were performed with 30 μl of exosome fractions derived 
from N2a cells or cortical neurons to determine the unknown titers for both DMSO 
control and inhibitor treated groups, respectively. N2a cells were either pre- or post-
treated with inhibitor, where cells were first treated with inhibitor (5 μM) for 4 h followed 
by infection for 72 h or vice versa, respectively. Supernatants collected from uninfected 
controls and cells infected with LGTV (laboratory virus stocks with known titers) (48 h 
p.i.) were processed for exosome isolation. Purified exosomes were resuspended in 
PBS and processed for either RNA extraction or used for infection of new cells to 
determine re-infection kinetics or used to determine viral titers by plaque assays. For 
GW4869 treatment on laboratory virus stocks, the viral supernatants (collected from 
Vero cells) were treated with known titers (7.4 x 106 pfu/ml). 30 μl of the virus stocks 
were used and treated with either DMSO or inhibitor (5 and 10 μM for 4 h at 37°C) 
followed by immunoblotting with 4G2 antibody. For 4G2 functional blocking antibody 
studies, N2a cells (2 x 105) were plated, treated with 5 μg of antibody for 4 h and 
infected cells with freshly isolated exosomes from LGTV-infected (72 h p.i.) N2a cells. 
N2a cells were infected through infectious exosomes for 72 h p.i. and collected for RNA 
extractions and QRT-PCR analysis. Untreated samples serve as a control. For Pitstop-2 
inhibitor treatment, N2a cells (2 x 105) were treated with 30 μMPitstop-2 (dissolved in 
DMSO) for 15 min followed by infection through freshly isolated exosomes from LGTV-
infected (72 h p.i.) N2a cells. Cells were collected for RNA extractions after 72 h p.i. and 
further processed for QRT-PCR. DMSO treated cells served as controls. 
 
Statistics 
The statistical difference observed in data sets was analyzed using GraphPad Prism6 
software and Microsoft Excel. The non-paired, two-tail Student t-test was performed (for 
data to compare two means) for the entire analysis. Error bars represent mean (+SD) 
values, P-values of <0.05 were considered significant in all analysis. Statistical test and 






All animal work in this study was carried out in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the 
National Institute of Health. The approved protocol from the Institutional Animal Care 
and Use Committee (Animal Welfare Assurance Number: A3172-01) (permit number: 






EXOSOMES MEDIATE ZIKV TRANSMISSION THROUGH SMPD3 




Mosquito-borne Zika virus (ZIKV) is a positive-sense single-stranded RNA virus that 
belongs to the family Flaviviridae and flavivirus genus (Wang et al., 2017b). ZIKV has 
been highlighted due to its recent epidemic outbreak in Brazil and disseminates in 
several parts of the Western Hemisphere including the United States of America (Russo 
and Beltrao-Braga, 2017; Wang et al., 2017b). ZIKV refers to the Spondweni 
serocomplex and is firmly conserved with dengue (DENV) and the West Nile virus 
(WNV) (Wang et al., 2017b). Mostly, infections with ZIKV are asymptomatic (∼80%) 
with flu-like symptoms and affiliate with the clinical phenomenon. The transmission of 
ZIKV by sexual approaches, with reproductive viral particles that be detected in semen 
for at least two months, pose a significant global threat and a pathogen of high priority 
concern to the public health (Maxian et al., 2017; Moreira et al., 2017). Typically, Aedes 
aegypti, a mosquito species, transmits the majority of ZIKV infections to humans. 
However, ZIKV can also be disseminated through sexual contacts and transfusions of 
human blood by the clinical actions. In humans, the greatest concern is the vertical 
transmission of ZIKV from mother to neonates and this has drawn humans’ attention 
due to the associated neurological manifestations (Faizan et al., 2016; Russo and 
Beltrao-Braga, 2017; van den Pol et al., 2017b; Wang et al., 2017b). ZIKV infection has 
been shown to affect both the Central Nervous system (CNS) and the Peripheral 
Nervous System (PNS).  It also causes severe neurological complications such as  
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Guillain-Barré syndrome (GBS with muscle weakness and paralysis) and the 
conscientious manifestation of microcephaly (Faizan et al., 2016; Lagunas-Rangel et 
al., 2017; Russo and Beltrao-Braga, 2017; van den Pol et al., 2017b; Wang et al., 
2017b). Microcephaly, a less studied neurodevelopmental disorder is a magnificent 
reduction in brain size and intellectual disability with deficient cell proliferation and 
severe death of cortical progenitor cells and their neuronal progeny (Olagnier et al., 
2016; Lagunas-Rangel et al., 2017; Wen et al., 2017). 
Although the emergence of ZIKV-associated congenital microcephaly and 
neuropathogenesis is being studied extensively, this line of research is currently very 
limited. Recently, significant and stunning progress has been made in developing stem 
cell-based cellular and animal models (Olagnier et al., 2016). Besides the identification 
of hidden molecular mechanisms and development of therapeutic strategies and 
vaccines, the engagement of human tissues samples has led to a better perception of 
ZIKV infections (Olagnier et al., 2016; Russo and Beltrao-Braga, 2017; van den Pol et 
al., 2017b). In a developmental ZIKV infected mouse model, it has been shown that 
astrocytes were targeted throughout the brain after ZIKV entered the CNS after 
peripheral inoculations (Van den Pol et al., 2017b). ZIKV has been shown to 
significantly infect and replicate in mouse neural stem cells (mNSCs), mouse astroglial 
cells, and different regions of brain including neocortex and hippocampal regions (CA1 
and CA3), thereby raising several concerns related to long-term memory issues 
(Olagnier et al., 2016; Van den Pol et al., 2017b). ZIKV RNA has been detected in 
neural tissues, human neural progenitors, matured neurons and has been interacted 
with an increase in the apoptosis-related genes in those neuronal cells (Li et al., 2016; 
Oh et al., 2017a; Van den Pol et al., 2017b). The cerebral cortex, a four-layered 
structure that mediates the higher cognitive functions, including learning and memory 
has been severely affected in microcephalic patients (Faizan et al., 2016). Two 
independent studies have also shown that ZIKV infection can significantly reduce the 
growth of neural stem cells and brain organoids that can be directly connected to the 
ZIKV-associated congenital microcephaly (Ming et al., 2017; Qian et al., 2017; Wen et 
al., 2017). A comparative analysis approach in the developing neocortex has identified 
ZIKV specific alterations and preferential infection of neural stem cells (Brault et al., 
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2016). However, this study does not elucidate the critical steps of how ZIKV arrives the 
brain. Also, the transmission dynamics of ZIKV in and between neurons or their stem 
cells is broadly unexplored. 
Exosomes have been shown to perform both neuroprotective and toxic roles in 
the CNS (Chivet et al., 2012). Several reports have indicated neuronal exosomes serve 
as novel therapeutic targets for neurological disorders such as Alzheimer’s disease 
(Chivet et al., 2012; Janas et al., 2016; Kanninen and Malm, 2016). In this current study, 
the assumption that ZIKV uses exosomes to transmit to other neurons and spread 
infection through neuronal connectivity in establishing embryonic fetal and neonatal 
brains was evaluated. This study shows that exosomes derived from mouse cortical 
neurons carry ZIKV infectious RNA and proteins that mediate viral transmission to other 
neurons, thus assisting in viral dissemination throughout the CNS. Also, this work 
suggests that neutral Sphingomyelinase SMPD3 (nSMase2), an enzyme sphingomyelin 
phosphodiesterase, is engaged in ZIKV infection, replication, and mediates viral 
materials transmission via neurons derived exosomes. SMPD3 hydrolyzes 
sphingomyelin to phosphocholine and ceramide and is predominantly expressed in the 
neurons of the CNS to control postnatal growth and development (Stoffel et al., 2005; 
Stoffel et al., 2016; Menck et al., 2017). Furthermore, SMPD3 has been shown to 
inhabit in the Golgi apparatus and is ubiquitously expressed, thereby suggesting its 
significant role in ZIKV replication (Stoffel et al., 2005; Stoffel et al., 2016). Taken 
together, this study not only provides a model in understanding the importance of 
exosomes but can also explore some new strategies on the development of exosomal-








ZIKV Infect Mouse Cortical Neurons in a Time and Dose-Dependent Manner 
Smaller head circumference, intellectual ability and seizures that characterize 
microcephaly, has been strongly associated with ZIKA virus (ZIKV) infections (Faizan et 
al., 2016; Olagnier et al., 2016; Wen et al., 2017). Also, an interaction between ZIKV 
and diminished neuronal differentiation or expended cell death in neuronal cells has 
been shown (Faizan et al., 2016; Russo and Beltrao-Braga, 2017; van den Pol et al., 
2017a). In spite of determine the right time of neuronal differentiation and to analyze if 
cells in primary cultures are perhaps not in progenitor state during ZIKV infection, 
Neuronal cultures for either 72 or 120 h (post-plating) were plated followed by infection 
with ZIKV (for another 72 h p.i., 5 MOI; Multiplication of Infection). Freshly dissected 
primary murine cortical neurons culture from embryonic (E16) developing mouse brains 
were infected. Primary cultures were stained for both neuronal marker MAP-2 
(Microtubule Associated Protein-2) and GFAP (Glial Fibrillary Acidic Protein), a 
transitional filament protein used as astrocyte marker (Figure 25). At both post-plating 
time points of 72 and 120 h, it had been found that progenitor cells were fully 
differentiated as neurons as revealed by the staining for MAP-2 (green) followed by 
detection with Alexa Fluor 488 (Figure 25). No astrocytes or other glial cells or neuronal 
precursor cells (NPCs) (for GFAP positive staining, and detection with Alexa Fluor 594) 
had been found in the primary cultures of murine cortical neurons at 72 or 120 h of post-
plating, followed by infection with ZIKV (for another 72 h) (Figure 25). Also, the bright 
field (BF) images, predominantly showed neuronal cells in the primary cultures at both 
72 and 120 h post-plating of cells (Figure 25). Infection of primary cultures of cortical 
neurons at/after 72 or 120 h post-plating had no differences upon ZIKV infection. Some 
of the DAPI-positive but weak MAP-2 stained cells were found to have strong staining 
for ZIKV Envelope (E) protein (detected by 4G2 monoclonal antibody, followed by Alexa 
Fluor 594 secondary antibody) (Figure 26). It was presumed that neuronal cells perhaps 
had revoked their neurites due to severe ZIKV infection, thus leading to neuronal death 
in those weak MAP-2 stained cells. It was also observed that ZIKV rapidly infected (5 














compared to the uninfected control (Figure 27A). Furthermore, cortical neurons’ death 
with ZIKV infection was harsh at 120 h p.i., comparing to the infection at early time 
points, suggesting longer incubation times leading to severe damage and neuronal 
death, perhaps contributing to tissue loss (Figure 27A). Several neuronal connections 
were eliminated, and severe damage was shown due to massive cell deaths in murine 
cortical neurons at 120 h p.i., (Figure 27A). No morphological changes or cell loss at 
earlier tested time points (24, 48 and 72 h p.i.) of ZIKV infection (Figure 27A) were 
Figure 25. Murine Cortical Neurons in Primary Cultures are Differentiated as Neurons from 
Progenitor Cells  
Phase-contrast and fluorescent microscopic images showed the primary cultures of cortical neurons 
from uninfected (UI) or ZIKV (I) infected (MOI 5; 72 h p.i.) groups at two different time points (72 and 
120 h post-plating). Cortical neurons were stained for a neuronal marker (MAP-2) or astrocyte marker 
(GFAP) to show the presence of neurons and the absence of glial cells. DAPI staining for nuclei 
served as an internal control. Uninfected neurons served as a control. Representative images 
obtained from the EVOS FL system were shown. Scale bar indicated 200 μm in all panels. This figure 












found. The quantitative analysis for measuring cell viability of primary cultures of cortical 
neurons by MTT assay showed the decreasing of viable cells at later time points (72, 96 
and 120 h) of ZIKV infection (Figure 27B).  
To measure the neuronal cell loss, is due to longer incubations with ZIKV 
infection, an independent experiment with different doses (MOI 1, 2.5 and 5) of ZIKV 
was performed. At 72 h p.i., not many considerable morphological changes were found 
in ZIKV infected cortical neurons at tested doses (of MOI 1, 2.5 and 5) (Figure 28A). 
Whereas, the quantitative analysis provided by MTT assay indicated some reduction in 
cell viability at 72 h post-ZIKV infection with 5 MOI (Figure 28B). These results suggest 
that neuronal cell death at 96 h p.i., and onwards is mostly due to the consequences of 
protracted infection of neurons with ZIKV and the neuronal stress related to infection. 
QRT-PCR analysis performed on the neuronal samples collected at different time points 
proved that ZIKV loads (both E-gene and NS5 mRNA transcripts) were magnificently (P 
Figure 26. Cortical Neurons Showed Diminished MAP-2 Signals Upon ZIKV Infection  
Primary cultures of cortical neurons showed the enhanced ZIKV E-protein staining (as detected by the 
4G2 monoclonal antibody, followed by Alexa Fluor 594) and the reduced MAP-2 fluorescence (as 
detected by MAP-2 monoclonal antibody followed by Alexa Fluor 488) in cells. Bright-field and DAPI 
images were shown as controls. Neurons were infected with ZIKV (5 MOI; 72 h p.i.) viral stocks and 
representative images obtained from the EVOS FL system were shown. Scale bar indicated 200 μm in 




< 0.05) enhanced at 72 h p.i., in comparison to the other time points (of 24, 48 and 96 h 
p.i.,) (Figures 29A and B). The lower loads of ZIKV at 96 h p.i. was perhaps because of 
the severe neuronal cell death observed at this time point (Figures 29A and 29B). 
Immunoblotting analysis (using a highly cross-reactive 4G2 monoclonal antibody that 
recognizes the viral Envelope (E)-protein) showed similar results with increased ZIKV E-
protein at 72 h p.i., in comparison to the loads at other time points (Figure 29C). It was 
also shown that HSP70 (heat-shock protein 70, an enriched marker in mammalian 
exosomes) loads were boosted upon ZIKV infection at 48, 72 and 96 h p.i., when 
compared to their corresponding uninfected controls (Figure 29C). HSP70 levels were 
rarely detected at 24 h p.i. in the tested conditions (Figure 29C). Furthermore, a dose-
dependent enhancement in ZIKV loads was evidence both at the RNA (E-gene and 
NS5 mRNA transcripts) and protein levels when cortical neurons were infected with 1, 
2.5 or 5 MOI at 72 h p.i. (Figures 29D-29F). In both time and dose-response tested 
groups (Figures 29A, 29B, 29D and 29E), NS5 mRNA amplification was found to be 
higher in comparison to the E-gene amplification; hence NS5 detection was used in our 
further analysis. Total protein profile gel images served as loading controls in the 
immunoblotting analysis (Figures 29C and 29F). Densitometry analysis from total cell 
lysates showed the quantitative differences in E-protein (from both the time point and 
dose-response samples) and HSP70 levels obtained between the ZIKV infected (MOI 5) 
and uninfected controls (Figures 30A-30C). Overall, these results suggested time- and 
dose-dependent infection kinetics of ZIKV in mouse cortical neurons. 
 
Detection of Exosomes Derived from Mouse Cortical Neurons by Cryo-EM and 
Western Blot 
Regardless of the importance of ZIKV infection and its cause of severe neurological 
complications such as GBS and the more attentive manifestation of microcephaly in 
neonates, the transmission modes of ZIKV within the neonatal and adult brain cells 
were known little. Increased HSP70 levels in neuronal cells upon infection (Figure 29C) 
suggested that ZIKV perhaps uses neuronal exosomes for transmission and spread of 
infection in the brain. It has been shown that cortical neurons release exosomes in 














 (Olagnier et al., 2016; Zhou et al., 2018b). Due to increased viral loads at 72 h p.i., this 
time point was considered for the isolation of exosomes from cortical neuronal cultures. 
Using either density gradient centrifugation technique; OptiPrep™ (DG-Exo isolation), or 
by differential ultracentrifugation, exosomes from murine cortical neurons were isolated 
(Tauro et al., 2012; Olagnier et al., 2016). Detailed protocols and descriptions are 
Figure 27. Murine Cortical Neurons in Primary Cultures are Susceptible to ZIKV Infection at 
Longer Incubation Time  
(A) Phase-contrast images showed primary cultures of cortical neurons from uninfected (UI) and ZIKV 
(I) infected (MOI 5) groups at different time points (of 24, 48, 72, 96, and 120 h p.i.). Uninfected 
neurons served as a control. Representative images obtained from the EVOS FL system were shown. 
Scale bar indicated 100 μm in all panels.  
(B) MTT assay showed cell viability of mouse cortical neurons at different time points (of 24, 48, 72, 
96, and 120 h p.i.) upon ZIKV infection (5 MOI). Relative optical density showed live cells in culture. 
Uninfected controls kept for 120 h were considered as controls.  





published in the recent work on neuronal exosomes (Olagnier et al., 2016; Zhou et al., 
2019). Cryo-Electron Microscopy (EM) performed on neuronal cell-derived exosomes 
showed their sizes in the ranges of 30-200 nm in diameter (Figure 30A) that are similar 
to exosomes isolated from other mammalian cells. Quantitative analysis of the 
heterogeneous populations of neuronal exosomes was performed to determine any 
differences between ZIKV-infected and uninfected cell-derived exosomes (Figures 30B 
and 30C). The highest percentage of exosomes size was between 50-100 nm and 100-
150 nm (in diameter) in both uninfected and ZIKV-infected groups (Figures 30B and 
30C). However, ZIKV infected neuronal cell-derived exosomes had increased 
percentages in 0-50 nm but decreased percentages in 100-150 nm and 150-200 nm 
sizes in comparison to the uninfected group (Figures 30B and 30C). Also, higher 
percentages of larger exosomes or Extracellular Vesicles (EVs) of sizes 200-500 nm 
were observed upon ZIKV infection in comparison to the uninfected group (Figures 30B 
and 30C). In addition, the higher number of exosomes in cryo-EM images collected from 
ZIKV-infected (n = 25) group was noted in comparison to the uninfected (n = 13) group 
(Figure 30D). These data suggest increased production and or release of neuronal 
exosomes upon ZIKV infection. 
To find whether ZIKV proteins are evident in neuronal exosomes, six different 
fractions from samples collected at 72 h p.i. were collected, following the Opti- Prep™ 
(DG-Exo) isolation method as described in (Tauro et al., 2012; Zhou et al., 2018b). 
Neuronal HSP70 was detected in 20 μl of the infected exosomes from three to five 
fractions. Barely detectable levels of HSP70 were noted in fractions one, two and six but 
enhanced levels were noted in fractions three to five (Figure 30E). HSP70 loads were 
also detected in exosomal fractions three-five obtained from uninfected cortical neuronal 
cells, but with higher levels in fractions five (Figure 30E). Additionally, for detailed 
characterization of exosomes, the presence of other exosomal markers such as CD63 
and CD9 were detected in fractions from both ZIKV-infected and uninfected groups 
(Figure 30E). CD63 loads were enriched in fractions three-six in ZIKV infected and 
fractions four-six in uninfected controls. Barely detectable loads were observed in one 
and two fractions in both infected and uninfected groups (Figure 30E). CD9 was also 














detectable levels were found in fractions two and three of the infected group (Figure 
30E). In other fractions (one and six), CD9 loads (Figure 30E) could not be detected. It 
was found that ZIKV E-protein levels were enhanced in infected exosomal fraction four, 
however, other fractions (two, three and five) also showed a weak signal for E-protein 
(Figure 30E). As expected, ZIKV E-protein was not detected in any uninfected fractions 
(Figure 30E). 
Figure 28. Murine Cortical Neurons in Primary Cultures are not Affected with 1 and 2.5 MOI Doses 
of ZIKV at 72 p.i. 
(A) Phase-contrast images showed primary cultures of cortical neurons from uninfected (UI) or ZIKV-
infected (72 h p.i.) groups and at different doses of infection (MOI 1, 2.5 and 5) were shown. 
Uninfected neurons served as a control. Representative images obtained from the EVOS FL system 
were shown. Scale bar indicated 400 μm in all panels.  
(B) MTT assay showed the cell viability of mouse cortical neurons at different doses (1, 2.5, and 5 
MOI) of ZIKV infection (72 h p.i.). Relative optical density showed live cells in culture. Uninfected 
controls kept for 120 h were considered as controls. 




















Figure 29. ZIKV Infects Primary Cultures of Cortical Neurons in a Time- and Dose-Dependent 
Manner  
(A-B) QRT-PCR analysis showed the ZIKV loads (MOI 5) determined by either E-gene or NS5 mRNA 
transcripts in neuronal cells at different time points (of 24, 48, 72, and 96 h p.i.). Uninfected cells (UI) 
at indicated time points served as controls.  
(C) Immunoblotting analysis showed the ZIKV E-protein levels at different time points (24, 48, 72, and 
96 h p.i., MOI 5). HSP70 loads served as an internal control.  
(D-E) The ZIKV loads at different MOI of infection (1, 2.5, 5 MOI) determined by either E-gene or NS5 
mRNA transcripts were shown from 72 h p.i. 
(F) Immunoblotting analysis showed the viral E-protein loads in cortical neurons upon infection with 
various doses (1, 2.5, 5 MOI). Uninfected cells were used as control in all panels.  
The total protein profiles shown by Coomassie-stained gels served as loading controls. All gene 
transcript levels were normalized to mouse beta-actin. P values were determined by the Student’s two-
tail t-test. 


















Figure 30. Exosomes Derived from Murine Cortical Neurons are in Heterogenous Populations  
(A) Cryo-EM representative images showed the exosomes isolated from uninfected (UI) or ZIKV-
infected (I) (MOI 5; 72 h p.i.) cortical neuronal cells. Scale bar indicated 100 nm.  
(B) The size distribution of exosomes isolated from uninfected or ZIKV-infected neuronal cells was 
shown. The Y-axis represented the exosome number and X-axis indicated the exosome size in 
diameter (e.g., 0-50 nm).  
(C-D) Percentages were calculated based on the total number of exosomes in each size range. 
Exosome numbers counted from uninfected and ZIKV-infected groups were shown. The Y-axis 
represented the exosome number and X-axis indicated the samples analyzed. P values were 
determined by the Student’s two-tail t-test.  
(E) Immunoblotting images from OptiPrep density gradient exosomes preparation (DG-Exo-isolation) 
showed the enhanced ZIKV-E (MOI 5, 72 h p.i.) protein loads and presence of HSP70, CD63 and 
CD9 (exosomal markers) in different exosome fractions. Exosomes derived from uninfected cells 
served as controls. Roman numerical indicated the fraction numbers. 





Cortical Neurons Derived Exosomes Contain ZIKV RNA and proteins 
Since, in most of the cases,  ZIKV-E protein was detected in fraction 4 (the fraction with 
enhanced levels of all exosomal markers), this fraction was assumed as more viral 
RNA/proteins presented and their coincidence to increased infectivity on the naïve 
recipient cells. It was found that naïve primary murine cortical neurons cultures were 
infected via incubations (for 72 h) with infectious exosomes from different preparations 
(derived from ZIKV-infected cortical neurons, at 72 h p.i., and 5 MOI) showed the 
highest infectivity with fraction 4 (Figure 31A). Exosomes from lower fractions 5 and 6, 
also suggested enhanced infectivity in comparison to the upper (1-3) fractions (Figure 
31A). Next, loads of ZIKV in exosomes derived from cortical neurons infected at 
different time points (of 24, 48, 72, and 96 h p.i., 5 MOI) were measured. Like viral loads 
obtained in cortical neuronal cells, ZIKV RNA loads were magnificently (P < 0.05) higher 
at 72 h p.i., when compared to the other time points (of 24, 48 and 96 h p.i.) (Figure 
31B). The lower loads of ZIKV at 96 h p.i., is perhaps because of the neuronal cell 
death observed at this time point (Figure 27A). It was presumed that a smaller number 
of exosomes were released upon the massive death of neurons at 96 h p.i., (Figure 
31B). Immunoblotting with 4G2 antibody showed increased ZIKV E-protein loads at 72 h 
p.i., in a time-dependent manner, comparing to the viral loads at 24 and 48 h p.i., 
(Figure 31D). The reduced loads of ZIKV RNA and E-protein at 96 h p.i., matches with 
the severe neuronal loss at this time point (Figures 31B and 31D). HSP70 in exosomes 
derived from neuronal cells was detected further indicated the presence of the 
exosomal marker in both uninfected and infected exosomal lysates (Figure 31D). 
Furthermore, increased ZIKV RNA and E-protein loads were shown in neurons derived 
exosomes with a raise in viral doses from 1, 2.5 and 5 MOI at 72 h p.i., (Figures 31C 
and 31E). Total protein profiles were considered as loading controls in the 
immunoblotting analysis (Figures 31D and 31E). These results suggested that cortical 







ZIKV RNA and Proteins Securely Contained inside Exosomes are Infectious 
during Transmission 
RNase A-treatment assays were performed, to test the probability that ZIKV RNA is not 
perhaps outside the exosomes, and thus taken up by the recipient cells. ZIKV-infected 
neuronal cells derived exosomes (from 72 h p.i., 5 MOI) were freshly isolated 
(resuspended in PBS) and co-incubated with RNase A (5 μg/ml, for 15 min, at 37°C). 
No differences were found in ZIKV NS5 transcript loads between infected-treated and 
untreated groups (Figure 32A). The uninfected group treated with RNase A treated as 
an internal control (Figure 32A). The laboratory viral stocks (5 MOI) with known titers 
(Vero cell culture supernatants, 14 days post-infection) were treated with RNase A, 
aiming not to ignore the effect of RNase A on viruses. No differences were detected in 
viral loads determined from naïve cortical neuronal cells upon incubation with laboratory 
viral stocks generated from RNase A-treated or untreated groups (Figure 32A). As the 
previous results with DENV2 (Vora et al., 2018), it was the assumption that the flavivirus 
RNA genome is secured inside exosomes/virions and is not capable of RNase A-
mediated degradation. Next, it was tested if the exosome-mediated viral transmission is 
relying on ZIKV E-protein in naïve cortical neuronal cells. Infectious exosomes (enclose 
viral RNA and proteins) or laboratory-generated viral stocks (high infectious dose of 
MOI 8 or low dose of MOI 0.8) were treated with antibodies (3 μg of each) ZV-2, ZV-16 
or with highly affinity neutralizing antibodies ZV-54, ZV-67 (Zhao et al., 2016) for 4 h at 
37°C followed by ZIKV infection (for 72 h). No differences in ZIKV loads were detected 
in neuronal cells re-infected with infectious exosomes that were treated with either ZV-2 
or ZV-16 or with ZV-54 or ZV-67 neutralizing antibodies when compared with their 
corresponding untreated controls (Figure 32B). Antibody treatments of exosomes 
derived from uninfected cells were used as internal controls for the infectious exosome 
group (Figure 32B). A magnificent reduction was detected in ZIKV loads in neuronal 
cells that incubated with ZV-2, ZV-16 or ZV-54, ZV-67 antibodies, treated with high (8 
MOI) or low (0.8 MOI) doses of laboratory viral stocks in comparison to their 
corresponding untreated controls (Figure 32B). Furthermore, ZV-54 and ZV-67 
antibodies treatments with high (8 MOI) or low (0.8 MOI) doses of laboratory viral stocks 
showed significantly (P < 0.05) stronger neutralization effects in comparison to ZV-2 or 
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ZV-16 antibodies, in both the high and low viral doses groups (Figure 32B). In addition, 
immunofluorescence assays (IFA) were tested on neuronal cells (using 4G2 monoclonal 
antibody). Similar results were shown from infectivity assays suggesting no differences 
in ZIKV E-protein staining of neurons that were incubated with infectious exosomes that 
were either maintained untreated or treated with ZV-2, ZV-16 or highly affinity ZV-54 or 
ZV-67 neutralizing antibodies (Figure 35). Regarding to neuronal cells incubation with 
high (8 MOI) or low (0.8 MOI) viral doses of ZIKV (pre-treated with either ZV-2, ZV-16 or 
ZV- 54, ZV-67 antibodies), neutralization effects matching to less detection of viral E-
protein/staining and less fluorescently labeled cells was the evidence when compared 
with their corresponding untreated controls (Figures 36 and 37). It was also assumed 
that when compared with ZV-2 and ZV-16, the extremely affinity ZV-54 or ZV-67 
antibodies had higher neutralization effects with dramatically depressed E-protein 
stained positive cells. Next, cortical neurons were treated with 5 μg of 4G2 antibody 
(that neutralizes ZIKV poorly), followed by infection via exosomes derived from ZIKV-
infected neuronal cells (72 h p.i., 5 MOI), to investigate if treatment with 4G2 antibody 
influences or impedes viral transmission (Figure 32C). No differences in viral loads were 
detected in antibody-treated or untreated groups of neuronal cells, considering the 
incubation of infectious exosomes derived from ZIKV-infected neurons (Figure 32C). 
The inclusion of ZIKV laboratory stocks with known titers (MOI 5) suggested reduced 
viral loads in cortical neurons served with 4G2 antibody when compared with the 
untreated controls (Figure 32C). These data suggest that E-protein is securely enclosed 
the exosomes. Whereas, E-protein on the surface of the virions is reachable to ZV-2, 
ZV-16, ZV-54 or ZV-67 or 4G2 antibodies and treatments with these antibodies 
suggested differential neutralizing effects due to the use of laboratory viral stocks. 
These results further indicated that E-protein is perhaps not on the surface of exosomes 
and may not be required for manipulating viral RNA and protein transmission via 
exosomes. To determine if the exosomes-mediated viral transmission is clathrin-
dependent, cortical neuronal cells were co-incubate with clathrin specific inhibitor 
(Pitstop-2; 30 μM for 15 min) and infected these Pitstop-2 treated cells with infectious 
exosomes isolated from ZIKV-infected (5 MOI; 72 h p.i.) cortical neuronal cells. No 


















Figure 31. Exosomes Derived from Murine Cortical Neuronal Cells Contain Infectious ZIKV RNA 
and E-protein 
(A) Infection (72 h p.i.) of naïve primary cultures of murine cortical neurons showed the increased 
infectivity and transmission from infectious exosomal fractions 4-6 in comparison to other lower 
fractions (1-3).  
(B) QRT-PCR showed the ZIKV (I) RNA loads (MOI 5) from cortical neuronal cell-derived exosomes 
at different time points (24, 48, 72 and 96 h p.i.). Uninfected (UI) groups from each respective time 
point served as controls.  
(C) ZIKV loads from neuronal cell-derived exosomes collected from cortical neurons infected with 
different doses (MOI 1, 2.5 and 5) at 72 h p.i., were shown.  
(D) Immunoblotting showed the ZIKV-E protein loads (MOI 5) and HSP70 levels in neuronal cell-
derived exosomes isolated at different time point samples (24, 48, 72, and 96 h p.i.). HSP70 loads 
showed the presence and enrichment of exosomal marker and served as an internal control.  
(E) Immunoblotting showed the ZIKV-E protein loads at different doses (MOI 1, 2.5 and 5, at 72 h p.i.) 
of infection (I) in neuronal cell-derived exosomes collected from infected-cortical neurons. Uninfected 
(UI) cell-derived exosomes collected from uninfected cortical neurons served as a control.  
Total protein profiles served as controls. The ZIKV NS5 transcripts were normalized to mouse beta-
actin transcripts. P values were determined by the Student’s two-tail t-test. This figure was adapted 




















Pitstop-2 treated group when compared with the DMSO (vehicle)-treated controls 
(Figure 38). These data indicated that the transmission to naïve neuronal cells mediated 
by exosome is clathrin-independent.  
To test whether exosomal RNA was infectious to naïve cortical neurons, the viral 
titers were measured in exosomes by operating a virus dilution assay. Representative 
images from neuronal cells infected through incubations with exosomes or exosome-
depleted supernatants are shown from the virus dilution assay (Figure 33). Increased 
fluorescent signal (as determined by immunostaining with 4G2 antibody) was obvious in 
neurons infected with infectious exosomes when compared with infection upon 
Figure 32.  Exosomes from Primary Cultures of Cortical Neurons are Infectious and Transmit 
ZIKV to Naïve Neuronal Cells  
(A) Infections via freshly prepared exosomes from ZIKV-infected (MOI 5, 72 h p.i.) cortical neuronal 
cells or laboratory ZIKV viral stocks treated with RNase A on naïve cortical neuronal cells (72 h p.i.) 
were shown. Untreated ZIKV-infected or RNase A-treated uninfected exosome or untreated-virus 
stock groups served as controls.  
(B) ZIKV loads (72 h p.i.) in neuronal cells incubated with ZIKV-infectious exosomes or laboratory viral 
stocks (8 MOI as high dose or 0.8 MOI as low dose) treated with ZV-2, ZV-16 or ZV-54, ZV-67 
antibodies were shown. Cells incubated with uninfected cell-derived exosomes served as a control. 
The untreated groups included in all panels, respectively, served as controls.  
(C) QRT-PCR analysis showed the viral loads in cortical neurons treated with 4G2 antibody followed 
by infection with exosomes derived from ZIKV-infected (MOI 5; 72 h p.i.) cortical neurons or laboratory 
viral stocks. Untreated groups serve as controls. ns indicated no significance in all the groups.  






incubation with the supernatant fraction (Figure 33). As an internal control, the viral 
dilution assay was also implemented on cortical neuronal cells by infecting with ZIKV 
virus stocks (5 MOI, 72 h p.i.). Exosome-mediated ZIKV-infected cells detected 
enhanced E-protein staining with a 4G2 antibody when compared with the supernatant 
preparation- treated cells (Figure 33). Phase-contrast images showed similar 
















Quantification of fluorescent signals (determined by counting the percentages of 
fluorescently labeled infected cells staining the E-protein) in neuronal cells infected with 
exosome preparations when compared with the supernatant fraction (for 72 h p.i.) 
further supported the microscopic observation (Figure 34A). Dilution 6 was served for 
both microscopic and quantitative analysis of infected cells from each replicate. The  
Figure 33. Fluorescent and IFA Images of E-protein Detection 
(A,B) Representative fluorescent images showed the detection of E-protein in neuronal cells infected 
via exosomes (upper panel) derived from the ZIKV-infected (MOI 5; 72 h p.i.) cortical neurons or 
infected using ZIKV laboratory viral stocks (for 72 h p.i., lower panel). Neuronal cells treated with 
exosome-depleted supernatant (sup, in a similar ratio) served as a control for exosome group. 
Uninfected cells served as a control for ZIKV laboratory stock infected group. Scale bar indicated 200 

















quantification of fluorescent signals (determined by counting the percentages of 
fluorescently labeled infected cells showing the E-protein staining by 4G2 monoclonal 
antibody) in neuronal cells infected with ZIKV virus stocks (5 MOI, 72 h p.i.) suggested 
infectivity of the viral stocks (Figure 34B). Then, it was tested if exosomes derived from 
ZIKV infected neurons (from 72 h p.i., 5 MOI) are infectious and reproductive in 
uninfected/naïve cells. QRT-PCR analysis suggested that murine cortical neuronal cells 
treated with ZIKV-infected exosomes derived from neuronal cells (isolated from an 
independent batch of infected cells) rapidly transmitted infectious exosomal RNA to 
uninfected recipient neurons (Figure 34C). Also, it was indicated that infectious 
exosomal RNA replicated in the naïve/uninfected neuronal cells in a time-dependent 
manner at the measured time points of 24, 48, 72 and 96 h p.i. (Figure 34C). These 
results indicate that neuronal exosomal RNA is infectious, viable, and replicative in 
naïve recipient cortical neuronal cells of the CNS. 
Figure 34. Quantitative Assessment of the Number of ZIKV-Infected Cortical Neurons 
(A) Quantitative assessment of the number of ZIKV-infected (detected by the 4G2 antibody) (MOI 5; 
72 h p.i.) neuronal cells treated with exosomes (in dilution 6) or supernatant fractions were shown.  
(B) Quantitative assessment of the number of fluorescent neuronal cells, (detected by 4G2 antibody) 
infected (MOI 5; 72 h p.i.) with laboratory ZIKV viral stocks was shown.  
(C) ZIKV loads in cortical neuronal cells (at different time points of 24, 48, 72, and 96 h p.i., and 5 
MOI) infected via infectious exosomes were shown in naïve cortical neuronal cells for transmission 
and replication of viral RNA. The ZIKV loads were indicated based on NS5 transcripts normalized to 
mouse beta-actin transcript levels. P values were determined by the Student’s two-tail t-test.  

















Neutral Sphingomyelinase SMPD3 (nSMase2) Facilitates ZIKV Infection and 
Transmission via Exosomes 
It has been shown that the membrane-associated enzyme SMPD3 (nSMase2; 71 kDa) 
is one of the most investigated neutral Sphingomyelinase that is triggered by anionic 
phospholipids such as phosphatidylserine (PS) and phosphatidic acid (PA) (Clarke and 
Hannun, 2006; Menck et al., 2017). Activation of SMPD3 in cells plays a significant role 
in cellular responses (Stoffel et al., 2005; Clarke and Hannun, 2006; Menck et al., 
2017). The stimulation of nSMase upon ZIKV infection was obtained in both neuronal 
cells and exosomes resuspended in PBS. At both measured time points  
Figure 35. Murine Cortical Neurons Incubated with ZIKV Infectious Exosomes Pretreated with 
ZV-2, ZV-16, or ZV-54, ZV-67 Antibodies Had no Neutralizing Effects 
Infectious exosomes (20 μl of PBS suspension collected from ZIKV-infected (MOI 5; 72 h p.i.) cells) 
treated (4 h, 37 ° C) with antibodies ZV-2, ZV-16, or ZV-54, ZV-67 followed by incubations on primary 
cultures of mouse cortical neuronal cells (for 72 h) showed no neutralizing effects. The respective 
untreated groups served as controls for antibody treatments. Neurons were fixed, permeabilized, and 
stained for ZIKV E-protein (using the 4G2 monoclonal antibody, followed by Alexa Fluor 594 for 
detection) that showed no differences in infectivity when cultures were incubated with infectious 
exosomes pretreated with respective neutralizing antibodies. Images obtained from Bright Field (BF) 
and DAPI staining were shown as controls. Representative images obtained from the EVOS FL 
system were shown. Scale bar indicated 200 μm in all images. This figure was adapted from the 
















(24 and 72 h p.i.), neutral Sphingomyelinase activity (measured as milliunits) was 
magnificently (P < 0.05) enhanced in ZIKV-infected cortical neurons and in exosomes 
isolated from these neurons (Figures 39A and 39B). To address if the increasing in 
Sphingomyelinase activity is dependent on the cell number and the formation/release of 
exosomes, murine cortical neurons at different cell concentrations were plated and 
collected cells and derived exosomes at 72 h p.i., from ZIKV infected (5 MOI) or 
uninfected controls. No significant differences were detected in Sphingomyelinase 
activity from cells plated at different densities, perhaps the growing cells had kept the 
same fold of SMPD3 activity (Figure 39C). An increase in Sphingomyelinase activity 
was tested in exosomes derived from different number of cells plated in increasing  
Figure 36. Murine Cortical Neurons Incubated with High Dose of ZIKV Pre-treated with ZV-54, 
ZV-67 Antibodies Had Strong Neutralizing Effects  
Neuronal cultures incubated with a high dose of ZIKV (MOI 8) laboratory stocks pretreated with ZV-54, 
ZV-67 3 antibodies showed strong neutralizing effects in comparison to the ZV-2, ZV-16 antibodies- 
treated or untreated controls. Neurons were stained for ZIKV E-protein (using the 4G2 monoclonal 
antibody, followed by Alexa Fluor 594) that showed reduced infectivity (as indicated by reduced signal 
or intensity) in groups treated with antibodies. The untreated group served as a control for respective 
antibody treatments. Images obtained from Bright Field (BF) and DAPI staining were shown as 
controls. Representative images obtained from the EVOS FL system were shown. Scale bar indicated 













                                         
 
 
densities and this also reflected a rise in ZIKV infected cells derived exosomes (Figure 
39D). This result also corresponds with the increasing amounts of total proteins 
extracted from either cells or exosomes isolated from ZIKV-infected (5 MOI) or 
uninfected controls (Figures 40A-40F). No significant (P < 0.05) differences were 
detected in total protein amounts extracted from ZIKV-infected or uninfected cells and 
neither from total proteins collected from ZIKV-infected or uninfected exosomal lysates 
(Figures 40B, 40C, 40E and 40F). It was also known that ZIKV infection, significantly (P 
< 0.05) upregulated smpd3 transcripts levels in neuronal cells at both 72 and 96 h p.i. 
(Figure 41A). No differences in smpd3 transcript levels were found in exosomal 
preparations isolated from ZIKV-infected group in comparison to the uninfected controls 
(Figure 41B). As exosomal smpd3 transcripts were normalized to actin (Figure 41B), it 
Figure 37. Murine Cortical Neurons Incubated with Low Dose of ZIKV Pre-treated with ZV-54, ZV-
67 Antibodies Had Strong Neutralizing Effects  
Neuronal cultures incubated with a low dose of ZIKV (MOI 0.8) laboratory stocks pretreated with ZV-
54, ZV-67 antibodies showed strong neutralizing effects in comparison to the ZV-2, ZV-16 antibodies- 
treated or untreated controls. Neurons were stained for ZIKV E-protein (using the 4G2 monoclonal 
antibody, followed by Alexa Fluor 594) that showed the reduced signal or intensity in groups treated 
with antibodies. The untreated group served as a control for antibody treatments. Images obtained 
from Bright Field (BF) and DAPI staining’s were shown as controls. Representative images obtained 
from the EVOS FL system were shown. Scale bar indicated 200 μm in all images. This figure was 




was further confirmed that this is not because of the lower actin transcripts in 
exosomes. QRT-PCR analysis for gapdh loads and normalization to the smpd3 
transcripts with either of the housekeeping genes performed no significant (P < 0.05) 
differences (Figure 40G). Like the smpd3 transcripts levels, the SMPD3 protein loads 
were upregulated at both 72 and 96 h p.i., in ZIKV-infected neuronal cell lysates when 
compared with the uninfected controls (Figure 41C). Total protein profile gel image was 
considered as loading control (Figure 41C). Densitometry analysis from total cell lysates 
showed the quantitative differences in SMPD3 protein levels (from different time points) 
observed between the ZIKV infected (MOI 5) and uninfected controls (Figure 40H). 
Silencing of smpd3 expression by siRNA treatment showed significantly (P < 0.05) 
lower loads of smpd3 transcript levels at 72 h ZIKV p.i., when compared with the 
untreated or control (scrambled) siRNA-treated groups (Figure 41D). Significantly (P < 
0.05) reduced ZIKV loads were obtained in smpd3-siRNA- treated cells when compared 
with untreated or controlled-siRNA-treated control groups (Figure 41E). These results 




 Figure 38. Exosome-Mediated Viral Transmission is not Dependent on Clathrin  
QRT-PCR analysis showed the ZIKV loads (5 MOI, 72 h p.i.) from mouse cortical neurons either 
treated with clathrin specific inhibitor (Pitstop-2) or with DMSO control. The ZIKV NS5 gene transcript 
levels were normalized to mouse beta-actin. P value was determined by the Student’s two-tail t-test. 










Figure 39. ZIKV Induces Expression of SMPD3, a Neutral Sphingomyelinase Critical for Exosome 
Production and Release 
(A-B) Neutral sphingomyelinase activity assays performed on cell lysates or exosomal lysates were 
shown. Neuronal cell and exosomal lysates derived from ZIKV-infected (MOI 5) was used from 24 and 
72 h p.i. Lysates from uninfected neurons or exosomes served as controls. The Y-axis represented the 
activity of neutral sphingomyelinases (shown in milliunits) and X-axis indicated the hours in each 
panel.  
(C-D) SMPD3 activity (measured over the amount of total proteins) in neuronal cells or in neuronal 
cell-derived exosomes determined from different numbers/densities of plated cells were shown. The 
white bar indicated uninfected and the black bar denoted infected groups. The asterisk indicated 
significance.  

















Figure 40. SMPD3 Activity, Total Protein Amounts, Evaluation of SMPD3 Loads Normalized to 
gapdh and Densitometry of SMPD3 Immunoblot 
(A) SMPD3 activity from uninfected or infected cells, measured using cell lysates was shown.  
(B-C) Total protein loads determined from uninfected or infected cells were shown.  
(D) SMPD3 activity measured from uninfected or infected groups were shown.  
(E-F) Total protein loads determined from uninfected or infected exosomes were shown. Cells were 
plated at different densities (103, 104, 105, 106, 107), and exosomes were derived from these varying 
cell densities. The X-axis indicated the total protein loads determined from these cells or exosomes 
and the Y-axis showed different densities (103, 104, 105, 106, 107) of cells plated or exosomes derived 
from the varying numbers of cells. The dotted arrow represented a linear increase in SMPD3 activity.  
(G) QRT-PCR analysis showed the expression of smpd3 mRNA transcripts in uninfected (UI) or ZIKV-
infected (I) (MOI 5) cortical neuronal cell-derived exosomes isolated at different time points (24, 48 72 
and 96 h p.i.) of infection. The smpd3 gene transcript levels were normalized to mouse gapdh levels. P 
value was determined by the Student’s two-tail t-test.  
(H) Densitometry analysis for the immunoblotting image in Figure 41A showed the SMPD3 levels at 
different time points (24, 48, 72, and 96, h p.i.) in total cell lysates from uninfected (UI) or infected (MOI 

















Figure 41. SMPD3 Gene and Protein Levels of Cortical Neurons and Derived Exosomes 
(A-B) QRT-PCR analysis showed the expression of smpd3 mRNA transcripts in uninfected (UI) or 
ZIKV-infected (I) (MOI 5) cortical neuronal cells or in cortical neuronal cell-derived exosomes isolated 
at different time points (24, 48 72, and 96 h p.i.).  
(C) Immunoblotting analysis showed the SMPD3 protein levels in uninfected (UI) or ZIKV-infected (I) 
cortical neuronal cells at 24, 48 72, and 96 h p.i. The total protein profile image from Coomassie-
stained gel served as a control.  
(D-E) QRT-PCR analysis showed the expression of smpd3 or ZIKV NS5 mRNA transcript loads (I), to 
reveal silencing efficiency or viral burden in untreated (UT) or smpd3 specific siRNA or scrambled 
siRNA-treated ZIKV-infected (MOI 5; 72 h p.i.) murine cortical neuronal cells. Untreated cells were 
used as controls. The smpd3 or ZIKV NS5 gene transcript levels were normalized to mouse beta-actin 
levels. P values were determined by the Student’s two-tail t-test. This figure was adapted from the 




Exosome Inhibitor GW4869 Reduced ZIKV Loads and Transmission through 
SMPD3 
It has been announced by literature that inhibition of nSMases with exosome inhibitor 
GW4869 or by siRNA silencing amend the metabolite composition of cells and 
Extracellular Vesicles (EVs), therefore, blocking exosomes release (Menck et al., 2017). 
The inhibition effects of GW4869 inhibitor on exosome budding and release upon ZIKV 
infection in murine cortical neuronal cells were performed. GW4869 inhibitor treatment 
(20 μM) gained significantly (P < 0.05) reduced loads of ZIKV in infected cortical 
neurons (5 MOI, and at different time points of 24, 48 and 72 h p.i.) (Figures 42A-42C). 
No differences in ZIKV loads were obtained when neuronal cells were treated with lower 
doses (5 and 10 μM) of GW4869 inhibitor. Furthermore, it was suggested that the 
reduction in ZIKV loads in murine cortical neuronal cells was in a dose- and time-
dependent manner, a dramatic reduction in viral loads showed up at 72 h p.i. GW4869 
treatments at 20 μM concentration in comparison to the mock (vehicle; DMSO) groups 
(Figures 42A-42C). Immunoblotting with 4G2 antibody showed reduced ZIKV E-protein 
loads upon GW4869 treatment at 20 μM concentration when compared with the other 
doses of 5 and 10 μM and corresponding time points (24, 48 and 72 h p.i.,) and DMSO 
controls (Figure 42D). At 72 h p.i., treatment with GW4869 at 20 μM concentration, 
showed larger reduction in ZIKV E-protein loads when compared with the early tested  
time points of 24 and 48 h p.i., (Figure 42D). Total protein profile gel images from 
corresponding time points (24, 48 and 72 h p.i.) of ZIKV- infected neurons are 
considered as loading control (Figure 42D). Besides the murine cortical neuronal cells, 
the potential roles of GW4869 inhibitor on exosome release from ZIKV-infected cortical 
neurons were measured. QRT-PCR analysis suggested that exosomes isolated from 
cortical neurons treated with GW4869 inhibitor (at all tested doses of 5, 10 and 20 μM; 
and time points of 24, 48 and 72 h p.i.) had magnificently (P < 0.05) reduced ZIKV RNA 
loads when compared with the DMSO control (Figures 43A-43C). This reduction in ZIKV 
loads was more essential in exosomes in comparison to the reduction showed in 
cortical neurons that released these exosomes (Figures 42A-42C and Figures 43A-
















 reduced as well in cortical neurons-derived exosomes at all the tested doses (5, 10, 
and 20 μM) and time points (24, 48 and 72 h p.i.) when compared with their 
corresponding DMSO controls (Figure 43D). Total protein profile gel images from all 
time points (24, 48 and 72 h p.i.) of ZIKV infected neurons-derived exosomes 
considered as loading control (Figure 43D). Densitometry analysis from total cell (for 
Figure 42. ZIKV Infected Cortical Neurons Inhibitor Treatments 
(A-C) QRT-PCR analysis showed the expression of NS5 mRNA transcripts to reveal viral burden in 
cortical neuronal cells infected with ZIKV (MOI 5) at different time points of 24, 48, and 72 h p.i. ZIKV 
NS5 gene transcript levels were normalized to mouse beta-actin levels. P values were determined by 
the Student’s two-tail t-test.  
(D) Immunoblotting analysis showed the levels of viral E-protein in ZIKV-infected (MOI 5) cortical 
neuronal cell lysates from different time points (24, 48, and 72 h p.i.) of infection. GW4869 inhibitor 
was treated for four hours at tested doses of 5, 10, or 20 μM and at indicated time points of 24, 48, 
and 72 h p.i. Lysates prepared from DMSO-treated cells served as a mock control. The total protein 
profile images from Coomassie-stained gels served as controls.  




data shown in Figure 42D) and exosomal (for data shown in Figure 43D) lysates 
indicated the quantitative differences in E protein loads (from the GW4869 time points 
and dose-response immunoblot analysis) obtained between the ZIKV infected (MOI 5) 
and uninfected controls (Figures 44A-44C; for immunoblots shown in Figure 42D and 








Figure 43. ZIKV Infected Neuronal Exosomes Inhibitor Treatments 
(A-C) QRT-PCR analysis showed the expression of NS5 transcripts to reveal viral burden in ZIKV-
infected (MOI 5) cortical neuronal cell-derived exosomes collected at different time points of 24, 48, 
and 72 h p.i. ZIKV NS5 gene transcript levels were normalized to mouse beta-actin levels. P values 
were determined by the Student’s two-tail t-test.  
(D) Immunoblotting analysis showed the levels of viral E-protein in ZIKV infected (MOI 5) cortical 
neuronal cell-derived exosomal lysates at different time points (24, 48, and 72 h p.i.) of infection. 
GW4869 inhibitor was tested at 5, 10, or 20 μM concentrations and at indicated time points. Lysates 
prepared from DMSO-treated cells served as mock controls. Total protein profile images from 
Coomassie-stained gels served as controls.  
















Furthermore, it was found that upon treatment with GW4869 inhibitor, smpd3 transcript 
levels in both cortical neurons (Figures 45A-45C) and neuronal exosomes (Figures 
45D-45F) were crucially (P < 0.05) reduced (at 20 μM dose in cortical neurons and all 
tested doses of 5, 10 and 20 μM in neurons-derived exosomes at time points of 24, 48 
and 72 h p.i.) when compared with their corresponding DMSO-treated controls (Figure 
45). Like ZIKV loads, smpd3 transcript levels were also less in exosomes in comparison 
to the infected-cortical neurons (Figure 45). These results elucidate that exosome 
Figure 44. Densitometry Analysis for ZIKV E-protein Immunoblots Showed Differences in 
GW4869 Inhibitor Treated Samples 
(A-C) Densitometry analysis for the immunoblotting images in Figure 42D for viral E-protein at different 
viral doses (5, 10, and 20 μM) in total cell lysates generated at different time points (24, 48, and 72 h 
p.i.) from uninfected (UI) or ZIKV-infected (MOI 5) (I) groups were shown.  
(D-F) Densitometry analysis for E-protein levels in Figure 43D generated from total exosomal lysates 
at different doses (5, 10, and 20 μM) and at different time points (24, 48, and 72 h p.i.) from uninfected 
(UI) or ZIKV-infected (MOI 5) (I) groups were shown.  
















Figure 45. Treatment with GW4869 Affects smpd3 Loads in Murine Cortical Neurons and 
Neuronal Cell-Derived Exosomes 
(A-C) QRT-PCR analysis showed the expression of smpd3 mRNA transcripts in ZIKV-infected (MOI 5) 
cortical neurons collected at different time points of 24, 48, and 72 h p.i. The GW4869 inhibitor was 
tested at 5, 10, or 20 μM at all indicated time points. 
(D-F) QRT-PCR analysis showed the expression of smpd3 mRNA transcripts in ZIKV-infected (MOI 5) 
neuronal cell-derived exosomes collected at different time points of 24, 48, and 72 h p.i. The GW4869 
inhibitor was tested at 5, 10, or 20 μM at all indicated time points. DMSO groups served as mock 
controls. The smpd3 gene transcript levels were normalized to mouse beta-actin. P values were 
determined by the Student’s two-tail t-test. 







Neurotransmission, also known as synaptic transmission, is a procedure by which 
neuronal cells communicate with one another and send electrical impulses and 
signaling molecules/chemicals, including neurotransmitters (Di Maio, 2008). Axonal 
terminals of the mailing (presynaptic) neuron releases the neurotransmitters, including 
other cargo that binds to and activates the receptors or channels on the dendrites of a 
neuronal recipient (postsynaptic). With this firmly regulated neurotransmission process 
from sending neurons to the receiving neuron, the discharge of exosomes from sending 
neuronal cells and the entry of exosomes into neighboring receiving neuronal cells 
occurs on a continuous basis. Within a neural presynaptic terminal, two types of small 
membrane nanovesicles such as synaptic vesicles (SVs; that are ∼35-55 nm in 
diameter) and exosomes (inside Multivesicular Bodies (MVBs); that are 50-200 nm in 
diameter) are discharged (Chivet et al., 2012; Budnik et al., 2016). Exosomes have 
been proved to represent a variety of intercellular exchange of effector molecules in 
order to perform presynaptic neurons to modify gene and protein expression in 
postsynaptic neurons (Chivet et al., 2012; Budnik et al., 2016). Neuronal exosomes 
have suggested transferring both membrane and cytoplasmic proteins, functional lipids 
(involved in signal transduction) or RNA (Chivet et al., 2012; Budnik et al., 2016). In 
receiving neurons, exosomal mRNA will be translated and the small RNA, including 
miRNA that mediates gene silencing is stimulated to bind specific genes for depression 
(Chivet et al., 2012; Budnik et al., 2016). Recent studies of functional RNA, miRNA and 
proteins in the exosomes have increased the consideration that has led to the 
emergence of numerous studies in identifying novel molecules present in neuronal 
exosomes (Anderson et al., 2016; Zhou et al., 2018b). Due to the existence of RNA in 
the exosomes, it was assumed if exosomes are also cargos of viral RNA from the latest 
emerging ZIKV. Exosomes have been considered as vehicles of transmission for a 
variety of microorganisms, and recent studies of Langat virus and WNV transmission 
through neurons-derived exosomes have provided new understanding into vector-borne 
flaviviral diseases drug development (Anderson et al., 2016; Zhou et al., 2018b). The 
recent publication has also proved that the entire dengue virus (Serotype 2; DENV2) 
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viral RNA genome is present and transmitted via mosquito cell-derived exosomes (Vora 
et al., 2018). In this study, it proved that ZIKV RNA and proteins are securely 
transported to the neurons through infectious exosomes. So far, no studies have 
demonstrated whether ZIKV-caused neurological phenomenon such as microcephaly, 
involve host neuronal exosomes. 
The finding that neuronal cell-derived exosomes are the carriers of mosquito-
borne flavivirus infectious materials indicate an innovative mode of ZIKV transmission. 
In this current study with ZIKV infections, the presence of MAP-2 (served as a neuronal 
marker) and GFAP (astrocyte glial marker) absence clearly indicated the complete 
differentiation from progenitor cells to cortical neurons in these studies with ZIKV 
infections. The result with weak or absence of MAP-2 staining, and positive DAPI 
staining showing enhanced ZIKV E- protein levels, suggested that perhaps there is 
neurite retraction due to stimulation of cell death in ZIKV infected neuronal cells. 
Increased neuronal death at 120 h p.i., when compared with the 72 h p.i., of murine 
cortical neurons infected with ZIKV (MOI 5) suggests that more incubation time and 
increasing infectious dose could be liable for the massive death of cortical neurons and 
their networks in developing brains. Additional, enhanced viral loads at 72 h p.i., (at both 
mRNA and protein levels) in neuronal cells and neuronal cell-derived exosomes 
indicated timing of peak induction in viral replication in neuronal cells and their 
transmission through exosomes. The result of high ZIKV loads in neurons suggests that 
viral materials could be easily transferred into exosomes via axonal transportation. Early 
diagnosis and detection of ZIKV infections in mothers could possibly block the transport 
and/or dissemination of infectious viral material that cause damage to the neonatal 
cells. It was assumed that cortical neuronal cells are critically damaged leading to death 
and neuronal networking loss, could perhaps result in small size of microcephalic 
brains. It has been proved that endoplasmic reticulum stress in embryonic brains (in 
vivo) results in unfolded protein feedback during ZIKV infection and associated 
microcephalic circumstances. Induction in HSP70 loads upon ZIKV-infection or in 
uninfected cells over the period of post incubations of cortical neurons elucidates a 
significant role for this chaperone to protect cortical neuronal cells from stress and toxic 
effects encountered during longer post incubations and viral infections. Detection of 
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increased HSP70 loads in neuronal exosomes may indicate a similar neuroprotective 
function as well. Multiple attempts with cryo-EM analysis obtained no detection of 
virions/viral particles in any performed images. No virion(s) or viral particles were 
observed neither inside nor outside exosomes. The cultures at 72 h p.i. was used as the 
selected time point for exosome isolation and cryo-imaging investigation. Usually for 
virus structure determination, concentrated supernatants generated from longer 
infection (7-14 days p.i.) with high viral titers ranging from 109 to 1012 PFU/ml and high 
centrifugal forces around 200,000 g are reported (Tauro et al., 2012; Vora et al., 2018; 
Zhou et al., 2018b). These conditions were not used in this neuronal exosomes 
preparation. In this analysis, exosomes were found to exist in heterogeneous 
populations varying from sizes of 30-200 nm. However, larger exosomes or EVs were 
also observed in a size range of 200-350 nm. ZIKV-infected neuronal cell-derived 
exosomes showed a higher percentage of smaller exosomes (0-200 nm in diameter) or 
larger vesicles called EVs (200-500 nm in diameter) indicating dense packaging or 
larger cargo transport through these exosomes, respectively. The presence of HSP70, 
along with CD63 and CD9 in fractions 3-5, demonstrated these fractions to be 
exosomes (perhaps containing exosomes 30-200 nm in size) due to the enriched 
presence of exosomal markers. Increased detection of ZIKV-E-protein in fraction 4 
indicated that viral proteins are enriched in exosomes (of sizes 100-200 nm) that may 
correlate to fractions 3 and 4. The presence of the high amount of viral RNA and 
proteins in neurons derived exosomes in comparison to neuronal cells, suggest dense 
packaging of viral components in exosomes for transmission to neighboring neuronal 
cells. Infection of naïve recipient cortical neurons with infectious exosomal fraction 4 
containing concentrated viral E-protein elucidated the presence of a higher amount of 
viral RNA and its correspondence to enhanced infectivity. Larger amounts of viral E-
protein in exosomal fraction 4 directly correspond with the enhanced transmission. 
Additionally, these results address that an ample amount of viral material inside cells 
may randomly get transported into exosomes for transmission to neighboring neurons 
ending up with dissemination within the brains. The detection of no differences in viral 
loads or infectivity via exosomes treated with RNase A or antibodies (ZV-2, ZV-16 or 
ZV-54 or ZV-67), further indicates the presence of viral material secure inside 
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exosomes. An antibody binding to the exterior of virus particles brings out the 
neutralization of viral infectivity. The 4G2 monoclonal antibody has been proved as 
highly cross-reactive to several of the flaviviruses. However, a recent report has 
elucidated the 4G2 antibody as a poor neutralizing antibody for ZIKV (Haslwanter et al., 
2017). The current study suggested that the neutralization effects with 4G2 were lower 
in comparison to the other antibodies, include ZV-2 or ZV-16. In addition, the use of ZV-
54 or ZV- 67, the highly affinity neutralizing antibodies, indicated ZV-2 or ZV-16 
antibodies are less potential when compared with the ZV-54 and ZV-67 antibodies. 
These results agree with the previous study that measured neutralization effects on 
different ZIKV strains (Zhao et al., 2016). However, similar data with no differences in 
viral loads or infection were obtained with infectious exosomes when any of these 
antibodies were used (ZV-2, ZV-16, ZV-54 or ZV-67 or 4G2), indicating that viral E-
protein is located inside the lumen of these vesicles, but not exposed externally for 
binding to these neutralizing antibodies. Infections of naïve recipient cortical neurons via 
infectious neurons-derived exosomes further addressed exosomes as a novel mode for 
ZIKV transmission. It was assumed that exosome-mediated disseminated could be a 
rapid and efficient approach instead of matured virions-receptor manipulated 
transmission. In exosomes, large amount of viral material can be transmitted, and they 
can highly be infectious in recipient cells. Additionally, it is secure for the viral RNA and 
proteins to be protected and transported inside cargo toward to recipient cells via 
secured exosomes that can escape any immune checkpoints during transfer via longer 
journey such as periphery to the brain in the vertebrate host. 
Neutral Sphingomyelinase 2 (SMPD3), or sphingomyelin phosphodiesterase is 
an enzyme that is liable for cleaving sphingomyelin (SM) to phosphocholine and 
ceramide, a second messenger involved in multiple cellular phenomenon including 
cellular stress (Clarke and Hannun, 2006; Menck et al., 2017). The cryo-EM images 
indicated increased formation and release of neurons-derived exosomes upon ZIKV 
infection. It was assumed that increased activation and levels of SMPD3, in neuronal 
cells perhaps was correlated with the stimulated release of exosomes upon ZIKV 
infection. Detection of smpd3 mRNA levels suggested no crucial differences in neurons-
derived exosomes; however, its larger enzymatic activity in both neuronal cells and 
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exosomes indicated that SMPD3 was critical for the release of neuronal exosomes 
during ZIKV infection. It was proposed that like increased SMPD3 protein levels 
detected in neurons, exosomes perhaps have higher protein loads. Silencing of smpd3 
in cortical neurons performed a magnificent deduction in viral loads thereby, suggesting 
a requirement for this neutral sphingomyelinase in mediating ZIKV infection. These 
results indicated that ZIKV-infection could increase the formation and/or release of 
exosomes from cortical neuronal cells by stimulating the protein and activity of SMPD3. 
The cell density-independent increase in SMPD3 activity in exosomes in comparison to 
cells (from which exosomes were derived) suggested a strong role for this enzyme in 
the production and release of exosomes. In cells, SMPD3 activity was principally kept 
as the growing cells maintained the same fold of activity that was unrelated to of the cell 
numbers plated. In human macrophage THP-1 cells, SMPD3 has been proved to 
contribute to the release of exosomes by prompting the budding of exosomes into 
MVBs (Li et al., 2013; Lang et al., 2016). Inhibition of SMPD3 either through shRNA or 
siRNA or GW4869 inhibitor treatment, has been indicated to hamper the secretion of 
exosomes (Essandoh et al., 2015; Lang et al., 2016). GW4869 is a pharmacological 
agent that influences neutral sphingomyelinase activity and blocks exosome formation 
and secretion (Essandoh et al., 2015). Very recently, it has been addressed that 
GW4869 can impede ZIKV infection by perhaps reducing the amount of neutral 
Spingomyelinase-2 in human fetal astrocytes, however, no insights into the 
sphingomyelin metabolism were addressed (Huang et al., 2018). GW4869 inhibitor has 
also been shown to inhibit the ceramide-mediated budding of MVBs and release of 
mature exosomes from MVBs (Li et al., 2013; Essandoh et al., 2015; Lang et al., 2016). 
The inhibition in viral loads upon treatment with GW4869 (in a dose- and time-
dependent manner) addresses that GW4869 may be served as a candidate for the 
improvement of novel therapies to control ZIKV infection and transmission in and 
between cortical neurons. In both cortical neuronal cells and neuronal cell-derived 
exosomes, decreased ZIKV loads interact with decreased SMPD3 activity and levels 
upon GW4869 treatment in a dose- and time-dependent manner. These results indicate 
that SMPD3 enhances ZIKV infection and transmission through neurons derived 
exosomes in order to spread the infectious viral material. It will be highly intriguing to 
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understand the mechanism of how SMPD3 assists ZIKV replication in neuronal cells. 
The immediate future avenues from this study will concentrate on this novel aspect to 
elucidate the significance of SMPD3 and other neutral Sphingomyelinases in ZIKV 
infection and neuropathogenesis. The presence of increased ZIKV loads in exosomes in 
comparison to neuronal cells indicated that ZIKV infectious material is properly 
abundantly been packaged and maintained to spread through neuronal communication. 
It was assumed that a larger amount of GW4869 inhibitor is crucial in decreasing the 
ZIKV loads in neuronal cells. It was also suggested that longer incubations and 
increased amounts of the inhibitor indicated dramatic effects in decreasing ZIKV loads 
in neurons derived exosomes. The presence of increasing loads of ZIKV infectious 
material in exosomes may cause increased transmission causing neuropathogenesis 
and ultimately death/loss of cortical neurons. The future research efforts will address the 
underlying molecular mechanisms of SMPD3 and other neutral Sphingomyelinases in 
manipulating the transmission of ZIKV and its detrimental influence in causing 
microcephaly in neonatal brains. 
Considering the importance of SMPD3 in mediating transmission of ZIKV through 
neurons-derived exosomes and GW4869 in inhibiting the viral loads in both neurons 
and neuronal exosomes, it was assumed both as possible therapeutic applicants for 
controlling ZIKV infection and transmission in developing brains. The long-term future 
avenues will also define the schemes that depends on neutral Sphingomyelinases 
including SMPD3, that cause enhanced cortical neuronal cells death, and the underlying 
molecular mechanisms for ZIKV-induced microcephaly in developing/neonatal brains. 
The diminished size in the microcephalic brains of ZIKV infected neonates is provoked 
by a gradual decrease in neuron generation or due to the fast loss of dendritic 
connections (Ming et al., 2017; Wen et al., 2017). Higher release and transport of 
infectious exosomes via axonal transport may spread ZIKV infectious viral material to 
the dendritic branches of the neuronal recipients, thereby reducing the dendritic 
branching or arborization. Additionally, if ZIKV uses exosomes for transmission in the 
CNS, it could disseminate the infectious viral RNA and proteins to neural stem cells and 
thereby mediate the progenitor cells. Both these scenarios would ultimately cause 
decreased neuron cells numbers and act as a factor responsible for ZIKV-induced 
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neuronal cell death and microcephaly. Delineating the significance of exosomes and 
exosomes-associated host molecules that manipulate and assist ZIKV transmission 
would unravel the molecular mechanism(s) of infection by this neurotropic virus. 
 
3.4 EXPERIMENTAL PROCEDURE 
 
Isolation and Culture of Murine Cortical Neurons and ZIKV Infection 
C57BL/6 wild-type female mice with gestation period (day 13) were purchased from 
Charles River Laboratories and allowed to reacclimatize in our animal facility. Following 
ethical rules and regulations in accordance with the Institutional Animal Care and Use 
Committee, primary cultures of murine cortical neurons as disassociated cells were 
isolated from embryonic day-16 (E16) brains (Sultana et al., 2009; Zhou et al., 2018b). 
Murine cortical neuronal cells (2 × 105) were seeded in a 12-well plate and cultures 
were established in complete neurobasal medium with 10% FBS. One day post-plating 
(DIV; Day in vitro 1), half of the medium was replaced with FBS-free media, to control 
the growth of glial cells. After 48 h of plating, initiation of neuritogenesis was observed, 
and cortical neurons were infected with ZIKV (MOI 5 or with different MOI 1, 2.5 or 5; in 
dose-response experiments) at 72 h post-plating. Neurons were collected at either 
different time points (24, 48, 72, 96 or 120 h p.i., in infection kinetics and inhibitor 
treatment assays) or at 72 h p.i., in case of dose-response and other in vitro assays (as 
indicated in respective Figures and Figure legends). Following collection of neuronal 
cells and isolation of exosomes, samples were proceeded for RNA extractions and 
Real-Time Quantitative PCR (QRT-PCR). All culture medium and required supplements 
for neuronal culture isolation and maintenance were purchased from Invitrogen/ 
ThermoScientific Inc. ZIKV PRVABC59 strain was obtained from BEI Resources 
(catalog number: NR-50240) and propagated as per the instructions from the distributor. 
Due to increased viral loads in cortical neurons at 72 h p.i., this time point was 
considered for further analysis. Details for infection studies corresponding to the data 
shown in different figures are mentioned in the respective figure legends. Briefly, for 
reinfection experiments with infectious exosome fractions, 2 × 105 neurons were co-
incubated with 20 μl of neuronal cell-derived exosomal fractions. 400 μl (same ratio) of 
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the exosome-depleted supernatant fraction (collected from the step before PBS wash 
during exosome isolation) from neuronal cells was used to process for isolation of 
exosomes. Neuronal cells were harvested at different time points (24, 48, 72 and 96 h 
p.i.) and processed for RNA extractions followed by QRT-PCR. 
 
Immunofluorescence, Phase Contrast and Fluorescent Microscopy 
2-5 × 105 neuronal cells were plated in complete neurobasal medium and allowed to 
adhere overnight. Two days post-plating neuritogenesis was observed, cortical neurons 
were infected with ZIKV (MOI 5; in time point samples or with different MOI’s 1, 2.5, 5 in 
dose-response experiment) at either 72 or 120 h post-plating. Immunofluorescence 
(IFA) was performed as described (Vora et al., 2018). Briefly, cortical neuronal cells 
were fixed with 4% PFA, permeabilized, blocked (3% BSA) and stained with MAP-2 
antibody (Santa Cruz Biotechnology, Inc.) followed by detection with Alexa-Fluor 488 
secondary antibody. Sequentially neurons were further stained for either GFAP antibody 
(Santa Cruz Biotechnology, Inc.) or 4G2 monoclonal antibody (that detects ZIKV E-
protein) followed by detection with Alexa-Fluor 594 secondary antibody, respectively. 
Neuronal cell nuclei were detected with DAPI staining. Fluorescent images were 
obtained from 72 or 120 h p.i. cortical neuronal cells. Phase-contrast images were 
collected from both uninfected and ZIKV-infected cells at different days or time points 
(24, 48, 72, and 96 h p.i.) or at 72 h p.i. in neurons infected with different MOI (infection 
with dose-response or virus dilution assays). For neutralization assays with ZV-2, ZV-16 
or ZV-54, ZV-67 antibodies (Zhao et al., 2016), neurons were fixed and processed as 
described above, and immune-stained with 4G2 monoclonal antibody, followed by 
detection with Alexa Fluor 594 secondary antibody. Untreated cells represent no 
antibody treatments but were incubated either with infectious exosomes or with viral 
stocks (of known titers as described above). All cells were treated with DAPI to show 
cell nuclei in addition to bright field images that served as controls. Images were 
obtained using the EVOS Fluorescence System (Invitrogen/ ThermoScientific Inc.) and 
10X or 20X (in Figures 25 and 33) or at 10X magnification (in Figure 26). 
Representative images are shown for each time point or group. Scale bar is shown on 




MTT [3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl-2Htetrazolium bromide] assay was used 
to measure viability, which served as an index of living neuronal cells. Briefly, 5 mg/ml 
of stock solution was prepared by completely dissolving MTT (Sigma) in DMSO (100%) 
and followed by filter sterilizing (0.22 μm filter; Nalgene). Primary cultures of cortical 
neuronal cells were plated at the density of 1 × 104 cells per well in a 96-well plate. The 
confluence of the cells was less than 100% in all wells. For infection, neuronal cells 
were infected with ZIKV (MOI = 5) and at different time points (24, 48, 72, 96, and 120 
h) post-infection, then all medium from each well was removed, and added 90 μl of 
fresh medium to each well. 100 μl of PBS was added to empty wells for background 
estimation. 10 μl of prepared MTT solution was added to all the wells including PBS 
containing wells that served as blank controls. Plates were covered in aluminum foils 
and incubated at 37°C for 2-4 hours (until a purple precipitate was visible). 100 μl of 
DMSO solvent was added and plates were incubated at 37°C for another 15 min. 
Absorbance was read at 560 nm and reference plates were read at 650 nm. The 
uninfected control maintained for 120 h post-plating was considered to calculate the 
percentages of cell viability. Values from 650 nm reference read were subtracted from 
the values obtained at 560 nm to determine the neuronal cell viability numbers. Higher 
absorbance values indicated an increase in cell viability. 
 
RNA Extraction, cDNA Synthesis and QRT-PCR Analysis 
Following manufacturer’s instructions, total RNA was extracted using Aurum Total RNA 
Mini Kit (BioRad). RNA was extracted from cortical neurons or neuronal cell-derived 
exosomes infected (5 MOI) at indicated time points (24, 48, 72, 96 h p.i.) or with various 
doses (MOI 1, 2.5, 5) of ZIKV-infected group or uninfected controls. RNA was converted 
to cDNA using the BioRad iScript cDNA synthesis kit. The generated cDNA was used 
as a template for the amplification and determination of viral burden. For the detection 
of ZIKV replication, published forward and reversed primers for NS5 or E-gene region 
were used (Dutta et al., 2018). For SMPD3 gene expression analysis, the following 
forward and reversed primers were used from published study (Khavandgar et al., 
2011). To normalize the amounts of templates, mouse actin amplicons were quantified 
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with published primers (Zhou et al., 2018b). Primers for beta-actin were used in parallel 
for QRT-PCR normalization. The gapdh primer sequences were designed based on the 
published study (Xu et al., 2014). Equal amounts of mouse cDNA samples were used in 
parallel for beta actin, gapdh and ZIKV E-gene or NS5-gene. The ratio of ZIKV E-gene 
or NS5 amount/beta actin amount was used as an index to determine the rate of 
infection in each analyzed sample. QRT-PCR was performed using iQ-SYBR Green 
Supermix and CFX96 instrument (BioRad, USA). Standard curves were prepared using 
10-fold serial dilutions starting from standard 1-6 of known quantities of actin or gapdh 
or ZIKV E-gene or NS5-gene fragments and QRT-PCR reactions were performed as 
described (Zhou et al., 2018b). For RNase A treatment, fresh exosomes were isolated 
from either uninfected or ZIKV infected neuronal cells (2 × 107), distributed the infected 
exosomes as treated (5 μg/ml RNase A, 37°C for 15 min) or untreated groups. 
Uninfected exosomes (as similar volumes used in infected groups) treated with RNase 
A were used as control. For ZIKV laboratory viral stocks (5 MOI), the viral supernatants 
were treated directly with RNase A and incubated these samples on naïve primary 
cultures of murine cortical neurons. Non/poorly neutralizing antibodies ZV-2, ZV-16, or 
4G2 (Clone D1-4G2-4-15) were obtained from BEI Resources. The highly potent 
neutralizing antibodies ZV-54 and ZV-67 (Zhao et al., 2016) were a kind gift from Dr. 
Michael S. Diamond’s laboratory, at the Washington University School of Medicine, 
Saint Louis, MO. For ZV-2, ZV-16 or ZV-54, ZV-67 or 4G2 antibodies treatments or 
neutralization studies, either 3 μg (of ZV-2, ZV-16 or ZV-54, ZV-67) or 5 μg (of 4G2 
antibody) of antibodies was treated for 4 h at 37°C with either freshly isolated exosomes 
(20 μl of PBS suspension of exosomes from ZIKV infected cells, 72 h p.i., 5 MOI) or with 
ZIKV laboratory viral stocks (8 MOI as high dose or 0.8 MOI as low dose for ZV-2, ZV-
16 or ZV-54, ZV-67 antibodies or 5 MOI for 4G2 antibody treatments). In order to adjust 
the dose and reflect the infection of recipient cells with infectious exosomes, either high 
or low doses of viral stocks had been used with known titers for comparison. Exosomes 
were collected from an independent batch of ZIKV-infected or uninfected cells and were 
used in this analysis. Neuronal cells were infected through infectious exosomes or viral 
stocks (pretreated with respective antibodies) for 72 h p.i. and collected for RNA 
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extractions and processed for QRT-PCR. Untreated samples or neurons incubated with 
exosomes from uninfected cells served as experimental internal controls. 
 
Immunoblotting and Densitometry Analysis 
Briefly, 2 × 107 cortical neuronal cells were seeded on to six well-dishes for overnight 
incubation. The next day, half of the complete media was changed to no-FBS containing 
medium. Cells were infected with ZIKV (MOI 5) at 72 h post-plating and collected at 
different time points of 24, 48, 72, and 96 h p.i. or with different doses, of 1, 2.5 and 5 
MOI. Cell culture supernatants were collected from the same cells at different time 
points (24, 48, 72, and 96 h p.i.) of infection or at 72 h p.i. (from different MOI samples) 
and processed for exosome isolation. Exosome fractions were collected after PBS wash 
(two times), and adherent cells were collected from the same plates (washed twice with 
1 × PBS), and resuspended in modified RIPA buffer. Total protein amounts were 
estimated using the BCA kit (Pierce/ThermoScientific, Inc.). Whole cell and exosomal 
lysates (10-30 μg) were separated on 12% SDS-PAGE gels. After gel electrophoresis, 
blots were blocked with 5% milk buffer and probed with either 4G2 (obtained from 
Millipore, Sigma or BEI Resources) or HSP70 (Cell Signaling Technologies, Inc) or 
CD63 or CD9 monoclonal antibodies or SMPD3 polyclonal antibody (Santa Cruz 
Biotechnologies, Inc), followed by mouse or rabbit HRP-conjugated secondary 
antibodies (Santa Cruz Biotechnologies, Inc), respectively. Images showing total protein 
profiles obtained from Coomassie-stained gels served as loading controls. Antibody 
binding was detected with the WesternBright ECL kit (Advansta, BioExpress). Blots 
were imaged using Chemidoc MP imaging system and processed using Image Lab 
software obtained from the manufacturer (BioRad). Densitometry analysis from total cell 
and exosomal lysates (from both the time point and dose-response immunoblot 
analysis) between the ZIKV infected (MOI 5) and uninfected controls was performed 
considering their respective total profile gel images and the respective band. 
 
Isolation of Exosomes from Cell Culture Supernatant 
Exosomes were isolated by differential ultracentrifugation method (Théry et al., 2006). 
Isolation procedure and modifications are shown in chapter 2. Briefly, 1-2 × 107 cortical 
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neuronal cells were seeded for exosome isolation in complete neurobasal medium 
(overnight). Neurons were infected with ZIKV (MOI 5) for 72 h p.i. Briefly, cell culture 
supernatants were spun at 100,000 × g for 120 min. Supernatants collected after this 
spin served as exosome-depleted supernatant (EDS) fractions (used as a control in our 
study). The pellet containing exosomes and any contaminants were washed with ice-
cold PBS (another spin at 100,000 × g, for another 120 min). Resulting exosome pellets 
is referred to as exosome fractions in our study. Freshly prepared exosome pellets were 
resuspended in PBS and either frozen at −80°C or used for subsequent evaluations and 
assays or were resuspended in RNA lysis (Biorad) or modified RIPA buffers (G-
Biosciences, BioExpress) for total RNA or protein extractions. 
 
Cryo-Electron Microscopy 
The cryo-EM was performed in chapter 2. Briefly, purified concentrated suspensions of 
ZIKV-infected or uninfected exosomes resuspended in PBS were vitrified on carbon 
holey film grids and as previously described (Sherman et al., 2006; Sherman et al., 
2009). Frozen grids were stored under liquid Nitrogen and transferred to a cryo-
specimen holder under liquid Nitrogen before loading into a JEOL 2200FS, or a JEOL 
2100 electron microscopes (JEOL Ltd., 3-1-2 Musashino, Akishima, Tokyo 196-8558, 
Japan). Preliminary screening and imaging of exosomes was done using a 4k × 4k 
Gatan US4000 CCD camera and final imaging was done at indicated 40,000 × 
magnification with a 5k × 4k Direct Electron Detector Camera using a low dose imaging 
procedure. Images were acquired with a ca. 20 electrons/Å2 dose; the pixel size 
corresponded to 1.5 Å on the specimen scale. A 2.0-2.3 μm defocus range was used for 
imaging. For exosome size quantitation, the sizes were manually analyzed using scale 
bar from cryo-EM images and counted exosomes of different sizes per image in each 
group. Three independent estimations and counting were performed without any bias. 
Percentages (for size determination) were calculated based on the total number of 






OptiPrep™ Density Gradient Exosome (DG-Exo) Isolation 
2 × 107 cortical neuronal cells were infected with ZIKV (5 MOI and for 72 h p.i.). 
Uninfected neurons were used as controls. The detailed protocol for isolation of 
exosomes on the density gradient is shown in chapter 2. Briefly, supernatants (10 ml) 
from uninfected/infected cortical neurons were collected and centrifuged at 4°C (480 × g 
followed by 2000 × g for 10 min each to remove cell debris and dead cells). Cell culture 
supernatants were concentrated to ∼2 ml using the Corning Spin-X UF concentrators or 
centrifugal filter device with a 5 k nominal molecular weight limit (NMWL) (VWR). 
Concentrated cultures were processed for OptiPrep™ (DG-Exos) isolation as described 
in the chapter 2 (Tauro et al., 2012). Six individual fractions were collected from 
uninfected or infected groups (from top to bottom) manually after 18 h spin at 100,000 × 
g (with increasing density of iodixanol, and smaller size vesicles on bottom fractions) 
and diluted with 5 ml of sterile PBS. Fractions were centrifuged at 100,000 × g for 3 h at 
4°C, followed by another PBS wash and spin at similar centrifugal forces. DG-Exo 
fractions were resuspended in 80 μl of PBS and stored at −80°C until further analysis. 
Exosomal fractions were either processed for Western blotting analysis to detect viral E-
protein or the exosomal marker HSP70 or used in infection of naïve primary cultures of 
murine cortical neurons to determine the infectivity and transmission through infectious 
exosomal fractions. 
 
Viral Dilution Assay 
The virus dilution assay was performed as described in (Schoepp and Beaty, 1984). 
Briefly, neuronal cells were seeded (at a density of 1 × 105 cells/well in 225 μl of 
Neurobasal complete medium) on 96 well plates. Neurons were treated with either 
exosome fraction (20 μl) or with exosome-depleted supernatant fractions (EDS; 400 μl) 
or with laboratory ZIKV viral stocks (5 MOI) at 72 h post-plating and incubated for 
additional 5 days. In each group, six different dilutions were used (1-6) and at least eight 
independent replicates in addition to the uninfected negative controls. Neurons were 
fixed with the acetone-PBS mixture (3:1, for 20 min at −20°C), and plates were air-dried, 
washed with 1 × PBS and blocked with 5% FBS-PBS-0.05% Sodium Azide for 15 min at 
RT. ZIKV E-protein was detected by incubation with a 4G2 monoclonal antibody 
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(overnight at 4°C), followed by three washes with PBS. Samples were incubated with 
Alexa-594 labeled mouse secondary antibody for 1 h at RT, followed by washes (3×) 
with PBS. Plates were analyzed using the EVOS fluorescence system 
(Invitrogen/ThermoScientific, Inc.) and cells were scored for fluorescence or the 
presence or absence of infection in comparison to the infected positive controls 
(infected with laboratory prepared virus stocks) or uninfected negative controls. 
Representative images from dilutions 106 are shown. The percentage of infected 
neurons is shown from the same dilution for exosome and supernatant fractions. 
 
Neutral Sphingomyelinase Activity Assay 
For determining the activity of neutral Sphingomyelinases, the Colorimetric 
Sphingomyelinase Assay kit from SIGMA-Aldrich was used and followed the 
instructions from the manufacturer. Briefly, 1 × 107 cortical neuronal cells were plated 
and three-day post-plating infected with ZIKV (MOI 5) for either 24 or 72 h p.i. In an 
independent assay to test if an increase in SMPD3 activity is dependent/independent on 
cell number and exosome production and/release, mouse cortical neuronal cells were 
plated at densities of 103, 104, 105 , 106 and 107 cells per well in replicates and 
measured the total protein amounts and SMPD3 activity. SMPD3 activity was measured 
by either considering the same amounts of total protein (estimated by BCA assays), 
where SMPD3 activity was calculated over the total protein amounts, as shown in 
Figure 39C and 39D. It was also considered an equal volume of samples for 
determining the SMPD3 activity (Figures 40A and 40D). The total concentration of 
proteins estimated from uninfected or ZIKV infected neurons or exosomes derived from 
these neurons are shown in Figures 40B and 40C for cells or Figures 40E and 40F for 
exosomes. At different time points post-infection, cell culture supernatants were 
collected and processed for exosome isolation. Both cell and exosomal lysates were 
resuspended in 1 × PBS and were frozen at −80°C. 50 μl was used for each time point 
sample (uninfected or ZIKV infected) as 6 replicates. Absorbance from assay samples 
were measured at 655 nm. Calculations were performed using the Zero blank 
sphingomyelinase standard that is considered as background blank. All readings were 
subtracted from the background values. Standard curves were plotted using the 
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standard values and the amount of active sphingomyelinase present in the samples was 
determined based on the standard curve. 
 
Small Interfering RNA Transfections and Inhibitor Treatments 
For siRNA transfections and silencing of smpd3, 1 × 106 of cortical neurons were plated 
in complete neurobasal medium, allowed to adhere overnight, and changed to half of 
the medium without FBS on next day. For the silencing of smpd3, specific siRNA (from 
Santa Cruz Biotechnologies, Inc.) were purchased and transfections were performed as 
per the manufacturer instructions and protocols. Cells were infected with ZIKV (MOI 5, 
at 72 h post-plating) and collected at 72 h p.i. Followed by RNA extractions and cDNA 
synthesis. The silencing efficiency of smpd3 was analyzed by QRT-PCR. For inhibition 
of exosome release from neuronal cells, the selective inhibitor (GW4869) was used for 
Neutral Sphingomyelinase 2 (nSMase2 or SMPD3) (Santa Cruz Biotechnologies, Inc.) 
dissolved in DMSO. Cytotoxicity of the inhibitor was first analyzed; Neurons did not 
show any toxicity at tested doses (of 1-20 μM). For inhibitor studies, neurons (2 × 105 
for RNA and 1 × 107 for protein extractions) were plated in complete neurobasal 
medium. Cortical neurons were treated with GW4869 inhibitor (5, 10 or 20 μM) for 4 h at 
72 h post-plating, followed by ZIKV infection (5 MOI) at indicated time points (24, 48 and 
72 h p.i., for both RNA and protein extractions). Cells treated with similar volume (the 
volume used was considered for 20-μM GW4869) of DMSO were considered as control 
groups. Viral loads were determined at all tested time points followed by QRT-PCR 
analysis. Both whole cells and exosomal lysates (30 μg) were processed for 
immunoblotting with 4G2 monoclonal antibody, followed by a secondary antibody to 
detect ZIKV E-protein. 
 
Statistics 
Using GraphPad Prism6 software and Microsoft Excel, the statistical significance of the 
difference observed in data sets were analyzed. Non-paired, two-tail Student t-test was 
used for the entire analysis. Error bars represent mean (+SD) values; P values of <0.05 
were considered significant in all analyses. Statistical tests and P values are indicated 




All animal work in this study was carried out in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the 
National Institute of Health. The approved protocol from the Institutional Animal Care 
and Use Committee (Animal Welfare Assurance Number: A3172-01) (permit number: 








Since it is poorly understood on molecular determinants and mechanisms of arthropod-
borne Flavivirus transmission from vector to the vertebrate, our studies have been 
focused on this direction. LGTV and ZIKV were used as experimental models and the 
results showed for the first time that a cell line from medically significant arthropods, 
such as ticks and mosquitoes, secrete Extracellular Vesicles (EVs) including exosomes 
that mediate transmission of Flavivirus RNA and proteins to the human cells. With 
transmission via exosomes, infectious organisms such as LGTV and ZIKV, could invade 
host immune response and directly infect neighboring cells by endocytosis, resulting in 
causing severe damage to the host. For example, the harmful effects of ZIKA virus 
(ZIKV) infection is reflected by severe neurological manifestations, including 
microcephaly in neonates and other complications associated with Guillain-Barré 
syndrome in adults. 
This study is the first to show that tick-borne Langat virus (LGTV), a model 
pathogen firmly related to tick-borne encephalitis virus (TBEV), profusely uses 
arthropod exosomes for the dissemination of viral material to the human-skin 
keratinocytes (HaCaT) and blood endothelial cells (HUVEC). Cryo-electron microscopy 
indicated the presence of purified arthropod/neurons-derived exosomes with the size 
range of 30 to 200 nm in diameter. Both positive- and negative-sense strands of LGTV 
RNA and viral envelope-protein were found inside exosomes derived from arthropod, 
murine and human cells. Detection of Nonstructural 1 (NS1) protein in arthropod and 
neuronal exosomes further indicated that exosomes enclose viral proteins. Viral RNA 
and proteins in exosomes derived from tick and mammalian cells were protected, highly 
infectious and replicative in all evaluations. Treatment with GW4869, a selective 
inhibitor that blocks exosome secretion, could affect LGTV loads in both arthropod and 
mammalian cell-derived exosomes. Trans-well-migration assays addressed that 
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exosomes derived from infected-brain-microvascular endothelial cells (served as the 
constitution of Blood-Brain Barrier) assisted LGTV RNA and protein transmission, 
crossing of the barriers and infection of neurons. The neuronal infection suggested 
abundant loads of both tick-borne Langat virus, LGTV and mosquito-borne West Nile 
virus RNA in exosomes. The result also indicated that exosome-mediated LGTV viral 
transmission is clathrin-dependent. This study provided a new mechanism of Flaviviral 
transmission and infection approach for researches to investigate and think about. It 
also provided a novel target, in the form of exosomes, and strategy to counter viral 
infection, pathogenesis and to develop a therapeutic treatment. 
The transmission dynamics of ZIKV in or between neuronal cells, or within the 
developing brains of the fetus are not fully understood. The second study showed that 
using primary cultures of murine cortical neurons, ZIKV could use exosomes as 
mediators of viral transmission to disseminate infectious viral materials between 
neurons. Cryo-electron microscopy showed a heterogeneous population of neuronal 
exosomes with a size range of 30-200 nm. Increased formation of exosomes from 
neuronal cells was obtained upon ZIKV infection. Neuronal exosomes enclosed both 
ZIKV viral RNA and protein(s) that were severe infectious to naïve cells. Studies 
implemented with RNase A and neutralizing antibodies treatment studies addressed the 
presence of viral material inside exosomes. Exosomes derived from time- and dose-
dependent incubations suggested increasing viral loads indicating increased packaging 
and delivery of ZIKV RNA and proteins.  
Furthermore, it was noted that ZIKV induced both activity and gene expression of 
neutral Sphingomyelinase (nSMase)-2/SMPD3, an important molecule that regulates 
the production and release of exosomes. The silencing of SMPD3 in neuronal cells 
resulted in decreased viral burden and transmission via exosomes. Treatment with 
SMPD3 specific inhibitor GW4869, magnificently decreased ZIKV loads in both cortical 
neuronal cells and in exosomes derived from these neurons. Overall, these data 
indicate that ZIKV mediates SMPD3 activity in cortical neuronal cells for its infection and 
transmission via exosomes, perhaps leading to harsh neuronal death that may result in 
neurological phenomenon such as microcephaly in the developing embryonic brains. 
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Overall, these studies indicated that flaviviruses use arthropod-derived exosomes 
or exosomes from vertebrate cells as a novel approaches for infectious viral RNA and 
protein transmission from the vector to the host and dissemination with the host, 
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